<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/">
<channel>


<title>健康醫療 - CNMA新聞聯合網</title>
<link>https://www.cnma.org.tw/page/news/index.aspx?root=15</link>
<description>CNMA新聞聯合網電子報 健康醫療</description>

<item>
<title><![CDATA[呼吸道疾病高峰將至！台中榮總推「人生大富翁」衛教展 籲提前接種疫苗防重症]]></title>
<description><![CDATA[<span style="font-size:20px;">記者黃士軒/健康醫療報導<br />
<br />
<br />
隨著10月呼吸道疾病高峰期將至，臺中榮總攜手台灣家庭醫學醫學會舉辦「人生大富翁：健康不走回頭路，疫苗提前先守護」巡迴展，提醒民眾提前建立流感、新冠、肺炎鏈球菌及呼吸道細胞融合病毒（RSV）等呼吸道疾病防護觀念，降低感染及重症風險。<br />
<img alt=""...…]]></description>
<content:encoded><![CDATA[<span style="font-size:20px;">記者黃士軒/健康醫療報導<br />
<br />
<br />
隨著10月呼吸道疾病高峰期將至，臺中榮總攜手台灣家庭醫學醫學會舉辦「人生大富翁：健康不走回頭路，疫苗提前先守護」巡迴展，提醒民眾提前建立流感、新冠、肺炎鏈球菌及呼吸道細胞融合病毒（RSV）等呼吸道疾病防護觀念，降低感染及重症風險。<br />
<img alt="" src="https://www.cnma.org.tw/upload/web/IMG_6002(1).jpeg" /><br />
臺中榮總家庭醫學部朱為民科主任指出，流感、新冠肺炎、肺炎鏈球菌及RSV是臨床常見的呼吸道疾病，近年感染風險逐漸呈現全年化，加上秋冬氣溫下降進入好發期，各年齡層都應及早做好防護。<br />
<br />
家庭醫學部林佑儒醫師表示，高齡者、慢性病患者及照護者屬於呼吸道疾病高風險族群，感染後較容易進一步發展為肺炎或重症，因此更應重視預防。<br />
<br />
此次「人生大富翁」巡迴展自9月14日至18日在臺中榮總展出，以「健康資產」為概念，透過衛教展板、大富翁關卡、情境遊戲及衛教影片等互動方式，讓民眾了解疫苗與疾病預防相關知識。<br />
<br />
臺中榮總家庭醫學部主任許碧珊表示，成人疫苗接種同樣重要，目前政府提供流感、新冠肺炎及肺炎鏈球菌等公費疫苗，符合資格者可善用資源，並與醫師討論個人健康狀況、感染風險及適合的接種時程。<br />
<br />
院方也提供「線上疫苗評估工具」，民眾輸入年齡及健康狀況，即可查詢相關接種建議，希望透過多元衛教方式，鼓勵民眾在呼吸道疾病流行季前及早做好準備，建立全齡健康防護網。</span>]]></content:encoded>
<link>https://www.cnma.org.tw/page/news/show.aspx?num=53839</link>
<pubDate>Wed, 16 Sep 2026 00:00:00 GMT</pubDate>
<category>健康醫療</category>
<enclosure url="https://www.cnma.org.tw/upload/news/202609161654380.jpeg" />
</item>
<item>
<title><![CDATA[減重吃Buffet先喝酒壓食慾？還想打「瘦瘦針」救急 醫師揭兩大迷思]]></title>
<description><![CDATA[<span style="font-size:20px;">記者陳秋蘭/健康醫療報導<br />
<br />
<br />
減重期間遇上親友生日Buffet，不少人擔心一餐吃到飽讓減重計畫破功，網路甚至流傳「先喝酒壓食慾」，或臨時施打俗稱「瘦瘦針」的GLP-1類減重藥物來降低食量。衛生福利部新營醫院家醫科醫師侯昂廷提醒，酒精並非可靠的抑制食慾方式，減重藥物也不是聚餐前臨時使用的「救急針」。...…]]></description>
<content:encoded><![CDATA[<span style="font-size:20px;">記者陳秋蘭/健康醫療報導<br />
<br />
<br />
減重期間遇上親友生日Buffet，不少人擔心一餐吃到飽讓減重計畫破功，網路甚至流傳「先喝酒壓食慾」，或臨時施打俗稱「瘦瘦針」的GLP-1類減重藥物來降低食量。衛生福利部新營醫院家醫科醫師侯昂廷提醒，酒精並非可靠的抑制食慾方式，減重藥物也不是聚餐前臨時使用的「救急針」。<br />
<img alt="" src="https://www.cnma.org.tw/upload/web/IMG_6045(1).jpeg" /><br />
侯昂廷指出，研究顯示，飲酒後並不會因攝取酒精熱量而自然減少下一餐食量。一篇納入22項研究、701名受試者的系統性回顧與統合分析發現，相較未飲酒者，飲酒後食物攝取平均增加約82大卡；若連同酒精本身計算，總熱量平均增加約256大卡。<br />
<img alt="" src="https://www.cnma.org.tw/upload/web/img_6046(2).jpeg" /><br />
侯昂廷表示，Buffet本身就是高誘惑、多選擇的飲食環境，炸物、烤肉、披薩到甜點種類繁多，容易不知不覺</span>]]></content:encoded>
<link>https://www.cnma.org.tw/page/news/show.aspx?num=53852</link>
<pubDate>Wed, 16 Sep 2026 00:00:00 GMT</pubDate>
<category>健康醫療</category>
<enclosure url="https://www.cnma.org.tw/upload/news/202609161720210.jpeg" />
</item>
<item>
<title><![CDATA[黃偉哲見證「生命重啟」 台南OHCA急救成功率8年提升至39.45%]]></title>
<description><![CDATA[<span style="font-size:22px;">記者黃冠源/台南報導 &nbsp; &nbsp; &nbsp; 台南市政府今（10）日下午於永華市政中心舉辦「生命重啟・救在當下」緊急救護成果發表記者會，市長黃偉哲親自出席，與OHCA（到院前心肺功能停止）、STEMI（急性心肌梗塞）康復者，以及醫療指導醫師和第一線緊急救護技術員（EMT），一同見證台南市的緊急救護成果。台南近年持續精進到...…]]></description>
<content:encoded><![CDATA[<span style="font-size:22px;">記者黃冠源/台南報導 &nbsp; &nbsp; &nbsp; 台南市政府今（10）日下午於永華市政中心舉辦「生命重啟・救在當下」緊急救護成果發表記者會，市長黃偉哲親自出席，與OHCA（到院前心肺功能停止）、STEMI（急性心肌梗塞）康復者，以及醫療指導醫師和第一線緊急救護技術員（EMT），一同見證台南市的緊急救護成果。台南近年持續精進到院前緊急救護量能，8年來OHCA急救成功率由27.53%提升至39.45%，已有超過650名患者經搶救後健康出院，展現緊急醫療救護體系持續精進的成果。<br />
<img alt="" src="https://www.cnma.org.tw/upload/web/0e4a0034.jpg" /><br />
黃偉哲表示，看到急救紀錄影片中，患者從生死一線被成功搶救回來，令人相當感動。過去8年，台南OHCA急救成功率由27.53%提升至39.45%，這些數字背後，代表的是一個個珍貴生命與家庭的延續。感謝第一線救護人員、消防及醫護團隊，在分秒必爭的關鍵時刻，以專業及經驗全力搶救，為患者爭取生機。<br />
<br />
黃偉哲指出，緊急救護除了市府持續投入經費與資源，也有民間力量共同支持，展現公私協力守護生命的成果。市府將持續精進OHCA及急性心肌梗塞等緊急救護量能，強化院前、院後救護銜接，持續提升急救成功率，守護市民生命安全。<br />
<img alt="" src="https://www.cnma.org.tw/upload/web/0e4a0078.jpg" /><br />
記者會當中，黃偉哲與康復者、救護及醫療人員共同點亮「生命之樹」，象徵生命在眾人接力守護下重新綻放，藉由台南緊急救護體系，為市民築起生命安全防線。<br />
<br />
消防局表示，台南市在109年啟動救護E化系統，提升救護資訊傳遞效率，同年全面建置12導程心電圖設備，強化院前心臟急症判斷能力。隨著相關措施逐步推動，12導程心電圖施作人數已成長5倍，第一線救護團隊也多次於國內外競賽獲獎。<br />
<img alt="" src="https://www.cnma.org.tw/upload/web/0E4A0008.jpg" /><br />
消防局指出，每一次救護出勤都是與時間賽跑，未來將持續精進救護科技、設備及人員專業能力，深化與醫療體系合作，強化院前與院內救護銜接，讓關鍵時間發揮最大救命效益，為患者爭取更多搶救機會。</span><br />
&nbsp;]]></content:encoded>
<link>https://www.cnma.org.tw/page/news/show.aspx?num=53728</link>
<pubDate>Thu, 10 Sep 2026 00:00:00 GMT</pubDate>
<category>健康醫療</category>
<enclosure url="https://www.cnma.org.tw/upload/news/202609102340330.jpg" />
</item>
<item>
<title><![CDATA[台南新樓醫院為東區莊敬里居民健康把關　深入社區建立預防勝於治療觀念]]></title>
<description><![CDATA[<span style="font-size:22px;">記者黃冠源/台南報導 &nbsp; &nbsp; &nbsp; 台南新樓醫院社區健康中心，在（5）日走進台南市東區莊敬里，在活動中心舉辦社區健康篩檢活動，將多元醫療服務帶到居民熟悉的生活場域，鼓勵民眾主動關心自身健康，透過定期篩檢及早發現健康風險，建立「預防勝於治療」的健康生活觀念，議員蔡筱薇也特地前往關心里民身體健檢的情況。<br />...…]]></description>
<content:encoded><![CDATA[<span style="font-size:22px;">記者黃冠源/台南報導 &nbsp; &nbsp; &nbsp; 台南新樓醫院社區健康中心，在（5）日走進台南市東區莊敬里，在活動中心舉辦社區健康篩檢活動，將多元醫療服務帶到居民熟悉的生活場域，鼓勵民眾主動關心自身健康，透過定期篩檢及早發現健康風險，建立「預防勝於治療」的健康生活觀念，議員蔡筱薇也特地前往關心里民身體健檢的情況。<br />
<img alt="" src="https://www.cnma.org.tw/upload/web/575313.jpg" /><br />
這次活動安排多項健康篩檢服務，包含血糖檢測、尿糖篩檢、尿蛋白檢測、尿潛血檢測、肌力檢測、骨密度檢測及動脈血管檢測等，透過多元檢測，協助居民從不同面向了解自身健康狀況，及早掌握可能存在的健康風險。<br />
<br />
除了身體健康檢查之外，此次活動也特別設置「心靈點滴站」，將心理健康關懷融入社區篩檢服務。透過簡單的心理健康評估、傾聽與交流，讓居民除了關注血壓、血糖、骨質及心血管等身體健康指標，也能停下腳步關心自己的情緒與心理狀態，從身體到心靈落實全人健康照護。<br />
<img alt="" src="https://www.cnma.org.tw/upload/web/575312.jpg" /><br />
活動當天吸引許多莊敬里居民前往參加，現場在工作人員引導下依序完成各項檢測，長者也把握機會接受肌力、骨密度及動脈血管等檢測，進一步了解自身身體功能與健康狀況。「心靈點滴站」則提供另一個溫暖的交流空間，讓民眾有機會透過傾聽與互動，更加關注平時容易被忽略的情緒與心理健康。<br />
<br />
台南新樓醫院社區健康中心温筱婕主任表示，社區健康篩檢不只是協助民眾發現疾病，更重要的是建立「主動關心健康」的觀念。許多慢性疾病在早期不一定會出現明顯症狀，而心理健康同樣需要被重視，因此透過醫療團隊走入社區，讓居民能就近接受身體與心理健康相關服務，降低健康照護的門檻。未來新樓醫院也將持續深入社區，依照居民需求推動更多元的健康促進與預防保健服務。<br />
<img alt="" src="https://www.cnma.org.tw/upload/web/575315.jpg" /><br />
莊敬里林志勲里長表示，健康是每個家庭都非常重視的事情，這次在里內舉辦健康篩檢，讓居民不用特別跑到醫院，就能在熟悉的活動中心接受多項檢查，也能透過「心靈點滴站」關心自己的心理狀態，對社區居民來說相當便利。感謝台南新樓醫院將專業醫療資源帶進莊敬里，也期待未來能持續合作，讓更多健康服務走進社區，陪伴里民一起維持健康、安心的生活。<br />
<br />
透過醫療專業與社區在地力量的結合，讓健康照護不再只是醫院裡的服務，而是走進居民日常生活的一部分。此次健康篩檢不僅協助居民掌握自身健康狀況，也將身體健康與心理關懷一併納入，期盼透過持續性的社區健康服務，讓居民從「被動就醫」逐步走向「主動健康管理」，共同打造健康、安心且充滿活力的高齡友善社區。</span>]]></content:encoded>
<link>https://www.cnma.org.tw/page/news/show.aspx?num=53688</link>
<pubDate>Mon, 07 Sep 2026 00:00:00 GMT</pubDate>
<category>健康醫療</category>
<enclosure url="https://www.cnma.org.tw/upload/news/202609072158320.jpg" />
</item>
<item>
<title><![CDATA[洗腎人口破9.7萬！偉喬生醫推硫酸吲哚酚檢測助攻腎病風險評估]]></title>
<description><![CDATA[<span style="font-size:20px;"></span><!--StartFragment-->
<p class="MsoNormal" style="text-align:justify;text-justify:inter-ideograph;
layout-grid-mode:char"><span style="font-family:&quot;微軟正黑體&quo...…]]></description>
<content:encoded><![CDATA[<span style="font-size:20px;"></span><!--StartFragment-->
<p class="MsoNormal" style="text-align:justify;text-justify:inter-ideograph;
layout-grid-mode:char"><span style="font-family:&quot;微軟正黑體&quot;,sans-serif">記者:楊憲朋 報導<br />
<br />
台灣長期背負「洗腎王國」惡名，根據最新統計資料顯示，國內洗腎人口已突破<span lang="EN-US">9.7</span>萬人大關，慢性腎臟病（<span lang="EN-US">CKD</span>）患者推估恐將突破<span lang="EN-US">300</span>萬人。隨著超高齡社會到來，中壯年的腎病危機與「心腎共病」正大幅推升死亡率，一旦合併心臟衰竭，罹患慢性腎病風險更高達<span lang="EN-US">5</span>成。其實腎病並非不治之症，防範病情惡化關鍵，早篩早治是重要策略之一。為了揪出潛藏共病未爆彈，國民健康署已擴大成人預防保健服務，但部分臨床數據顯示，傳統指標在特定族群中可能存在時間差，導致不少腎友錯失黃金治療期，如何精準評估腎功能與相關風險、揪出病灶成為當務之急。<span lang="EN-US"><o:p></o:p></span></span></p>

<p class="MsoNormal" style="text-align:justify;text-justify:inter-ideograph;
layout-grid-mode:char"><span lang="EN-US" style="font-family:&quot;微軟正黑體&quot;,sans-serif"><o:p></o:p></span></p>

<p class="MsoNormal" style="text-align:justify;text-justify:inter-ideograph;
layout-grid-mode:char"><b><span style="font-family:&quot;微軟正黑體&quot;,sans-serif">圖說：林軒任醫師指出，硫酸吲哚酚檢測可協助評估腎小管分泌與回收狀態，敏銳捕捉到毒素累積的蛛絲馬跡。（資料來源：偉喬生醫）</span></b><img src="../../upload/web/images/圖說：林軒任醫師指出，硫酸吲哚酚檢測可協助評估腎小管分泌與回收狀態，敏銳捕捉到毒素累積的蛛絲馬跡。（資料來源：偉喬生醫）.jpg" /><b><span style="font-family:&quot;微軟正黑體&quot;,sans-serif"><span lang="EN-US"><o:p></o:p></span></span></b></p>

<p class="MsoNormal" style="text-align:justify;text-justify:inter-ideograph;
layout-grid-mode:char"><span lang="EN-US" style="font-family:&quot;微軟正黑體&quot;,sans-serif"><o:p>&nbsp;</o:p></span></p>

<p class="MsoNormal" style="text-align:justify;text-justify:inter-ideograph;
layout-grid-mode:char"><span style="font-family:&quot;微軟正黑體&quot;,sans-serif">許多民眾常納悶，為何健檢報告的肌酸酐（<span lang="EN-US">Creatinine</span>）、尿素氮（<span lang="EN-US">BUN</span>）數值看似過關，但腎臟卻早已悄悄罷工？亞洲大學附屬醫院腹膜透析室主任林軒任將人體代謝機制，巧妙比喻為排泄公司，他解釋：「腎臟在變差的過程中，就像是員工過勞，當員工因為糖尿病、高血壓或老化少掉一半，產值就會跟著掉下來。」而傳統指標如腎絲球過濾率（<span lang="EN-US">GFR</span>）雖可呈現出公司產值，但卻無法精準預測體內究竟剩下多少員工，也就是腎元、腎小管仍有效運作。相比之下，<a name="_Hlk239341702">硫酸吲哚酚（<span lang="EN-US">Indoxyl Sulfate, IS</span>）指標可協助評估腎小管分泌與回收狀態，</a>敏銳捕捉到毒素累積的蛛絲馬跡。</span><b><span style="font-family:&quot;微軟正黑體&quot;,sans-serif;mso-bidi-font-family:微軟正黑體;color:black;
mso-themecolor:text1;mso-ansi-language:ZH-TW;mso-no-proof:yes"><o:p></o:p></span></b></p>

<p class="MsoNormal" style="text-align:justify;text-justify:inter-ideograph;
layout-grid-mode:char"><span lang="EN-US" style="font-family:&quot;微軟正黑體&quot;,sans-serif"><o:p>&nbsp;</o:p></span></p>

<p class="MsoNormal" style="text-align:justify;text-justify:inter-ideograph;
mso-line-height-alt:0pt"><b><span style="font-family:&quot;微軟正黑體&quot;,sans-serif;
mso-bidi-font-family:微軟正黑體;color:black;mso-themecolor:text1">圖說：除了檢視一般腎功能指數，搭配硫酸吲哚酚輔助評估，更是及早攔截心腎共病的重要關鍵。（資料來源：偉喬生醫）</span></b><img src="../../upload/web/images/圖說：除了檢視一般腎功能指數，搭配硫酸吲哚酚輔助評估，更是及早攔截心腎共病的重要關鍵。（資料來源：偉喬生醫）.jpg" /><b><span style="font-family:&quot;微軟正黑體&quot;,sans-serif;
mso-bidi-font-family:微軟正黑體;color:black;mso-themecolor:text1"><span lang="EN-US"><o:p></o:p></span></span></b></p>

<p class="MsoNormal" style="text-align:justify;text-justify:inter-ideograph;
layout-grid-mode:char"><span lang="EN-US" style="font-family:&quot;微軟正黑體&quot;,sans-serif"><o:p>&nbsp;</o:p></span></p>

<p class="MsoNormal" style="text-align:justify;text-justify:inter-ideograph;
layout-grid-mode:char"><span style="font-family:&quot;微軟正黑體&quot;,sans-serif">面對中重度腎病與洗腎患者困境，隱形尿毒素殘留更是致命隱憂。林軒任醫師坦言，「我們洗腎只能把血液中的水溶性毒素清出來，但像硫酸吲哚酚這類親蛋白尿毒素，洗淨效率非常差，無法單靠現有技術有效清除。」一旦毒素持續累積體內，極易引發心血管與腦血管病變，譬如心肌梗塞、心衰竭等嚴重併發症，大幅增加死亡機率。以往臨床醫師難以準確預測透析患者的潛在危機，如今透過硫酸吲哚酚等多項綜合指標，便能更具體掌握心血管風險程度，協助醫護人員及早介入並調整治療策略。<span lang="EN-US"><o:p></o:p></span></span></p>

<p class="MsoNormal" style="text-align:justify;text-justify:inter-ideograph;
layout-grid-mode:char"><span lang="EN-US" style="font-family:&quot;微軟正黑體&quot;,sans-serif"><o:p>&nbsp;</o:p></span></p>

<p class="MsoNormal" style="text-align:justify;text-justify:inter-ideograph;
mso-line-height-alt:0pt"><b><span style="font-family:&quot;微軟正黑體&quot;,sans-serif;
mso-bidi-font-family:微軟正黑體;color:black;mso-themecolor:text1">圖說：防範無聲的健康殺手，腎病精準檢測成為未來防護新趨勢。（資料來源：偉喬生醫）</span></b><img src="../../upload/web/images/圖說：防範無聲的健康殺手，腎病精準檢測成為未來防護新趨勢。（資料來源：偉喬生醫）.jpg" /><b><span style="font-family:&quot;微軟正黑體&quot;,sans-serif;
mso-bidi-font-family:微軟正黑體;color:black;mso-themecolor:text1"><span lang="EN-US"><o:p></o:p></span></span></b></p>

<p class="MsoNormal" style="text-align:justify;text-justify:inter-ideograph;
layout-grid-mode:char"><span lang="EN-US" style="font-family:&quot;微軟正黑體&quot;,sans-serif"><o:p>&nbsp;</o:p></span></p>

<p class="MsoNormal" style="text-align:justify;text-justify:inter-ideograph;
layout-grid-mode:char"><span style="font-family:&quot;微軟正黑體&quot;,sans-serif">防範無聲的健康殺手，單靠傳統常規指標早已不夠看，走向精準醫學才是未來防護趨勢。林軒任醫師也提到，門診常遇到腎友自認少吃肉就能控制病情，但實際上檢視肌酸酐、尿素氮或尿蛋白數值仍無法確認。「透過監控體內硫酸吲哚酚的濃度數值，不只能驗證病人的飲食控制成效，更能作為早期篩檢的關鍵指標，真正落實早篩早治的防線。」醫師呼籲，民眾應善加利用成人預防保健資源，<a name="_Hlk239341844">除了檢視一般腎功能指數，搭配檢測硫酸吲哚酚來輔助評估，更是及早攔截心腎共病的重要關鍵</a>。<span lang="EN-US"><o:p></o:p></span></span></p>

<p class="MsoNormal" style="text-align:justify;text-justify:inter-ideograph;
layout-grid-mode:char"><span lang="EN-US" style="font-family:&quot;微軟正黑體&quot;,sans-serif"><o:p>&nbsp;</o:p></span></p>

<p class="MsoNormal" style="mso-line-height-alt:0pt"><b><span style="font-family:
&quot;微軟正黑體&quot;,sans-serif">專家意見：<span lang="EN-US"><o:p></o:p></span></span></b></p>

<p class="MsoNormal" style="mso-line-height-alt:0pt"><b><span style="font-family:
&quot;微軟正黑體&quot;,sans-serif">腎臟科醫師怎麼看硫酸吲哚酚？<span lang="EN-US"> feat. </span>引人入腎 林軒任醫師<span lang="EN-US"><o:p></o:p></span></span></b></p>

<p class="MsoNormal" style="mso-line-height-alt:0pt"><span lang="EN-US"><a href="https://www.youtube.com/watch?v=neRLQNZnpZg"><b><span style="font-family:
&quot;微軟正黑體&quot;,sans-serif">https://www.youtube.com/watch?v=neRLQNZnpZg</span></b></a><o:p></o:p></span></p>

<p class="MsoNormal" style="mso-line-height-alt:0pt"><b><span style="font-family:
&quot;微軟正黑體&quot;,sans-serif">引人入腎 林軒任醫師衛教網站<span lang="EN-US"><o:p></o:p></span></span></b></p>

<p class="MsoNormal" style="mso-line-height-alt:0pt"><span lang="EN-US"><a href="https://drelilin.com/"><b><span style="font-family:&quot;微軟正黑體&quot;,sans-serif">https://drelilin.com/</span></b></a></span><b><span lang="EN-US" style="font-family:&quot;微軟正黑體&quot;,sans-serif"><o:p></o:p></span></b></p>

<p class="MsoNormal" style="mso-line-height-alt:0pt"><span lang="EN-US"><o:p>&nbsp;</o:p></span></p>

<p class="MsoNormal" style="mso-line-height-alt:0pt"><b><span lang="EN-US" style="font-family:&quot;微軟正黑體&quot;,sans-serif"><o:p>&nbsp;</o:p></span></b></p>

<p class="MsoNormal" style="mso-line-height-alt:0pt"><b><span style="font-family:
&quot;微軟正黑體&quot;,sans-serif;mso-bidi-font-family:微軟正黑體;color:black;mso-themecolor:text1">【偉喬生醫集團】<span lang="EN-US"><o:p></o:p></span></span></b></p>

<p class="MsoNormal" style="mso-line-height-alt:0pt"><b><span style="font-family:
&quot;微軟正黑體&quot;,sans-serif;mso-bidi-font-family:微軟正黑體;color:black;mso-themecolor:text1">創立年：<span lang="EN-US">2013</span>年<span lang="EN-US"><o:p></o:p></span></span></b></p>

<p class="MsoNormal" style="mso-line-height-alt:0pt"><b><span style="font-family:
&quot;微軟正黑體&quot;,sans-serif;mso-bidi-font-family:微軟正黑體;color:black;mso-themecolor:text1">創辦人：莊詠鈞、鄭又瑋<span lang="EN-US"><o:p></o:p></span></span></b></p>

<p class="MsoNormal" style="text-align:justify;text-justify:inter-ideograph;
mso-line-height-alt:0pt"><b><span style="font-family:&quot;微軟正黑體&quot;,sans-serif;
mso-bidi-font-family:微軟正黑體;color:black;mso-themecolor:text1">文字簡介：集團整合蛋白質與抗體製造，延伸布局臨床前試驗、自動化細胞株開發與健康照護服務，建構橫跨生技研發到應用端的完整產業鏈。母公司偉喬生醫提供高品質關鍵生物原料，全球首創自主研發體外檢測試劑組，輔助評估腎功能。旗下事業體包括錫德斯生醫科技，具備<span lang="EN-US">TAF</span>認證<span lang="EN-US">GLP</span>實驗室與多元疾病動物模式建置能力。生德奈生物科技以創新微流體技術，致力於高通量、智慧化的細胞株開發解決方案。偉盛達偉信藥局則提供全方面健康管理的一站式專業服務。<span lang="EN-US"><o:p></o:p></span></span></b></p>

<p class="MsoNormal" style="mso-line-height-alt:0pt"><b><span style="font-family:
&quot;微軟正黑體&quot;,sans-serif;mso-bidi-font-family:微軟正黑體;color:black;mso-themecolor:text1">品牌官網：</span></b><span lang="EN-US"><a href="https://www.leadgenebio.com/zh/about-us/index"><b><span style="font-family:&quot;微軟正黑體&quot;,sans-serif;mso-bidi-font-family:微軟正黑體">https://www.leadgenebio.com/zh/about-us/index</span></b></a></span><b><span lang="EN-US" style="font-family:&quot;微軟正黑體&quot;,sans-serif;mso-bidi-font-family:微軟正黑體;
color:black;mso-themecolor:text1"><o:p></o:p></span></b></p>
<!--EndFragment-->]]></content:encoded>
<link>https://www.cnma.org.tw/page/news/show.aspx?num=53645</link>
<pubDate>Sat, 05 Sep 2026 00:00:00 GMT</pubDate>
<category>健康醫療</category>
<enclosure url="https://www.cnma.org.tw/upload/news/202609050510400.jpg" />
</item>
<item>
<title><![CDATA[捐血有愛、用血有據！ 奇美醫院推動「明智用血」理念，攜手病家共創精準照護]]></title>
<description><![CDATA[<span style="font-size:20px;"></span><!--StartFragment-->
<p align="right" class="MsoNormal" style="margin-top:0cm;margin-right:-36.0pt;
margin-bottom:0cm;margin-left:-36.0pt;margin-bottom:.0001pt;m...…]]></description>
<content:encoded><![CDATA[<span style="font-size:20px;"></span><!--StartFragment-->
<p align="right" class="MsoNormal" style="margin-top:0cm;margin-right:-36.0pt;
margin-bottom:0cm;margin-left:-36.0pt;margin-bottom:.0001pt;mso-para-margin-top:
0cm;mso-para-margin-right:-3.0gd;mso-para-margin-bottom:0cm;mso-para-margin-left:
-3.0gd;mso-para-margin-bottom:.0001pt;text-align:right;layout-grid-mode:char;
word-break:break-all">記者:徐素秋 台南市報導</p>

<p class="MsoNormal" style="margin-top:6.0pt;mso-para-margin-top:.5gd;text-align:
justify;text-justify:inter-ideograph"><b style="mso-bidi-font-weight:normal"><span style="font-size:14.0pt;mso-bidi-font-size:12.0pt;font-family:&quot;微軟正黑體&quot;,sans-serif;
mso-ascii-font-family:Arial;mso-hansi-font-family:Arial;color:black;mso-color-alt:
windowtext;background:#FDE9D9"><br />
挽袖捐血、精準用血！奇美醫院推「明智用血」勇奪亞太永續銀獎</span></b><b style="mso-bidi-font-weight:normal"><span lang="EN-US" style="font-size:14.0pt;
mso-bidi-font-size:12.0pt;font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:
微軟正黑體;mso-bidi-font-family:&quot;Times New Roman&quot;;background:#FDE9D9"><o:p></o:p></span></b></p>
<!--StartFragment-->

<p align="right" class="MsoNormal" style="margin-top:0cm;margin-right:-36.0pt;
margin-bottom:0cm;margin-left:-36.0pt;margin-bottom:.0001pt;mso-para-margin-top:
0cm;mso-para-margin-right:-3.0gd;mso-para-margin-bottom:0cm;mso-para-margin-left:
-3.0gd;mso-para-margin-bottom:.0001pt;text-align:right;layout-grid-mode:char;
word-break:break-all"><span style="font-size:13.0pt;font-family:&quot;微軟正黑體&quot;,sans-serif;
mso-ascii-font-family:Arial;mso-hansi-font-family:Arial">奇美醫療財團法人奇美醫院醫務秘書、輸血委員會主委暨加護醫學部主治醫師</span><span style="font-size:13.0pt;font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:
微軟正黑體;mso-bidi-font-family:&quot;Times New Roman&quot;"> </span><span style="font-size:
13.0pt;font-family:&quot;微軟正黑體&quot;,sans-serif;mso-ascii-font-family:Arial;mso-hansi-font-family:
Arial">陳志金</span><span lang="EN-US" style="font-size:13.0pt;font-family:&quot;Arial&quot;,sans-serif;
mso-fareast-font-family:微軟正黑體;mso-bidi-font-family:&quot;Times New Roman&quot;"><o:p></o:p></span></p>
<!--EndFragment-->

<p class="MsoNormal" style="text-align:justify;text-justify:inter-ideograph;
text-indent:24.0pt;mso-char-indent-count:2.0;punctuation-wrap:simple"><span style="font-family:&quot;新細明體&quot;,serif;mso-ascii-font-family:Arial;mso-hansi-font-family:
Arial">面對夏季血庫頻傳吃緊，除了號召民眾熱血挽袖，醫療端該如何珍惜每一袋得來不易的血液資源？奇美醫療財團法人奇美醫院醫務秘書、輸血委員會主委暨加護醫學部主治醫師陳志金表示，正因為「每一袋血都是救命資源」，因此，奇美醫院推動「明智用血</span><span lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;mso-bidi-font-family:&quot;Times New Roman&quot;">(Choosing Wisely)</span><span style="font-family:&quot;新細明體&quot;,serif;mso-ascii-font-family:Arial;
mso-hansi-font-family:Arial">」行動，告別過去「血紅素越高越安全」的傳統迷思，提出「我需要輸血嗎？明智選擇，有</span><span lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;mso-bidi-font-family:&quot;Times New Roman&quot;">7</span><span style="font-family:&quot;新細明體&quot;,serif;mso-ascii-font-family:Arial;mso-hansi-font-family:
Arial">就好！」觀念，倡導病況穩定的住院成人血紅素</span><span lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;
mso-bidi-font-family:&quot;Times New Roman&quot;">(Hb)</span><span style="font-family:
&quot;新細明體&quot;,serif;mso-ascii-font-family:Arial;mso-hansi-font-family:Arial">低於</span><span lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;mso-bidi-font-family:&quot;Times New Roman&quot;">7 g/dL</span><span style="font-family:&quot;新細明體&quot;,serif;mso-ascii-font-family:Arial;
mso-hansi-font-family:Arial">時再評估輸血。透過大數據管理與「輕推</span><span lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;mso-bidi-font-family:&quot;Times New Roman&quot;">(Nudge)</span><span style="font-family:&quot;新細明體&quot;,serif;mso-ascii-font-family:Arial;mso-hansi-font-family:
Arial">」策略，在</span><span lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;
mso-bidi-font-family:&quot;Times New Roman&quot;">2025</span><span style="font-family:
&quot;新細明體&quot;,serif;mso-ascii-font-family:Arial;mso-hansi-font-family:Arial">年實現全院總血品用量較</span><span lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;mso-bidi-font-family:&quot;Times New Roman&quot;">2023</span><span style="font-family:&quot;新細明體&quot;,serif;mso-ascii-font-family:Arial;mso-hansi-font-family:
Arial">年大幅下降</span><span lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;
mso-bidi-font-family:&quot;Times New Roman&quot;">30%</span><span style="font-family:
&quot;新細明體&quot;,serif;mso-ascii-font-family:Arial;mso-hansi-font-family:Arial">的顯著成效，將珍貴血品留給急性大出血等真正危急的病人。這項結合實證醫學與永續管理的卓越成果，更榮獲「</span><span lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;mso-bidi-font-family:&quot;Times New Roman&quot;">2026 APSAA</span><span style="font-family:&quot;新細明體&quot;,serif;mso-ascii-font-family:Arial;
mso-hansi-font-family:Arial">亞太永續行動獎」</span><span lang="EN-US" style="font-family:
&quot;Arial&quot;,sans-serif;mso-bidi-font-family:&quot;Times New Roman&quot;">SDG 03</span><span style="font-family:&quot;新細明體&quot;,serif;mso-ascii-font-family:Arial;mso-hansi-font-family:
Arial">銀獎肯定，展現醫療品質與社會責任雙贏的優異範本。</span><span lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;
mso-bidi-font-family:&quot;Times New Roman&quot;"><o:p></o:p></span></p>

<p class="MsoNormal" style="margin-top:12.0pt;mso-para-margin-top:1.0gd;
text-align:justify;text-justify:inter-ideograph;punctuation-wrap:simple"><b style="mso-bidi-font-weight:normal"><span style="font-size:14.0pt;mso-bidi-font-size:
12.0pt;font-family:&quot;微軟正黑體&quot;,sans-serif;mso-ascii-font-family:Arial;mso-hansi-font-family:
Arial;color:black;mso-color-alt:windowtext;background:#FDE9D9">用數據與同儕提醒不強迫！「輕推」讓全院血品用量兩年大降三成</span></b><span lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;mso-bidi-font-family:&quot;Times New Roman&quot;"><o:p></o:p></span></p>

<p class="MsoNormal" style="text-align:justify;text-justify:inter-ideograph;
text-indent:24.0pt;mso-char-indent-count:2.0;punctuation-wrap:simple"><span style="font-family:&quot;新細明體&quot;,serif;mso-ascii-font-family:Arial;mso-hansi-font-family:
Arial">奇美醫院自</span><span lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;
mso-bidi-font-family:&quot;Times New Roman&quot;">2023</span><span style="font-family:
&quot;新細明體&quot;,serif;mso-ascii-font-family:Arial;mso-hansi-font-family:Arial">年底從冷凍沉澱血品著手，透過共識及視覺化回饋，讓醫療人員多問一句「真的需要嗎？」採取「輕推」策略，不以強制規定或禁止方式限制醫療決策，而是透過數據與同儕比較，協助醫師在適當時機做出更精準的用血選擇。</span><span lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;mso-bidi-font-family:&quot;Times New Roman&quot;">2025</span><span style="font-family:&quot;新細明體&quot;,serif;mso-ascii-font-family:Arial;mso-hansi-font-family:
Arial">年相較於</span><span lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;
mso-bidi-font-family:&quot;Times New Roman&quot;">2023</span><span style="font-family:
&quot;新細明體&quot;,serif;mso-ascii-font-family:Arial;mso-hansi-font-family:Arial">年，冷凍沉澱血品使用量下降超過</span><span lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;mso-bidi-font-family:&quot;Times New Roman&quot;">53%</span><span style="font-family:&quot;新細明體&quot;,serif;mso-ascii-font-family:Arial;mso-hansi-font-family:
Arial">、紅血球下降</span><span lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;
mso-bidi-font-family:&quot;Times New Roman&quot;">17%</span><span style="font-family:
&quot;新細明體&quot;,serif;mso-ascii-font-family:Arial;mso-hansi-font-family:Arial">、冷凍血漿下降</span><span lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;mso-bidi-font-family:&quot;Times New Roman&quot;">40%</span><span style="font-family:&quot;新細明體&quot;,serif;mso-ascii-font-family:Arial;mso-hansi-font-family:
Arial">、血小板下降</span><span lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;
mso-bidi-font-family:&quot;Times New Roman&quot;">16%</span><span style="font-family:
&quot;新細明體&quot;,serif;mso-ascii-font-family:Arial;mso-hansi-font-family:Arial">，全院血品總用量下降</span><span lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;mso-bidi-font-family:&quot;Times New Roman&quot;">30%</span><span style="font-family:&quot;新細明體&quot;,serif;mso-ascii-font-family:Arial;mso-hansi-font-family:
Arial">，成功改變臨床習慣。奇美醫療財團法人奇美醫院醫務秘書、輸血委員會主委暨加護醫學部主治醫師陳志金強調，這些數字不是「少做了多少醫療」，而是更精準地分辨什麼時候一定要做、什麼時候可以不做，讓有限的血液資源真正留給最需要的人。</span><span lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;mso-bidi-font-family:&quot;Times New Roman&quot;"><o:p></o:p></span></p>

<p class="MsoNormal" style="margin-top:12.0pt;mso-para-margin-top:1.0gd;
text-align:justify;text-justify:inter-ideograph;punctuation-wrap:simple"><b style="mso-bidi-font-weight:normal"><span style="font-size:14.0pt;mso-bidi-font-size:
12.0pt;font-family:&quot;微軟正黑體&quot;,sans-serif;mso-ascii-font-family:Arial;mso-hansi-font-family:
Arial;color:black;mso-color-alt:windowtext;background:#FDE9D9">明智用血不是「越少越好」，危急時刻該輸就要快</span></b><b style="mso-bidi-font-weight:normal"><span lang="EN-US" style="font-size:14.0pt;
mso-bidi-font-size:12.0pt;font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:
微軟正黑體;mso-bidi-font-family:&quot;Times New Roman&quot;;background:#FDE9D9"><o:p></o:p></span></b></p>

<p class="MsoNormal" style="text-align:justify;text-justify:inter-ideograph;
text-indent:24.0pt;mso-char-indent-count:2.0;punctuation-wrap:simple"><span style="font-family:&quot;新細明體&quot;,serif;mso-ascii-font-family:Arial;mso-hansi-font-family:
Arial">面對大量出血等緊急狀況，輸血是搶救生命的重要處置，不能因為推動明智用血而延誤。奇美醫院</span><span lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;mso-bidi-font-family:&quot;Times New Roman&quot;">2024</span><span style="font-family:&quot;新細明體&quot;,serif;mso-ascii-font-family:Arial;mso-hansi-font-family:
Arial">年導入可用於緊急大量出血的</span><span lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;
mso-bidi-font-family:&quot;Times New Roman&quot;">O</span><span style="font-family:&quot;新細明體&quot;,serif;
mso-ascii-font-family:Arial;mso-hansi-font-family:Arial">型低抗體力價全血，讓搶救時能更快補充病人所需的血液成分，爭取寶貴時間。奇美醫療財團法人奇美醫院醫務秘書、輸血委員會主委暨加護醫學部主治醫師陳志金表示，明智用血不是「越少越好」，而是「該給的不能少，該快的不能慢」。</span><span lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;mso-bidi-font-family:&quot;Times New Roman&quot;"><o:p></o:p></span></p>

<p class="MsoNormal" style="margin-top:12.0pt;mso-para-margin-top:1.0gd;
text-align:justify;text-justify:inter-ideograph;punctuation-wrap:simple"><b style="mso-bidi-font-weight:normal"><span style="font-size:14.0pt;mso-bidi-font-size:
12.0pt;font-family:&quot;微軟正黑體&quot;,sans-serif;mso-ascii-font-family:Arial;mso-hansi-font-family:
Arial;color:black;mso-color-alt:windowtext;background:#FDE9D9">從術前準備到自體血回收，讓病人有機會少用甚至不用輸血</span></b><b style="mso-bidi-font-weight:normal"><span lang="EN-US" style="font-size:14.0pt;
mso-bidi-font-size:12.0pt;font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:
微軟正黑體;mso-bidi-font-family:&quot;Times New Roman&quot;;background:#FDE9D9"><o:p></o:p></span></b></p>

<p class="MsoNormal" style="text-align:justify;text-justify:inter-ideograph;
text-indent:24.0pt;mso-char-indent-count:2.0;punctuation-wrap:simple"><span style="font-family:&quot;新細明體&quot;,serif;mso-ascii-font-family:Arial;mso-hansi-font-family:
Arial">除了改善血品使用，奇美醫院也從治療流程前端著手，讓部分病人有機會「不必走到輸血這一步」。今年</span><span lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;mso-bidi-font-family:&quot;Times New Roman&quot;">3</span><span style="font-family:&quot;新細明體&quot;,serif;mso-ascii-font-family:Arial;mso-hansi-font-family:
Arial">月，一名</span><span lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;
mso-bidi-font-family:&quot;Times New Roman&quot;">68</span><span style="font-family:&quot;新細明體&quot;,serif;
mso-ascii-font-family:Arial;mso-hansi-font-family:Arial">歲心臟病病人接受冠狀動脈繞道手術，團隊透過手術前準備、精準麻醉、即時監測、減少失血與回收自體血液等方式，全程沒有使用別人的血，病人術後第</span><span lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;mso-bidi-font-family:&quot;Times New Roman&quot;">4</span><span style="font-family:&quot;新細明體&quot;,serif;mso-ascii-font-family:Arial;mso-hansi-font-family:
Arial">天即可自行步行出院。奇美醫療財團法人奇美醫院醫務秘書、輸血委員會主委暨加護醫學部主治醫師陳志金指出，這個案例也說明，減少輸血不代表少照顧，而是透過更完整的術前規劃與精準治療，在確保病人安全的前提下，降低對血液資源的依賴。</span><span lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;mso-bidi-font-family:&quot;Times New Roman&quot;"><o:p></o:p></span></p>

<p class="MsoNormal" style="margin-top:12.0pt;mso-para-margin-top:1.0gd;
text-align:justify;text-justify:inter-ideograph;punctuation-wrap:simple"><b style="mso-bidi-font-weight:normal"><span style="font-size:14.0pt;mso-bidi-font-size:
12.0pt;font-family:&quot;微軟正黑體&quot;,sans-serif;mso-ascii-font-family:Arial;mso-hansi-font-family:
Arial;color:black;mso-color-alt:windowtext;background:#FDE9D9">「有</span></b><b style="mso-bidi-font-weight:normal"><span lang="EN-US" style="font-size:14.0pt;
mso-bidi-font-size:12.0pt;font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:
微軟正黑體;mso-bidi-font-family:&quot;Times New Roman&quot;;color:black;mso-color-alt:windowtext;
background:#FDE9D9">7</span></b><b style="mso-bidi-font-weight:normal"><span style="font-size:14.0pt;mso-bidi-font-size:12.0pt;font-family:&quot;微軟正黑體&quot;,sans-serif;
mso-ascii-font-family:Arial;mso-hansi-font-family:Arial;color:black;mso-color-alt:
windowtext;background:#FDE9D9">就好」不是死守數字，關鍵是看病人、不只看報告</span></b><b style="mso-bidi-font-weight:normal"><span lang="EN-US" style="font-size:14.0pt;
mso-bidi-font-size:12.0pt;font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:
微軟正黑體;mso-bidi-font-family:&quot;Times New Roman&quot;;background:#FDE9D9"><o:p></o:p></span></b></p>

<p class="MsoNormal" style="text-align:justify;text-justify:inter-ideograph;
text-indent:24.0pt;mso-char-indent-count:2.0;punctuation-wrap:simple"><span style="font-family:&quot;新細明體&quot;,serif;mso-ascii-font-family:Arial;mso-hansi-font-family:
Arial">奇美醫院今年進一步將明智用血的重點擴大到臨床最常使用的紅血球，並以民眾容易理解的「我需要輸血嗎？明智選擇，有</span><span lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;mso-bidi-font-family:&quot;Times New Roman&quot;">7</span><span style="font-family:&quot;新細明體&quot;,serif;mso-ascii-font-family:Arial;mso-hansi-font-family:
Arial">就好！」作為溝通主題。對大多數病況穩定的住院成人而言，血紅素</span><span lang="EN-US" style="font-family:
&quot;Arial&quot;,sans-serif;mso-bidi-font-family:&quot;Times New Roman&quot;">(Hemoglobin</span><span style="font-family:&quot;新細明體&quot;,serif;mso-ascii-font-family:Arial;mso-hansi-font-family:
Arial">，</span><span lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;
mso-bidi-font-family:&quot;Times New Roman&quot;">Hb)</span><span style="font-family:
&quot;新細明體&quot;,serif;mso-ascii-font-family:Arial;mso-hansi-font-family:Arial">低於</span><span lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;mso-bidi-font-family:&quot;Times New Roman&quot;">7 g/dL</span><span style="font-family:&quot;新細明體&quot;,serif;mso-ascii-font-family:Arial;
mso-hansi-font-family:Arial">時，才需要進一步考慮輸血，但是否輸血仍需綜合評估病人的症狀、是否持續出血及整體病況。奇美醫療財團法人奇美醫院醫務秘書、輸血委員會主委暨加護醫學部主治醫師陳志金呼籲，「</span><span lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;mso-bidi-font-family:&quot;Times New Roman&quot;">7</span><span style="font-family:&quot;新細明體&quot;,serif;mso-ascii-font-family:Arial;mso-hansi-font-family:
Arial">」並非所有病人都適用的絕對標準，也不是代表血紅素</span><span lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;
mso-bidi-font-family:&quot;Times New Roman&quot;">7</span><span style="font-family:&quot;新細明體&quot;,serif;
mso-ascii-font-family:Arial;mso-hansi-font-family:Arial">以上就不能輸血，而是希望民眾理解，輸血不能只看檢驗值，更要回到病人本身。若遇大量出血、血壓不穩、嚴重缺氧或有其他危急狀況，仍應由醫療團隊依臨床狀況及時處理。</span><span lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;mso-bidi-font-family:&quot;Times New Roman&quot;"><o:p></o:p></span></p>

<p class="MsoNormal" style="margin-top:12.0pt;mso-para-margin-top:1.0gd;
text-align:justify;text-justify:inter-ideograph;punctuation-wrap:simple"><b style="mso-bidi-font-weight:normal"><span style="font-size:14.0pt;mso-bidi-font-size:
12.0pt;font-family:&quot;微軟正黑體&quot;,sans-serif;mso-ascii-font-family:Arial;mso-hansi-font-family:
Arial;color:black;mso-color-alt:windowtext;background:#FDE9D9">盼「明智用血」走出醫院，讓民眾也能問一句「真的需要嗎？」</span></b><b style="mso-bidi-font-weight:normal"><span lang="EN-US" style="font-size:14.0pt;
mso-bidi-font-size:12.0pt;font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:
微軟正黑體;mso-bidi-font-family:&quot;Times New Roman&quot;;background:#FDE9D9"><o:p></o:p></span></b></p>

<p class="MsoNormal" style="text-align:justify;text-justify:inter-ideograph;
text-indent:24.0pt;mso-char-indent-count:2.0;punctuation-wrap:simple"><span style="font-family:&quot;新細明體&quot;,serif;mso-ascii-font-family:Arial;mso-hansi-font-family:
Arial">為將專業的實證醫學轉化為大眾聽得懂的語言，奇美醫院於今年</span><span lang="EN-US" style="font-family:
&quot;Arial&quot;,sans-serif;mso-bidi-font-family:&quot;Times New Roman&quot;">7</span><span style="font-family:&quot;新細明體&quot;,serif;mso-ascii-font-family:Arial;mso-hansi-font-family:
Arial">月</span><span lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;
mso-bidi-font-family:&quot;Times New Roman&quot;">17</span><span style="font-family:&quot;新細明體&quot;,serif;
mso-ascii-font-family:Arial;mso-hansi-font-family:Arial">日舉辦全院超過</span><span lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;mso-bidi-font-family:&quot;Times New Roman&quot;">100</span><span style="font-family:&quot;新細明體&quot;,serif;mso-ascii-font-family:Arial;mso-hansi-font-family:
Arial">人參與「明智用血</span><span lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;
mso-bidi-font-family:&quot;Times New Roman&quot;">(Choosing Wisely)</span><span style="font-family:&quot;新細明體&quot;,serif;mso-ascii-font-family:Arial;mso-hansi-font-family:
Arial">啟動大會」，將推廣重點由醫療人員延伸至民眾。奇美醫院也設計專屬網頁與</span><span lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;mso-bidi-font-family:&quot;Times New Roman&quot;">QR Code</span><span style="font-family:&quot;新細明體&quot;,serif;mso-ascii-font-family:Arial;
mso-hansi-font-family:Arial">，讓民眾用手機就能了解何時需要輸血、何時可先觀察或治療貧血，也可以回答簡單問題、留下自己的疑問與建議。奇美醫療財團法人奇美醫院醫務秘書、輸血委員會主委暨加護醫學部主治醫師陳志金表示，希望藉此促進醫病溝通，讓民眾擁有充足資訊，可以和醫療團隊一起討論「這項治療真的適合我嗎？」，共同為健康把關。</span><span lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;mso-bidi-font-family:&quot;Times New Roman&quot;"><o:p></o:p></span></p>

<p class="MsoNormal" style="margin-top:12.0pt;mso-para-margin-top:1.0gd;
text-align:justify;text-justify:inter-ideograph;punctuation-wrap:simple"><b style="mso-bidi-font-weight:normal"><span style="font-size:14.0pt;mso-bidi-font-size:
12.0pt;font-family:&quot;微軟正黑體&quot;,sans-serif;mso-ascii-font-family:Arial;mso-hansi-font-family:
Arial;color:black;mso-color-alt:windowtext;background:#FDE9D9">捐血是社會的信任，明智用血是醫療的承諾</span></b><b style="mso-bidi-font-weight:normal"><span lang="EN-US" style="font-size:14.0pt;
mso-bidi-font-size:12.0pt;font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:
微軟正黑體;mso-bidi-font-family:&quot;Times New Roman&quot;;background:#FDE9D9"><o:p></o:p></span></b></p>

<p class="MsoNormal" style="text-align:justify;text-justify:inter-ideograph;
text-indent:24.0pt;mso-char-indent-count:2.0;punctuation-wrap:simple"><span style="font-family:&quot;新細明體&quot;,serif;mso-ascii-font-family:Arial;mso-hansi-font-family:
Arial">奇美醫療財團法人奇美醫院醫務秘書、輸血委員會主委暨加護醫學部主治醫師陳志金提醒，血液無法人工製造，從民眾捐血後，還須經過檢驗、製備及調度，才能送到醫療現場。血庫不足是整個社會共同面對的問題，民眾願意挽袖捐血，醫院也應該珍惜每一袋血。「該輸的，一袋都不能少；不需要的，一袋也不要多。需要時，全力以赴；不需要時，有勇氣不做。」從一袋血開始，奇美醫院期待讓明智用血</span><span lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;mso-bidi-font-family:&quot;Times New Roman&quot;">(Choosing Wisely)</span><span style="font-family:&quot;新細明體&quot;,serif;mso-ascii-font-family:Arial;
mso-hansi-font-family:Arial">從醫院內的品質改善，變成病人、醫療人員與社會共同參與的行動。</span><span lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;mso-bidi-font-family:&quot;Times New Roman&quot;"><o:p></o:p></span></p>
<!--EndFragment--><img src="../../upload/web/images/捐血有愛、用血有據！奇美醫院推動「明智用血」理念，攜手病家共創精準照護.jpg" />]]></content:encoded>
<link>https://www.cnma.org.tw/page/news/show.aspx?num=53634</link>
<pubDate>Fri, 04 Sep 2026 00:00:00 GMT</pubDate>
<category>健康醫療</category>
<enclosure url="https://www.cnma.org.tw/upload/news/202609040420080.jpg" />
</item>
<item>
<title><![CDATA[血糖控制不佳別硬撐 醫：適時使用胰島素有助穩定控糖]]></title>
<description><![CDATA[<span style="font-size:20px;">記者李宥漮/健康醫療報導<br />
<br />
<br />
不少糖尿病患者聽到「打胰島素」便心生抗拒，擔心一旦開始就得終身施打。台南市立安南醫院新陳代謝科醫師張嘉裕表示，胰島素並非糖尿病治療的「最後一步」，對血糖明顯偏高或口服藥控制不佳的患者，適時使用反而有助快速穩定血糖，後續也能依控制情況調整治療。<br />
<img ...…]]></description>
<content:encoded><![CDATA[<span style="font-size:20px;">記者李宥漮/健康醫療報導<br />
<br />
<br />
不少糖尿病患者聽到「打胰島素」便心生抗拒，擔心一旦開始就得終身施打。台南市立安南醫院新陳代謝科醫師張嘉裕表示，胰島素並非糖尿病治療的「最後一步」，對血糖明顯偏高或口服藥控制不佳的患者，適時使用反而有助快速穩定血糖，後續也能依控制情況調整治療。<br />
<img alt="" src="https://www.cnma.org.tw/upload/web/IMG_5373.jpeg" /><br />
54歲翁小姐因視力模糊就醫，檢查發現糖化血色素（HbA1c）高達11.4%，餐後血糖超過300 mg/dL，並出現微量蛋白尿。經採取胰島素救援治療，搭配口服降血糖藥物及基礎型胰島素，半年後HbA1c降至約7%，空腹血糖也逐漸穩定，之後經醫師評估停用胰島素，改以口服藥物持續控制。<br />
<br />
張嘉裕指出，新診斷糖尿病患者若血糖嚴重超標，單靠口服藥物可能需要較長時間才能改善，適時使用胰島素可降低高血糖對身體造成的負擔。待血糖穩定後，部分患者可逐步減量甚至停用，並非「一打就回不去」。<br />
<br />
另有一名69歲蔡女士罹患糖尿病約8年，長期使用多種口服降血糖藥物，HbA1c仍達9.2%。醫師評估後加入低劑量基礎型胰島素，12個月後HbA1c降至約7%，空腹血糖也明顯改善。<br />
<br />
張嘉裕表示，目前糖尿病治療包括口服降血糖藥、腸泌素類藥物及胰島素等，應依患者年齡、體型、病程、血糖型態及共病情況個別評估。若長期血糖偏高或使用多種藥物仍未達標，應及早與醫師討論治療策略，避免增加腎臟、眼睛、神經及心血管等併發症風險。</span>]]></content:encoded>
<link>https://www.cnma.org.tw/page/news/show.aspx?num=53600</link>
<pubDate>Thu, 03 Sep 2026 00:00:00 GMT</pubDate>
<category>健康醫療</category>
<enclosure url="https://www.cnma.org.tw/upload/news/202609031341190.jpeg" />
</item>
<item>
<title><![CDATA[亂用瘦瘦針險送命！婦人昏厥送醫，查出癌症多處轉移]]></title>
<description><![CDATA[<span style="font-size:16px;">記者:楊憲朋 台南市報導</span><br />
<br />
<!--StartFragment-->
<p align="center" class="MsoNormal" style="text-align:center;layout-grid-mode:char"><b style="mso-bidi-font-weigh...…]]></description>
<content:encoded><![CDATA[<span style="font-size:16px;">記者:楊憲朋 台南市報導</span><br />
<br />
<!--StartFragment-->
<p align="center" class="MsoNormal" style="text-align:center;layout-grid-mode:char"><b style="mso-bidi-font-weight:normal"><span style="font-size:16.0pt;mso-bidi-font-size:
13.5pt;font-family:&quot;微軟正黑體&quot;,sans-serif;mso-ascii-font-family:Arial;mso-hansi-font-family:
Arial">奇美醫院提「三不原則」，個人化團隊助民眾安全瘦身</span></b><b style="mso-bidi-font-weight:normal"><span lang="EN-US" style="font-size:16.0pt;mso-bidi-font-size:13.5pt;font-family:&quot;Arial&quot;,sans-serif;
mso-fareast-font-family:微軟正黑體;mso-bidi-font-family:&quot;Times New Roman&quot;"><o:p></o:p></span></b></p>

<p class="MsoNormal" style="layout-grid-mode:char"><b style="mso-bidi-font-weight:
normal"><span lang="EN-US" style="mso-bidi-font-size:16.0pt;font-family:&quot;Arial&quot;,sans-serif;
mso-fareast-font-family:微軟正黑體;mso-bidi-font-family:&quot;Times New Roman&quot;;
mso-fareast-language:ZH-HK"><o:p>&nbsp;</o:p></span></b></p>

<p align="right" class="MsoNormal" style="text-align:right;layout-grid-mode:char;
word-break:break-all"><span style="font-size:13.0pt;font-family:&quot;微軟正黑體&quot;,sans-serif;
mso-ascii-font-family:Arial;mso-hansi-font-family:Arial">奇美醫療財團法人奇美醫院內分泌新陳代謝科主治醫師</span><span style="font-size:13.0pt;font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:
微軟正黑體;mso-bidi-font-family:&quot;Times New Roman&quot;"> </span><span style="font-size:
13.0pt;font-family:&quot;微軟正黑體&quot;,sans-serif;mso-ascii-font-family:Arial;mso-hansi-font-family:
Arial">黃偉輔</span><span lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;
mso-bidi-font-family:&quot;Times New Roman&quot;"><o:p></o:p></span></p>

<p class="MsoNormal" style="margin-top:6.0pt;mso-para-margin-top:.5gd;text-align:
justify;text-justify:inter-ideograph;punctuation-wrap:simple"><b style="mso-bidi-font-weight:normal"><span style="font-family:&quot;微軟正黑體&quot;,sans-serif;
mso-ascii-font-family:Arial;mso-hansi-font-family:Arial;color:black;mso-color-alt:
windowtext;background:#D9D9D9;mso-shading:white;mso-pattern:gray-15 auto">【瘦瘦針聲量大增，但用錯人、用錯方法，代價可能是延誤癌症的診斷！】</span></b><b style="mso-bidi-font-weight:normal"><span lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;
mso-fareast-font-family:微軟正黑體;mso-bidi-font-family:&quot;Times New Roman&quot;;
background:#D9D9D9;mso-shading:white;mso-pattern:gray-15 auto"><o:p></o:p></span></b></p>

<p class="MsoNormal" style="text-align:justify;text-justify:inter-ideograph;
text-indent:24.0pt;mso-char-indent-count:2.0;punctuation-wrap:simple"><span style="font-family:標楷體;mso-ascii-font-family:Arial;mso-hansi-font-family:Arial">案例：『一名</span><span lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:標楷體;
mso-bidi-font-family:&quot;Times New Roman&quot;">50</span><span style="font-family:標楷體;
mso-ascii-font-family:Arial;mso-hansi-font-family:Arial">多歲女性，原本沒有慢性病史，身高約</span><span lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:Arial">160</span><span style="font-family:標楷體;mso-ascii-font-family:Arial;mso-hansi-font-family:Arial">公分、體重約</span><span lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:標楷體;
mso-bidi-font-family:&quot;Times New Roman&quot;">60</span><span style="font-family:標楷體;
mso-ascii-font-family:Arial;mso-hansi-font-family:Arial">公斤。因追求減重效果，今</span><span lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:標楷體;
mso-bidi-font-family:&quot;Times New Roman&quot;">(115)</span><span style="font-family:
標楷體;mso-ascii-font-family:Arial;mso-hansi-font-family:Arial">年</span><span lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:標楷體;
mso-bidi-font-family:&quot;Times New Roman&quot;">1</span><span style="font-family:標楷體;
mso-ascii-font-family:Arial;mso-hansi-font-family:Arial">月起透過網路購得未經醫師處方的瘦瘦針，每週自行施打</span><span lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:標楷體;
mso-bidi-font-family:&quot;Times New Roman&quot;">2.5</span><span style="font-family:
標楷體;mso-ascii-font-family:Arial;mso-hansi-font-family:Arial">毫克。她其實並不符合用藥適應症，連續施打</span><span lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:標楷體;
mso-bidi-font-family:&quot;Times New Roman&quot;">3</span><span style="font-family:標楷體;
mso-ascii-font-family:Arial;mso-hansi-font-family:Arial">個月後，不但體重沒有下降，僅出現輕微嘔吐，卻仍在</span><span lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:標楷體;
mso-bidi-font-family:&quot;Times New Roman&quot;">4</span><span style="font-family:標楷體;
mso-ascii-font-family:Arial;mso-hansi-font-family:Arial">月底自行將劑量增加到</span><span lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:標楷體;
mso-bidi-font-family:&quot;Times New Roman&quot;">3.75</span><span style="font-family:
標楷體;mso-ascii-font-family:Arial;mso-hansi-font-family:Arial">毫克。</span><span lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:標楷體;
mso-bidi-font-family:&quot;Times New Roman&quot;"><o:p></o:p></span></p>

<p class="MsoNormal" style="margin-top:12.0pt;mso-para-margin-top:1.0gd;
text-align:justify;text-justify:inter-ideograph;text-indent:24.0pt;mso-char-indent-count:
2.0;punctuation-wrap:simple"><span style="font-family:標楷體;mso-ascii-font-family:
Arial;mso-hansi-font-family:Arial">在最後一次施打後，開始出現持續性噁心、嘔吐及食慾極差，症狀愈發嚴重。由於她從未向醫師透漏自己正在施打瘦瘦針，期間多次至診所及急診就醫，卻被認為是急性腸胃炎或藥物副作用，未能及時找出真正病因。</span><span lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:標楷體;
mso-bidi-font-family:&quot;Times New Roman&quot;"><o:p></o:p></span></p>

<p class="MsoNormal" style="margin-top:12.0pt;mso-para-margin-top:1.0gd;
text-align:justify;text-justify:inter-ideograph;text-indent:24.0pt;mso-char-indent-count:
2.0;punctuation-wrap:simple"><span style="font-family:標楷體;mso-ascii-font-family:
Arial;mso-hansi-font-family:Arial">直到</span><span lang="EN-US" style="font-family:
&quot;Arial&quot;,sans-serif;mso-fareast-font-family:標楷體;mso-bidi-font-family:&quot;Times New Roman&quot;">6</span><span style="font-family:標楷體;mso-ascii-font-family:Arial;mso-hansi-font-family:Arial">月初，她因短暫意識喪失被送到奇美醫療財團法人奇美醫院急診，檢查發現低血鈉、低血鉀併心電圖</span><span lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:標楷體;
mso-bidi-font-family:&quot;Times New Roman&quot;">QT</span><span style="font-family:標楷體;
mso-ascii-font-family:Arial;mso-hansi-font-family:Arial">間期延長。住院後，腹脹與嘔吐仍持續，經安排胃鏡、腹部電腦斷層、磁振造影及切片檢查，最終確診為胃癌及膽囊腺癌合併胃出口阻塞，並已轉移至肝臟、腎上腺、淋巴結與肺部。』</span><span lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:標楷體;
mso-bidi-font-family:&quot;Times New Roman&quot;"><o:p></o:p></span></p>

<p class="MsoNormal" style="margin-top:12.0pt;mso-para-margin-top:1.0gd;
text-align:justify;text-justify:inter-ideograph;text-indent:24.0pt;mso-char-indent-count:
2.0;punctuation-wrap:simple"><span style="font-family:&quot;新細明體&quot;,serif;mso-ascii-font-family:
Arial;mso-hansi-font-family:Arial">奇美醫療財團法人奇美醫院內分泌新陳代謝科主治醫師黃偉輔表示，這起案例最值得警惕之處，在於病人停用瘦瘦針近一個月後，症狀不但沒有緩解，反而持續惡化。當症狀與藥物作用時間明顯不符時，就不該再歸咎於藥物，必須積極尋找其他原因。最終證實，病人持續嘔吐的真正原因並非瘦瘦針，而是腫瘤造成胃出口阻塞。若持續將症狀視為藥物副作用，癌症診斷恐將進一步延誤。此案例也凸顯民眾切勿自行購買處方藥物，並應於就醫時主動告知所有用藥資訊，才能協助醫師做出正確判斷，避免錯失治療時機。</span><span lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:標楷體;
mso-bidi-font-family:&quot;Times New Roman&quot;"><o:p></o:p></span></p>

<p class="MsoNormal" style="margin-top:12.0pt;mso-para-margin-top:1.0gd;
text-align:justify;text-justify:inter-ideograph;punctuation-wrap:simple"><b style="mso-bidi-font-weight:normal"><span style="font-size:14.0pt;mso-bidi-font-size:
12.0pt;font-family:&quot;微軟正黑體&quot;,sans-serif;mso-ascii-font-family:Arial;mso-hansi-font-family:
Arial;color:black;mso-color-alt:windowtext;background:#FDE9D9;mso-shading-themecolor:
accent6;mso-shading-themetint:51">瘦得快不等於瘦得安全，「瘦瘦針」須正確使用</span></b><b style="mso-bidi-font-weight:normal"><span lang="EN-US" style="font-size:14.0pt;
mso-bidi-font-size:12.0pt;font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:
微軟正黑體;mso-bidi-font-family:&quot;Times New Roman&quot;;background:#FDE9D9;mso-shading-themecolor:
accent6;mso-shading-themetint:51"><o:p></o:p></span></b></p>

<p class="MsoNormal" style="text-align:justify;text-justify:inter-ideograph;
text-indent:24.0pt;mso-char-indent-count:2.0;punctuation-wrap:simple"><span style="font-family:&quot;新細明體&quot;,serif;mso-ascii-font-family:Arial;mso-hansi-font-family:
Arial">世界衛生組織統計，</span><span lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;
mso-bidi-font-family:&quot;Times New Roman&quot;">2022</span><span style="font-family:
&quot;新細明體&quot;,serif;mso-ascii-font-family:Arial;mso-hansi-font-family:Arial">年全球約有</span><span lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;mso-bidi-font-family:&quot;Times New Roman&quot;">25</span><span style="font-family:&quot;新細明體&quot;,serif;mso-ascii-font-family:Arial;mso-hansi-font-family:
Arial">億成人過重、其中</span><span lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;
mso-bidi-font-family:&quot;Times New Roman&quot;">8.9</span><span style="font-family:
&quot;新細明體&quot;,serif;mso-ascii-font-family:Arial;mso-hansi-font-family:Arial">億人已達肥胖標準；在臺灣，依據</span><span lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;mso-bidi-font-family:&quot;Times New Roman&quot;">2023</span><span style="font-family:&quot;新細明體&quot;,serif;mso-ascii-font-family:Arial;mso-hansi-font-family:
Arial">年「台灣成人肥胖防治實證指引」第二版，成人過重及肥胖盛行率已超過五成。肥胖不只是外觀或體重計上的數字，大型追蹤研究顯示，</span><span lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;mso-bidi-font-family:&quot;Times New Roman&quot;">BMI</span><span style="font-family:&quot;新細明體&quot;,serif;mso-ascii-font-family:Arial;mso-hansi-font-family:
Arial">介於</span><span lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;
mso-bidi-font-family:&quot;Times New Roman&quot;">30</span><span style="font-family:&quot;新細明體&quot;,serif;
mso-ascii-font-family:Arial;mso-hansi-font-family:Arial">至</span><span lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;mso-bidi-font-family:&quot;Times New Roman&quot;">35</span><span style="font-family:&quot;新細明體&quot;,serif;mso-ascii-font-family:Arial;mso-hansi-font-family:
Arial">者平均壽命約減少</span><span lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;
mso-bidi-font-family:&quot;Times New Roman&quot;">2</span><span style="font-family:&quot;新細明體&quot;,serif;
mso-ascii-font-family:Arial;mso-hansi-font-family:Arial">至</span><span lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;mso-bidi-font-family:&quot;Times New Roman&quot;">4</span><span style="font-family:&quot;新細明體&quot;,serif;mso-ascii-font-family:Arial;mso-hansi-font-family:
Arial">年，</span><span lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;
mso-bidi-font-family:&quot;Times New Roman&quot;">BMI</span><span style="font-family:
&quot;新細明體&quot;,serif;mso-ascii-font-family:Arial;mso-hansi-font-family:Arial">達</span><span lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;mso-bidi-font-family:&quot;Times New Roman&quot;">40</span><span style="font-family:&quot;新細明體&quot;,serif;mso-ascii-font-family:Arial;mso-hansi-font-family:
Arial">以上者更可能少活</span><span lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;
mso-bidi-font-family:&quot;Times New Roman&quot;">8</span><span style="font-family:&quot;新細明體&quot;,serif;
mso-ascii-font-family:Arial;mso-hansi-font-family:Arial">至</span><span lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;mso-bidi-font-family:&quot;Times New Roman&quot;">10</span><span style="font-family:&quot;新細明體&quot;,serif;mso-ascii-font-family:Arial;mso-hansi-font-family:
Arial">年。近兩年，俗稱「瘦瘦針」的腸泌素類藥物在門診與社群媒體上聲量大增，奇美醫療財團法人奇美醫院內分泌新陳代謝科主治醫師黃偉輔提醒，肥胖是一種會復發、持續進展的慢性疾病，不是單純靠意志力就能解決。藥物雖能帶來明顯減重效果，卻可能伴隨腸胃不適、膽囊疾病、肌肉流失及停藥復胖等問題，更要避免將所有不適都歸咎於藥物，以免延誤其他疾病。</span><span lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;mso-bidi-font-family:&quot;Times New Roman&quot;"><o:p></o:p></span></p>

<p class="MsoNormal" style="margin-top:12.0pt;mso-para-margin-top:1.0gd;
text-align:justify;text-justify:inter-ideograph;punctuation-wrap:simple"><b style="mso-bidi-font-weight:normal"><span style="font-size:14.0pt;mso-bidi-font-size:
12.0pt;font-family:&quot;微軟正黑體&quot;,sans-serif;mso-ascii-font-family:Arial;mso-hansi-font-family:
Arial;color:black;mso-color-alt:windowtext;background:#FDE9D9;mso-shading-themecolor:
accent6;mso-shading-themetint:51">從毒蜥唾液到一週一針，</span></b><b style="mso-bidi-font-weight:
normal"><span lang="EN-US" style="font-size:14.0pt;mso-bidi-font-size:12.0pt;
font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:微軟正黑體;mso-bidi-font-family:
&quot;Times New Roman&quot;;color:black;mso-color-alt:windowtext;background:#FDE9D9;
mso-shading-themecolor:accent6;mso-shading-themetint:51">30</span></b><b style="mso-bidi-font-weight:normal"><span style="font-size:14.0pt;mso-bidi-font-size:
12.0pt;font-family:&quot;微軟正黑體&quot;,sans-serif;mso-ascii-font-family:Arial;mso-hansi-font-family:
Arial;color:black;mso-color-alt:windowtext;background:#FDE9D9;mso-shading-themecolor:
accent6;mso-shading-themetint:51">年研究化身減重與健康效益雙贏</span></b><b style="mso-bidi-font-weight:
normal"><span lang="EN-US" style="font-size:14.0pt;mso-bidi-font-size:12.0pt;
font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:微軟正黑體;mso-bidi-font-family:
&quot;Times New Roman&quot;;background:#FDE9D9;mso-shading-themecolor:accent6;mso-shading-themetint:
51"><o:p></o:p></span></b></p>

<p class="MsoNormal" style="text-align:justify;text-justify:inter-ideograph;
text-indent:24.0pt;mso-char-indent-count:2.0;punctuation-wrap:simple"><span style="font-family:&quot;新細明體&quot;,serif;mso-ascii-font-family:Arial;mso-hansi-font-family:
Arial">奇美醫療財團法人奇美醫院內分泌新陳代謝科主治醫師黃偉輔指出，</span><span lang="EN-US" style="font-family:
&quot;Arial&quot;,sans-serif;mso-bidi-font-family:&quot;Times New Roman&quot;">GLP-1</span><span style="font-family:&quot;新細明體&quot;,serif;mso-ascii-font-family:Arial;mso-hansi-font-family:
Arial">是人體進食後自然產生的腸泌素，能幫助調節食慾與飽足感。科學家在美洲毒蜥唾液發現與人體腸泌素</span><span lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;mso-bidi-font-family:&quot;Times New Roman&quot;">GLP-1</span><span style="font-family:&quot;新細明體&quot;,serif;mso-ascii-font-family:Arial;mso-hansi-font-family:
Arial">高度相似的物質後，經過長期結構改造，成功發展出半衰期延長的</span><span lang="EN-US" style="font-family:
&quot;Arial&quot;,sans-serif;mso-bidi-font-family:&quot;Times New Roman&quot;">semaglutide</span><span style="font-family:&quot;新細明體&quot;,serif;mso-ascii-font-family:Arial;mso-hansi-font-family:
Arial">（週纖達）及新一代同時作用於</span><span lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;
mso-bidi-font-family:&quot;Times New Roman&quot;">GIP</span><span style="font-family:
&quot;新細明體&quot;,serif;mso-ascii-font-family:Arial;mso-hansi-font-family:Arial">、</span><span lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;mso-bidi-font-family:&quot;Times New Roman&quot;">GLP-1</span><span style="font-family:&quot;新細明體&quot;,serif;mso-ascii-font-family:Arial;mso-hansi-font-family:
Arial">受體的</span><span lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;
mso-bidi-font-family:&quot;Times New Roman&quot;">tirzepatide</span><span style="font-family:&quot;新細明體&quot;,serif;mso-ascii-font-family:Arial;mso-hansi-font-family:
Arial">（猛健樂）。</span><b style="mso-bidi-font-weight:normal"><span lang="EN-US" style="font-size:14.0pt;mso-bidi-font-size:12.0pt;font-family:&quot;Arial&quot;,sans-serif;
mso-fareast-font-family:微軟正黑體;mso-bidi-font-family:&quot;Times New Roman&quot;;
background:#FDE9D9;mso-shading-themecolor:accent6;mso-shading-themetint:51"><o:p></o:p></span></b></p>

<p class="MsoNormal" style="margin-top:12.0pt;mso-para-margin-top:1.0gd;
text-align:justify;text-justify:inter-ideograph;text-indent:24.0pt;mso-char-indent-count:
2.0;punctuation-wrap:simple"><span style="font-family:&quot;新細明體&quot;,serif;mso-ascii-font-family:
Arial;mso-hansi-font-family:Arial">在臨床試驗中，</span><span lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;mso-bidi-font-family:&quot;Times New Roman&quot;">semaglutide 2.4</span><span style="font-family:&quot;新細明體&quot;,serif;mso-ascii-font-family:Arial;
mso-hansi-font-family:Arial">毫克於</span><span lang="EN-US" style="font-family:
&quot;Arial&quot;,sans-serif;mso-bidi-font-family:&quot;Times New Roman&quot;">68</span><span style="font-family:&quot;新細明體&quot;,serif;mso-ascii-font-family:Arial;mso-hansi-font-family:
Arial">週平均可減重約</span><span lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;
mso-bidi-font-family:&quot;Times New Roman&quot;">17%</span><span style="font-family:
&quot;新細明體&quot;,serif;mso-ascii-font-family:Arial;mso-hansi-font-family:Arial">（約</span><span lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;mso-bidi-font-family:&quot;Times New Roman&quot;">18</span><span style="font-family:&quot;新細明體&quot;,serif;mso-ascii-font-family:Arial;mso-hansi-font-family:
Arial">公斤），並降低</span><span lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;
mso-bidi-font-family:&quot;Times New Roman&quot;">20%</span><span style="font-family:
&quot;新細明體&quot;,serif;mso-ascii-font-family:Arial;mso-hansi-font-family:Arial">重大心血管事件風險，亞洲族群的效益甚至更明顯；</span><span lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;mso-bidi-font-family:&quot;Times New Roman&quot;">tirzepatide</span><span style="font-family:&quot;新細明體&quot;,serif;mso-ascii-font-family:Arial;mso-hansi-font-family:
Arial">在</span><span lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;
mso-bidi-font-family:&quot;Times New Roman&quot;">72</span><span style="font-family:&quot;新細明體&quot;,serif;
mso-ascii-font-family:Arial;mso-hansi-font-family:Arial">週平均減重更達</span><span lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;mso-bidi-font-family:&quot;Times New Roman&quot;">22.5%</span><span style="font-family:&quot;新細明體&quot;,serif;mso-ascii-font-family:Arial;mso-hansi-font-family:
Arial">，內臟脂肪減少約</span><span lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;
mso-bidi-font-family:&quot;Times New Roman&quot;">4</span><span style="font-family:&quot;新細明體&quot;,serif;
mso-ascii-font-family:Arial;mso-hansi-font-family:Arial">成，還能降低糖尿病前期發展成第二型糖尿病的風險達</span><span lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;mso-bidi-font-family:&quot;Times New Roman&quot;">94%</span><span style="font-family:&quot;新細明體&quot;,serif;mso-ascii-font-family:Arial;mso-hansi-font-family:
Arial">。奇美醫療財團法人奇美醫院內分泌新陳代謝科主治醫師黃偉輔說明，減重</span><span lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;mso-bidi-font-family:&quot;Times New Roman&quot;">5%</span><span style="font-family:&quot;新細明體&quot;,serif;mso-ascii-font-family:Arial;mso-hansi-font-family:
Arial">，血壓、血糖就會改善；減</span><span lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;
mso-bidi-font-family:&quot;Times New Roman&quot;">10%</span><span style="font-family:
&quot;新細明體&quot;,serif;mso-ascii-font-family:Arial;mso-hansi-font-family:Arial">到</span><span lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;mso-bidi-font-family:&quot;Times New Roman&quot;">15%</span><span style="font-family:&quot;新細明體&quot;,serif;mso-ascii-font-family:Arial;mso-hansi-font-family:
Arial">，心血管與睡眠呼吸中止都看得到進步；超過</span><span lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;
mso-bidi-font-family:&quot;Times New Roman&quot;">15%</span><span style="font-family:
&quot;新細明體&quot;,serif;mso-ascii-font-family:Arial;mso-hansi-font-family:Arial">，部分第二型糖尿病甚至可能緩解。</span><span lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;mso-bidi-font-family:&quot;Times New Roman&quot;"><o:p></o:p></span></p>

<p class="MsoNormal" style="margin-top:12.0pt;mso-para-margin-top:1.0gd;
text-align:justify;text-justify:inter-ideograph;punctuation-wrap:simple"><b style="mso-bidi-font-weight:normal"><span style="font-size:14.0pt;mso-bidi-font-size:
12.0pt;font-family:&quot;微軟正黑體&quot;,sans-serif;mso-ascii-font-family:Arial;mso-hansi-font-family:
Arial;color:black;mso-color-alt:windowtext;background:#FDE9D9;mso-shading-themecolor:
accent6;mso-shading-themetint:51">隱藏風險與副作用！停藥可能復胖、肌肉也可能跟著流失</span></b><b style="mso-bidi-font-weight:normal"><span lang="EN-US" style="font-size:14.0pt;
mso-bidi-font-size:12.0pt;font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:
微軟正黑體;mso-bidi-font-family:&quot;Times New Roman&quot;;background:#FDE9D9;mso-shading-themecolor:
accent6;mso-shading-themetint:51"><o:p></o:p></span></b></p>

<p class="MsoNormal" style="text-align:justify;text-justify:inter-ideograph;
text-indent:24.0pt;mso-char-indent-count:2.0;punctuation-wrap:simple"><span style="font-family:&quot;新細明體&quot;,serif;mso-ascii-font-family:Arial;mso-hansi-font-family:
Arial">奇美醫療財團法人奇美醫院內分泌新陳代謝科主治醫師黃偉輔提醒，再好的藥也有代價。常見副作用以噁心（發生率逾</span><span lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;mso-bidi-font-family:&quot;Times New Roman&quot;">4</span><span style="font-family:&quot;新細明體&quot;,serif;mso-ascii-font-family:Arial;mso-hansi-font-family:
Arial">成）、腹瀉、嘔吐等腸胃道不適為主，並可能提高膽囊與膽道疾病的風險。此外，減去的體重中約有四分之一來自肌肉等瘦體組織，若缺乏足夠蛋白質攝取與阻力訓練，可能出現「體重下降、肌肉也流失」的情況，長輩尤其要小心肌少症；停藥後體重會逐步回升，因此藥物應視為長期體重管理的一環，而非短期速成工具；本人、家族有甲狀腺髓質癌或第二型多發性內分泌腫瘤病史者禁用；有胰臟炎病史者需謹慎；因為藥物會延緩胃排空，接受全身麻醉手術前建議先停藥，計畫懷孕者則應提前數週至</span><span lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;mso-bidi-font-family:&quot;Times New Roman&quot;">2</span><span style="font-family:&quot;新細明體&quot;,serif;mso-ascii-font-family:Arial;mso-hansi-font-family:
Arial">個月停用，這些都必須由醫師進行評估。</span><span lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;
mso-bidi-font-family:&quot;Times New Roman&quot;"><o:p></o:p></span></p>

<p class="MsoNormal" style="margin-top:12.0pt;mso-para-margin-top:1.0gd;
text-align:justify;text-justify:inter-ideograph;punctuation-wrap:simple"><b style="mso-bidi-font-weight:normal"><span style="font-size:14.0pt;mso-bidi-font-size:
12.0pt;font-family:&quot;微軟正黑體&quot;,sans-serif;mso-ascii-font-family:Arial;mso-hansi-font-family:
Arial;color:black;mso-color-alt:windowtext;background:#FDE9D9;mso-shading-themecolor:
accent6;mso-shading-themetint:51">奇美醫院提三不原則：不亂買、不隱瞞、不硬撐</span></b><b style="mso-bidi-font-weight:normal"><span lang="EN-US" style="font-size:14.0pt;
mso-bidi-font-size:12.0pt;font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:
微軟正黑體;mso-bidi-font-family:&quot;Times New Roman&quot;;background:#FDE9D9;mso-shading-themecolor:
accent6;mso-shading-themetint:51"><o:p></o:p></span></b></p>

<p class="MsoNormal" style="text-align:justify;text-justify:inter-ideograph;
text-indent:24.0pt;mso-char-indent-count:2.0;punctuation-wrap:simple"><span style="font-family:&quot;新細明體&quot;,serif;mso-ascii-font-family:Arial;mso-hansi-font-family:
Arial">針對坊間亂象，奇美醫療財團法人奇美醫院內分泌新陳代謝科主治醫師黃偉輔提出三點呼籲：一、不要在網路或非醫療管道購買來路不明的針劑，這類藥物是處方藥，適應症為</span><span lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;mso-bidi-font-family:&quot;Times New Roman&quot;">BMI 30</span><span style="font-family:&quot;新細明體&quot;,serif;mso-ascii-font-family:Arial;
mso-hansi-font-family:Arial">以上，或</span><span lang="EN-US" style="font-family:
&quot;Arial&quot;,sans-serif;mso-bidi-font-family:&quot;Times New Roman&quot;">BMI 27</span><span style="font-family:&quot;新細明體&quot;,serif;mso-ascii-font-family:Arial;mso-hansi-font-family:
Arial">以上併有高血壓、血脂異常、糖尿病前期、睡眠呼吸中止等共病者，體重正常者使用只有風險、沒有好處；二、用藥期間務必主動告知所有看診的醫師與藥師，包括急診與手術麻醉前；三、若該有的效果沒出現，或副作用持續超過合理時間，請盡快回診檢查，而非自行加藥或停藥，別把警訊當成副作用。</span><span lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;mso-bidi-font-family:&quot;Times New Roman&quot;"><o:p></o:p></span></p>

<p class="MsoNormal" style="margin-top:12.0pt;mso-para-margin-top:1.0gd;
text-align:justify;text-justify:inter-ideograph;punctuation-wrap:simple"><b style="mso-bidi-font-weight:normal"><span style="font-size:14.0pt;mso-bidi-font-size:
12.0pt;font-family:&quot;微軟正黑體&quot;,sans-serif;mso-ascii-font-family:Arial;mso-hansi-font-family:
Arial;color:black;mso-color-alt:windowtext;background:#FDE9D9;mso-shading-themecolor:
accent6;mso-shading-themetint:51">奇美醫院減重團隊陪你長期管理，幫助民眾安全瘦身</span></b><b style="mso-bidi-font-weight:normal"><span lang="EN-US" style="font-size:14.0pt;
mso-bidi-font-size:12.0pt;font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:
微軟正黑體;mso-bidi-font-family:&quot;Times New Roman&quot;;background:#FDE9D9;mso-shading-themecolor:
accent6;mso-shading-themetint:51"><o:p></o:p></span></b></p>

<p class="MsoNormal" style="text-align:justify;text-justify:inter-ideograph;
text-indent:24.0pt;mso-char-indent-count:2.0;punctuation-wrap:simple"><span style="font-family:&quot;新細明體&quot;,serif;mso-ascii-font-family:Arial;mso-hansi-font-family:
Arial">奇美醫院內分泌新陳代謝科結合醫師、營養師、衛教師與運動處方，提供完整的體重管理與代謝共病照護，從飲食、運動、行為治療到藥物選擇，為每位民眾量身規劃。奇美醫療財團法人奇美醫院內分泌新陳代謝科主治醫師黃偉輔提醒，減重是一場長期的健康投資，找對專業團隊，才能瘦得漂亮，也瘦得安全。</span><span lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;mso-bidi-font-family:&quot;Times New Roman&quot;"><o:p></o:p></span></p>

<p class="MsoNormal" style="text-align:justify;text-justify:inter-ideograph;
punctuation-wrap:simple"><span style="font-family:&quot;新細明體&quot;,serif;mso-ascii-font-family:
Arial;mso-hansi-font-family:Arial">奇美醫院內分泌暨新陳代謝科結合醫師、營養師、衛教師及運動處方，從飲食、運動、行為調整到藥物治療，提供個別化體重管理。黃偉輔醫師提醒，減重不是追求短期體重數字，而是長期守住健康，配合「健康臺灣深耕計畫」，奇美醫院持續推動健康促進與慢性病預防，協助民眾建立健康生活型態，守護代謝健康。</span><span lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;mso-bidi-font-family:&quot;Times New Roman&quot;"><o:p></o:p></span></p>

<p align="center" class="MsoNormal" style="margin-top:12.0pt;mso-para-margin-top:
1.0gd;text-align:center;layout-grid-mode:char"><b style="mso-bidi-font-weight:
normal"><span style="font-size:16.0pt;mso-bidi-font-size:12.0pt;font-family:
&quot;微軟正黑體&quot;,sans-serif;mso-ascii-font-family:Arial;mso-hansi-font-family:Arial;
mso-bidi-font-family:Arial;color:black;mso-color-alt:windowtext;background:
#F2DBDB">奇美醫療財團法人奇美醫院</span></b><b style="mso-bidi-font-weight:normal"><span lang="EN-US" style="font-size:16.0pt;mso-bidi-font-size:12.0pt;font-family:&quot;Arial&quot;,sans-serif;
mso-fareast-font-family:微軟正黑體;color:black;mso-color-alt:windowtext;background:
#F2DBDB"></span></b><br />
<b style="mso-bidi-font-weight:normal"><span style="font-size:16.0pt;
mso-bidi-font-size:12.0pt;font-family:&quot;微軟正黑體&quot;,sans-serif;mso-ascii-font-family:
Arial;mso-hansi-font-family:Arial;mso-bidi-font-family:Arial;color:black;
mso-color-alt:windowtext;background:#F2DBDB">內分泌新陳代謝科主治醫師</span></b><b style="mso-bidi-font-weight:
normal"><span style="font-size:16.0pt;mso-bidi-font-size:
12.0pt;font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:微軟正黑體;color:black;
mso-color-alt:windowtext;background:#F2DBDB"> </span><span style="font-size:16.0pt;mso-bidi-font-size:12.0pt;font-family:
&quot;微軟正黑體&quot;,sans-serif;mso-ascii-font-family:Arial;mso-hansi-font-family:Arial;
mso-bidi-font-family:Arial;color:black;mso-color-alt:windowtext;background:
#F2DBDB">黃偉輔</span></b><br />
<img src="../../upload/web/images/奇美醫療財團法人奇美醫院內分泌新陳代謝科主治醫師黃偉輔表示，...瘦針險送命！婦人昏厥送醫，查出癌症多處轉移！奇美醫院提「三不原則」，個人化團隊助民眾安全瘦身.jpg" /><b style="mso-bidi-font-weight:
normal"><span style="font-size:16.0pt;mso-bidi-font-size:12.0pt;font-family:
&quot;微軟正黑體&quot;,sans-serif;mso-ascii-font-family:Arial;mso-hansi-font-family:Arial;
mso-bidi-font-family:Arial;color:black;mso-color-alt:windowtext;background:
#F2DBDB"></span><span lang="EN-US" style="font-size:16.0pt;mso-bidi-font-size:12.0pt;font-family:&quot;Arial&quot;,sans-serif;
mso-fareast-font-family:微軟正黑體;background:#F2DBDB"><o:p></o:p></span></b></p>

<p class="MsoNormal" style="layout-grid-mode:char"><b style="mso-bidi-font-weight:
normal"><span style="font-family:&quot;微軟正黑體&quot;,sans-serif;mso-ascii-font-family:Arial;
mso-hansi-font-family:Arial;mso-bidi-font-family:Arial">【專長</span></b><br />
<b style="mso-bidi-font-weight:normal"><span lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;
mso-fareast-font-family:微軟正黑體"><o:p></o:p></span></b></p>

<p class="MsoNormal" style="text-align:justify;text-justify:inter-ideograph;
layout-grid-mode:char"><span style="font-family:&quot;微軟正黑體&quot;,sans-serif;mso-ascii-font-family:
Arial;mso-hansi-font-family:Arial">內分泌、糖尿病、甲狀腺疾病、高尿酸、高血脂、肥胖等代謝異常、副甲狀腺病變及骨質疏鬆、腎上腺</span><span lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:微軟正黑體;
mso-bidi-font-family:&quot;Times New Roman&quot;">-</span><span style="font-family:&quot;微軟正黑體&quot;,sans-serif;
mso-ascii-font-family:Arial;mso-hansi-font-family:Arial">腦下垂體病變、各種內分泌異常等。</span><span lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:微軟正黑體;
mso-bidi-font-family:&quot;Times New Roman&quot;"><o:p></o:p></span></p>
<!--EndFragment-->]]></content:encoded>
<link>https://www.cnma.org.tw/page/news/show.aspx?num=53350</link>
<pubDate>Sat, 22 Aug 2026 00:00:00 GMT</pubDate>
<category>健康醫療</category>
<enclosure url="https://www.cnma.org.tw/upload/news/202608220514120.jpg" />
</item>
<item>
<title><![CDATA[憂鬱症治療不用再「憑運氣」，腦波＋AI提前預測療效  奇美張俊鴻醫師與國內外研究團隊研究成果登國際期刊與學會雙重肯定]]></title>
<description><![CDATA[<span style="font-size:18px;"></span><!--StartFragment-->
<p align="right" class="MsoNormal" style="text-align:right;layout-grid-mode:char;
punctuation-wrap:simple;word-break:break-all"><span style=...…]]></description>
<content:encoded><![CDATA[<span style="font-size:18px;"></span><!--StartFragment-->
<p align="right" class="MsoNormal" style="text-align:right;layout-grid-mode:char;
punctuation-wrap:simple;word-break:break-all"><span style="font-size:13.0pt;
font-family:&quot;微軟正黑體&quot;,sans-serif;mso-ascii-font-family:Arial;mso-hansi-font-family:
Arial">記者:楊憲朋 台南市報導<br />
<br />
<br />
奇美醫療財團法人奇美醫院精神醫學部主治醫師</span><span style="font-size:13.0pt;font-family:
&quot;Arial&quot;,sans-serif;mso-fareast-font-family:微軟正黑體;mso-bidi-font-family:&quot;Times New Roman&quot;"> </span><span style="font-size:13.0pt;font-family:&quot;微軟正黑體&quot;,sans-serif;mso-ascii-font-family:
Arial;mso-hansi-font-family:Arial">張俊鴻</span><span lang="EN-US" style="font-size:
13.0pt;font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:微軟正黑體;mso-bidi-font-family:
&quot;Times New Roman&quot;"><o:p></o:p></span></p>

<p class="MsoNormal" style="margin-top:12.0pt;mso-para-margin-top:1.0gd;
text-align:justify;text-justify:inter-ideograph"><b><span style="font-size:
14.0pt;font-family:&quot;微軟正黑體&quot;,sans-serif;mso-ascii-font-family:Arial;mso-hansi-font-family:
Arial;color:black;mso-color-alt:windowtext;background:#FDE9D9;mso-shading-themecolor:
accent6;mso-shading-themetint:51">研究登國際期刊！治療前先找線索，腦波結合</span></b><b><span lang="EN-US" style="font-size:14.0pt;font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:
微軟正黑體;mso-bidi-font-family:&quot;Times New Roman&quot;;color:black;mso-color-alt:windowtext;
background:#FDE9D9;mso-shading-themecolor:accent6;mso-shading-themetint:51">AI</span></b><b><span style="font-size:14.0pt;font-family:&quot;微軟正黑體&quot;,sans-serif;mso-ascii-font-family:
Arial;mso-hansi-font-family:Arial;color:black;mso-color-alt:windowtext;
background:#FDE9D9;mso-shading-themecolor:accent6;mso-shading-themetint:51">預測憂鬱症療效</span></b><b><span lang="EN-US" style="font-size:14.0pt;font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:
微軟正黑體;mso-bidi-font-family:&quot;Times New Roman&quot;;background:#FDE9D9;mso-shading-themecolor:
accent6;mso-shading-themetint:51"><o:p></o:p></span></b></p>

<p class="MsoNormal" style="text-align:justify;text-justify:inter-ideograph;
text-indent:24.0pt;mso-char-indent-count:2.0;punctuation-wrap:simple"><span style="font-family:&quot;新細明體&quot;,serif;mso-ascii-font-family:Arial;mso-hansi-font-family:
Arial">憂鬱症治療不再只是「試了才知道有沒有效」，未來有機會透過腦波與人工智慧，在治療前就提供更多線索。奇美醫療財團法人奇美醫院精神醫學部主治醫師張俊鴻與國內外研究團隊，結合腦波</span><span lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;mso-bidi-font-family:&quot;Times New Roman&quot;">(EEG)</span><span style="font-family:&quot;新細明體&quot;,serif;mso-ascii-font-family:Arial;mso-hansi-font-family:
Arial">、人工智慧</span><span lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;
mso-bidi-font-family:&quot;Times New Roman&quot;">(AI)</span><span style="font-family:
&quot;新細明體&quot;,serif;mso-ascii-font-family:Arial;mso-hansi-font-family:Arial">及非侵入性的經顱刺激治療</span><span lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;mso-bidi-font-family:&quot;Times New Roman&quot;">(TMS)</span><span style="font-family:&quot;新細明體&quot;,serif;mso-ascii-font-family:Arial;mso-hansi-font-family:
Arial">，探討如何在治療前預測難治型憂鬱症病人接受顱刺激治療後的療效。研究成果已發表於國際期刊《</span><span lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;mso-bidi-font-family:&quot;Times New Roman&quot;">Brain Stimulation</span><span style="font-family:&quot;新細明體&quot;,serif;mso-ascii-font-family:
Arial;mso-hansi-font-family:Arial">》，並獲得台灣精神生理學會「優秀期刊論文獎</span><span lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;mso-bidi-font-family:&quot;Times New Roman&quot;">(Best Paper Award)</span><span style="font-family:&quot;新細明體&quot;,serif;mso-ascii-font-family:
Arial;mso-hansi-font-family:Arial">」肯定，張俊鴻醫師日前也受邀於學術會議專題演講，分享研究成果及未來人工智慧應用於精神醫療的發展方向。</span><span lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;mso-bidi-font-family:&quot;Times New Roman&quot;;
color:red"><o:p></o:p></span></p>

<p class="MsoNormal" style="margin-top:12.0pt;mso-para-margin-top:1.0gd;
text-align:justify;text-justify:inter-ideograph"><b><span style="font-size:
14.0pt;font-family:&quot;微軟正黑體&quot;,sans-serif;mso-ascii-font-family:Arial;mso-hansi-font-family:
Arial;color:black;mso-color-alt:windowtext;background:#FDE9D9;mso-shading-themecolor:
accent6;mso-shading-themetint:51">治療不再憑運氣！</span></b><b><span lang="EN-US" style="font-size:14.0pt;font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:
微軟正黑體;mso-bidi-font-family:&quot;Times New Roman&quot;;color:black;mso-color-alt:windowtext;
background:#FDE9D9;mso-shading-themecolor:accent6;mso-shading-themetint:51">AI</span></b><b><span style="font-size:14.0pt;font-family:&quot;微軟正黑體&quot;,sans-serif;mso-ascii-font-family:
Arial;mso-hansi-font-family:Arial;color:black;mso-color-alt:windowtext;
background:#FDE9D9;mso-shading-themecolor:accent6;mso-shading-themetint:51">解碼腦電波打造「量身訂做」療程</span></b><b><span lang="EN-US" style="font-size:14.0pt;font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:
微軟正黑體;mso-bidi-font-family:&quot;Times New Roman&quot;;background:#FDE9D9;mso-shading-themecolor:
accent6;mso-shading-themetint:51"><o:p></o:p></span></b></p>

<p class="MsoNormal" style="text-align:justify;text-justify:inter-ideograph;
text-indent:24.0pt;mso-char-indent-count:2.0;punctuation-wrap:simple"><span style="font-family:&quot;新細明體&quot;,serif;mso-ascii-font-family:Arial;mso-hansi-font-family:
Arial">憂鬱症是常見的精神疾病，多數病人可藉由藥物、心理治療或其他方式改善，但仍有部分病人即使接受多種抗憂鬱藥物治療，症狀仍持續存在，臨床上稱為「難治型憂鬱症」。近年經顱磁刺激</span><span lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;mso-bidi-font-family:&quot;Times New Roman&quot;">(TMS)</span><span style="font-family:&quot;新細明體&quot;,serif;mso-ascii-font-family:Arial;mso-hansi-font-family:
Arial">成為重要的非藥物治療選擇，治療過程不需麻醉，透過磁場刺激與情緒調節相關的腦部區域，協助改善症狀，但不同病人的治療反應仍有差異。奇美醫療財團法人奇美醫院精神醫學部主治醫師張俊鴻表示，若能在治療前掌握病人腦部的生理特徵，就有機會更早找到適合的治療方式。</span><span lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;mso-bidi-font-family:&quot;Times New Roman&quot;"><o:p></o:p></span></p>

<p class="MsoNormal" style="margin-top:12.0pt;mso-para-margin-top:1.0gd;
text-align:justify;text-justify:inter-ideograph"><b><span style="font-size:
14.0pt;font-family:&quot;微軟正黑體&quot;,sans-serif;mso-ascii-font-family:Arial;mso-hansi-font-family:
Arial;color:black;mso-color-alt:windowtext;background:#FDE9D9;mso-shading-themecolor:
accent6;mso-shading-themetint:51">檢查手續大簡化！</span></b><b><span lang="EN-US" style="font-size:14.0pt;font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:
微軟正黑體;mso-bidi-font-family:&quot;Times New Roman&quot;;color:black;mso-color-alt:windowtext;
background:#FDE9D9;mso-shading-themecolor:accent6;mso-shading-themetint:51">30</span></b><b><span style="font-size:14.0pt;font-family:&quot;微軟正黑體&quot;,sans-serif;mso-ascii-font-family:
Arial;mso-hansi-font-family:Arial;color:black;mso-color-alt:windowtext;
background:#FDE9D9;mso-shading-themecolor:accent6;mso-shading-themetint:51">個電極縮至</span></b><b><span lang="EN-US" style="font-size:14.0pt;font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:
微軟正黑體;mso-bidi-font-family:&quot;Times New Roman&quot;;color:black;mso-color-alt:windowtext;
background:#FDE9D9;mso-shading-themecolor:accent6;mso-shading-themetint:51">8</span></b><b><span style="font-size:14.0pt;font-family:&quot;微軟正黑體&quot;,sans-serif;mso-ascii-font-family:
Arial;mso-hansi-font-family:Arial;color:black;mso-color-alt:windowtext;
background:#FDE9D9;mso-shading-themecolor:accent6;mso-shading-themetint:51">個，</span></b><b><span lang="EN-US" style="font-size:14.0pt;font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:
微軟正黑體;mso-bidi-font-family:&quot;Times New Roman&quot;;color:black;mso-color-alt:windowtext;
background:#FDE9D9;mso-shading-themecolor:accent6;mso-shading-themetint:51">AI</span></b><b><span style="font-size:14.0pt;font-family:&quot;微軟正黑體&quot;,sans-serif;mso-ascii-font-family:
Arial;mso-hansi-font-family:Arial;color:black;mso-color-alt:windowtext;
background:#FDE9D9;mso-shading-themecolor:accent6;mso-shading-themetint:51">分析仍保有預測能力</span></b><b><span lang="EN-US" style="font-size:14.0pt;font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:
微軟正黑體;mso-bidi-font-family:&quot;Times New Roman&quot;;background:#FDE9D9;mso-shading-themecolor:
accent6;mso-shading-themetint:51"><o:p></o:p></span></b></p>

<p class="MsoNormal" style="text-align:justify;text-justify:inter-ideograph;
text-indent:24.0pt;mso-char-indent-count:2.0;punctuation-wrap:simple"><span style="font-family:&quot;新細明體&quot;,serif;mso-ascii-font-family:Arial;mso-hansi-font-family:
Arial">這項研究的一大亮點在於「實用性」。傳統腦波檢查需要貼上記錄</span><span lang="EN-US" style="font-family:
&quot;Arial&quot;,sans-serif;mso-bidi-font-family:&quot;Times New Roman&quot;">30</span><span style="font-family:&quot;新細明體&quot;,serif;mso-ascii-font-family:Arial;mso-hansi-font-family:
Arial">個位置的複雜電極，找出與經顱磁刺激</span><span lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;
mso-bidi-font-family:&quot;Times New Roman&quot;">(TMS)</span><span style="font-family:
&quot;新細明體&quot;,serif;mso-ascii-font-family:Arial;mso-hansi-font-family:Arial">治療反應的相關特徵，不僅耗時且不便；但研究團隊發現，透過人工智慧</span><span lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;mso-bidi-font-family:&quot;Times New Roman&quot;">(AI)</span><span style="font-family:&quot;新細明體&quot;,serif;mso-ascii-font-family:Arial;mso-hansi-font-family:
Arial">技術，將電極簡化至僅需</span><span lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;
mso-bidi-font-family:&quot;Times New Roman&quot;">8</span><span style="font-family:&quot;新細明體&quot;,serif;
mso-ascii-font-family:Arial;mso-hansi-font-family:Arial">個主要位置，預測精準度卻幾乎與</span><span lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;mso-bidi-font-family:&quot;Times New Roman&quot;">30</span><span style="font-family:&quot;新細明體&quot;,serif;mso-ascii-font-family:Arial;mso-hansi-font-family:
Arial">個電極相當。奇美醫療財團法人奇美醫院精神醫學部主治醫師張俊鴻強調，這代表未來的腦波檢查有機會變得更簡單、更快速，病人不必承受繁瑣的檢查流程，診所與一般醫院也更容易導入，提升未來臨床普及的可能性。</span><span lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;mso-bidi-font-family:&quot;Times New Roman&quot;"><o:p></o:p></span></p>

<p class="MsoNormal" style="margin-top:12.0pt;mso-para-margin-top:1.0gd;
text-align:justify;text-justify:inter-ideograph"><b><span style="font-size:
14.0pt;font-family:&quot;微軟正黑體&quot;,sans-serif;mso-ascii-font-family:Arial;mso-hansi-font-family:
Arial;color:black;mso-color-alt:windowtext;background:#FDE9D9;mso-shading-themecolor:
accent6;mso-shading-themetint:51">跨院、跨國合作！展現臺灣腦科學、</span></b><b><span lang="EN-US" style="font-size:14.0pt;font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:
微軟正黑體;mso-bidi-font-family:&quot;Times New Roman&quot;;color:black;mso-color-alt:windowtext;
background:#FDE9D9;mso-shading-themecolor:accent6;mso-shading-themetint:51">AI</span></b><b><span style="font-size:14.0pt;font-family:&quot;微軟正黑體&quot;,sans-serif;mso-ascii-font-family:
Arial;mso-hansi-font-family:Arial;color:black;mso-color-alt:windowtext;
background:#FDE9D9;mso-shading-themecolor:accent6;mso-shading-themetint:51">與腦刺激技術跨域整合實力</span></b><b><span lang="EN-US" style="font-size:14.0pt;font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:
微軟正黑體;mso-bidi-font-family:&quot;Times New Roman&quot;;background:#FDE9D9;mso-shading-themecolor:
accent6;mso-shading-themetint:51"><o:p></o:p></span></b></p>

<p class="MsoNormal" style="text-align:justify;text-justify:inter-ideograph;
text-indent:24.0pt;mso-char-indent-count:2.0;punctuation-wrap:simple"><span style="font-family:&quot;新細明體&quot;,serif;mso-ascii-font-family:Arial;mso-hansi-font-family:
Arial">這項卓越的科研成果，是跨院、跨國及跨領域合作的結晶。研究團隊除了奇美醫療財團法人奇美醫院精神醫學部主治醫師張俊鴻外，還包含宏智生醫團隊、三軍總醫院張勳安教授、高雄榮民總醫院朱哲生醫師，以及荷蘭馬斯垂克大學</span><span lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;mso-bidi-font-family:&quot;Times New Roman&quot;">(Maastricht University) Alexander T. Sack</span><span style="font-family:&quot;新細明體&quot;,serif;
mso-ascii-font-family:Arial;mso-hansi-font-family:Arial">教授等專家共同參與。獲獎不僅肯定了團隊的付出，更向國際，展現臺灣在腦科學、人工智慧</span><span lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;mso-bidi-font-family:&quot;Times New Roman&quot;">(AI)</span><span style="font-family:&quot;新細明體&quot;,serif;mso-ascii-font-family:Arial;mso-hansi-font-family:
Arial">與非侵入性腦刺激研究上的跨領域整合能力。本研究呼應「健康臺灣深耕計畫」精神，結合人工智慧與腦科學技術，推動精準精神醫療發展，提升病人照護品質與治療效益。</span><span lang="EN-US"><o:p></o:p></span></p>

<p class="MsoNormal" style="margin-top:12.0pt;mso-para-margin-top:1.0gd;
text-align:justify;text-justify:inter-ideograph"><b><span style="font-size:
14.0pt;font-family:&quot;微軟正黑體&quot;,sans-serif;mso-ascii-font-family:Arial;mso-hansi-font-family:
Arial;color:black;mso-color-alt:windowtext;background:#FDE9D9;mso-shading-themecolor:
accent6;mso-shading-themetint:51">從「哪種治療有效」走向「誰適合哪種治療」</span></b><b><span lang="EN-US" style="font-size:14.0pt;font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:
微軟正黑體;mso-bidi-font-family:&quot;Times New Roman&quot;;background:#FDE9D9;mso-shading-themecolor:
accent6;mso-shading-themetint:51"><o:p></o:p></span></b></p>

<p class="MsoNormal" style="text-align:justify;text-justify:inter-ideograph;
text-indent:24.0pt;mso-char-indent-count:2.0;punctuation-wrap:simple"><span style="font-family:&quot;新細明體&quot;,serif;mso-ascii-font-family:Arial;mso-hansi-font-family:
Arial">奇美醫療財團法人奇美醫院精神醫學部主治醫師張俊鴻表示，目前</span><span lang="EN-US" style="font-family:
&quot;Arial&quot;,sans-serif;mso-bidi-font-family:&quot;Times New Roman&quot;">AI</span><span style="font-family:&quot;新細明體&quot;,serif;mso-ascii-font-family:Arial;mso-hansi-font-family:
Arial">腦波預測仍處於研究與驗證階段，尚需更多不同醫療院所及大規模研究確認臨床應用價值，未來將持續投入</span><span lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;mso-bidi-font-family:&quot;Times New Roman&quot;">AI</span><span style="font-family:&quot;新細明體&quot;,serif;mso-ascii-font-family:Arial;mso-hansi-font-family:
Arial">、腦波、生物標記與</span><span lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;
mso-bidi-font-family:&quot;Times New Roman&quot;">TMS</span><span style="font-family:
&quot;新細明體&quot;,serif;mso-ascii-font-family:Arial;mso-hansi-font-family:Arial">研究。精神醫學最重要的目標，是將先進的腦科學研究轉化為診間隨手可用的臨床工具，減少病人在各種治療之間反覆嘗試與等待的煎熬。未來醫療將不再只是回答「哪種治療有效」，而是能精準告訴每一位病人「哪一種治療對你最有效」。</span><span lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;mso-bidi-font-family:&quot;Times New Roman&quot;"><o:p></o:p></span></p>

<p class="MsoNormal" style="margin-top:12.0pt;mso-para-margin-top:1.0gd;
text-align:justify;text-justify:inter-ideograph;text-indent:24.0pt;mso-char-indent-count:
2.0;punctuation-wrap:simple"><span style="font-family:&quot;新細明體&quot;,serif;mso-ascii-font-family:
Arial;mso-hansi-font-family:Arial">本研究以&ldquo;</span><span lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;mso-bidi-font-family:&quot;Times New Roman&quot;">EEG biomarkers of accelerated prolonged intermittent theta-burst stimulation in depression: Machine learning with a minimal-electrode montage</span><span style="font-family:&quot;新細明體&quot;,serif;mso-ascii-font-family:Arial;mso-hansi-font-family:
Arial">&rdquo;為題，已刊登於國際期刊《</span><span lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;
mso-bidi-font-family:&quot;Times New Roman&quot;">Brain Stimulation</span><span style="font-family:&quot;新細明體&quot;,serif;mso-ascii-font-family:Arial;mso-hansi-font-family:
Arial">》。</span><span lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;
mso-bidi-font-family:&quot;Times New Roman&quot;"><o:p></o:p></span></p>

<p align="center" class="MsoNormal" style="margin-top:12.0pt;mso-para-margin-top:
1.0gd;text-align:center;layout-grid-mode:char"><b style="mso-bidi-font-weight:
normal"><span style="font-size:16.0pt;mso-bidi-font-size:12.0pt;font-family:
&quot;微軟正黑體&quot;,sans-serif;mso-ascii-font-family:Arial;mso-hansi-font-family:Arial;
mso-bidi-font-family:Arial;color:black;mso-color-alt:windowtext;background:
#F2DBDB">奇美醫療財團法人奇美醫院精神醫學部主治醫師</span></b><b style="mso-bidi-font-weight:normal"><span style="font-size:16.0pt;mso-bidi-font-size:12.0pt;font-family:&quot;Arial&quot;,sans-serif;
mso-fareast-font-family:微軟正黑體;color:black;mso-color-alt:windowtext;background:
#F2DBDB"> </span></b><b style="mso-bidi-font-weight:normal"><span style="font-size:16.0pt;mso-bidi-font-size:12.0pt;font-family:&quot;微軟正黑體&quot;,sans-serif;
mso-ascii-font-family:Arial;mso-hansi-font-family:Arial;mso-bidi-font-family:
Arial;color:black;mso-color-alt:windowtext;background:#F2DBDB">張俊鴻</span></b><b style="mso-bidi-font-weight:normal"><span lang="EN-US" style="font-size:16.0pt;
mso-bidi-font-size:12.0pt;font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:
微軟正黑體;background:#F2DBDB"><o:p></o:p></span></b></p>

<p class="MsoNormal" style="layout-grid-mode:char"><b style="mso-bidi-font-weight:
normal"><span style="font-family:&quot;微軟正黑體&quot;,sans-serif;mso-ascii-font-family:Arial;
mso-hansi-font-family:Arial;mso-bidi-font-family:Arial">【專長】</span></b><b style="mso-bidi-font-weight:normal"><span lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;
mso-fareast-font-family:微軟正黑體"><o:p></o:p></span></b></p>

<p class="MsoListParagraph" style="text-align:justify;text-justify:inter-ideograph;
text-indent:-24.0pt;mso-list:l0 level1 lfo1;layout-grid-mode:char"><!--[if !supportLists]--><span lang="EN-US" style="font-family:Wingdings;mso-fareast-font-family:Wingdings;
mso-bidi-font-family:Wingdings"><span style="mso-list:Ignore">l<span style="font:7.0pt &quot;Times New Roman&quot;">&nbsp;&nbsp; </span></span></span><!--[endif]--><span style="font-family:&quot;微軟正黑體&quot;,sans-serif;mso-ascii-font-family:Arial;mso-hansi-font-family:
Arial">非侵入性腦刺激治療：經顱磁刺激</span><span lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;
mso-fareast-font-family:微軟正黑體;mso-bidi-font-family:新細明體">(rTMS</span><span style="font-family:&quot;微軟正黑體&quot;,sans-serif;mso-ascii-font-family:Arial;mso-hansi-font-family:
Arial">／</span><span lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;
mso-fareast-font-family:微軟正黑體;mso-bidi-font-family:新細明體">TBS)</span><span style="font-family:&quot;微軟正黑體&quot;,sans-serif;mso-ascii-font-family:Arial;mso-hansi-font-family:
Arial">、大腦微電流刺激</span><span lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;
mso-fareast-font-family:微軟正黑體;mso-bidi-font-family:新細明體">(CES)</span><span style="font-family:&quot;微軟正黑體&quot;,sans-serif;mso-ascii-font-family:Arial;mso-hansi-font-family:
Arial">、經顱光生物調節治療</span><span lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;
mso-fareast-font-family:微軟正黑體;mso-bidi-font-family:新細明體">(tPBM)<o:p></o:p></span></p>

<p class="MsoListParagraph" style="text-align:justify;text-justify:inter-ideograph;
text-indent:-24.0pt;mso-list:l0 level1 lfo1;layout-grid-mode:char"><!--[if !supportLists]--><span lang="EN-US" style="font-family:Wingdings;mso-fareast-font-family:Wingdings;
mso-bidi-font-family:Wingdings"><span style="mso-list:Ignore">l<span style="font:7.0pt &quot;Times New Roman&quot;">&nbsp;&nbsp; </span></span></span><!--[endif]--><span style="font-family:&quot;微軟正黑體&quot;,sans-serif;mso-ascii-font-family:Arial;mso-hansi-font-family:
Arial">精準精神醫學與腦科學：腦波評估、自律神經檢查</span><span lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;
mso-fareast-font-family:微軟正黑體;mso-bidi-font-family:新細明體">HRV</span><span style="font-family:&quot;微軟正黑體&quot;,sans-serif;mso-ascii-font-family:Arial;mso-hansi-font-family:
Arial">、人工智慧輔助精神醫學研究</span><span lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;
mso-fareast-font-family:微軟正黑體;mso-bidi-font-family:新細明體"><o:p></o:p></span></p>

<p class="MsoListParagraph" style="text-align:justify;text-justify:inter-ideograph;
text-indent:-24.0pt;mso-list:l0 level1 lfo1;layout-grid-mode:char"><!--[if !supportLists]--><span lang="EN-US" style="font-family:Wingdings;mso-fareast-font-family:Wingdings;
mso-bidi-font-family:Wingdings"><span style="mso-list:Ignore">l<span style="font:7.0pt &quot;Times New Roman&quot;">&nbsp;&nbsp; </span></span></span><!--[endif]--><span style="font-family:&quot;微軟正黑體&quot;,sans-serif;mso-ascii-font-family:Arial;mso-hansi-font-family:
Arial">情緒障礙治療：難治型憂鬱症、躁鬱症、焦慮症、強迫症、創傷後壓力症候群</span><span lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:微軟正黑體;mso-bidi-font-family:
新細明體">(PTSD)<o:p></o:p></span></p>

<p class="MsoListParagraph" style="text-align:justify;text-justify:inter-ideograph;
text-indent:-24.0pt;mso-list:l0 level1 lfo1;layout-grid-mode:char"><!--[if !supportLists]--><span lang="EN-US" style="font-family:Wingdings;mso-fareast-font-family:Wingdings;
mso-bidi-font-family:Wingdings"><span style="mso-list:Ignore">l<span style="font:7.0pt &quot;Times New Roman&quot;">&nbsp;&nbsp; </span></span></span><!--[endif]--><span style="font-family:&quot;微軟正黑體&quot;,sans-serif;mso-ascii-font-family:Arial;mso-hansi-font-family:
Arial">睡眠與身心醫學：失眠症、自律神經失調、壓力調適與身心症狀治療</span><span lang="EN-US" style="font-family:
&quot;Arial&quot;,sans-serif;mso-fareast-font-family:微軟正黑體;mso-bidi-font-family:新細明體"><o:p></o:p></span></p>

<p class="MsoListParagraph" style="text-align:justify;text-justify:inter-ideograph;
text-indent:-24.0pt;mso-list:l0 level1 lfo1;layout-grid-mode:char"><!--[if !supportLists]--><span lang="EN-US" style="font-family:Wingdings;mso-fareast-font-family:Wingdings;
mso-bidi-font-family:Wingdings"><span style="mso-list:Ignore">l<span style="font:7.0pt &quot;Times New Roman&quot;">&nbsp;&nbsp; </span></span></span><!--[endif]--><span style="font-family:&quot;微軟正黑體&quot;,sans-serif;mso-ascii-font-family:Arial;mso-hansi-font-family:
Arial">一般精神醫學與神經精神疾患：思覺失調症、失智症、腦傷後精神與認知功能障礙。</span><span lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:微軟正黑體;mso-bidi-font-family:
新細明體"><o:p></o:p></span></p>

<p class="MsoNormal" style="text-align:justify;text-justify:inter-ideograph;
layout-grid-mode:char"><b style="mso-bidi-font-weight:normal"><span style="font-family:&quot;微軟正黑體&quot;,sans-serif;mso-ascii-font-family:Arial;mso-hansi-font-family:
Arial;mso-bidi-font-family:Arial">【門診時間】</span></b><b style="mso-bidi-font-weight:
normal"><span lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:
微軟正黑體"><o:p></o:p></span></b></p>

<div align="center">
<table border="1" cellpadding="0" cellspacing="0" class="MsoTableGrid" style="border-collapse:collapse;mso-table-layout-alt:fixed;border:none;
 mso-border-alt:solid windowtext .5pt;mso-yfti-tbllook:1184;mso-padding-alt:
 0cm 5.4pt 0cm 5.4pt" width="554">
	<tbody>
		<tr style="mso-yfti-irow:0;mso-yfti-firstrow:yes">
			<td style="width:59.65pt;border:solid windowtext 1.0pt;mso-border-alt:
  solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt" width="80">
			<p align="center" class="MsoNormal" style="text-align:center;layout-grid-mode:
  char"><span style="font-family:&quot;微軟正黑體&quot;,sans-serif;mso-ascii-font-family:Arial;
  mso-hansi-font-family:Arial;mso-bidi-font-family:Arial">星期</span><span lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:
  微軟正黑體"><o:p></o:p></span></p>
			</td>
			<td style="width:59.65pt;border:solid windowtext 1.0pt;border-left:
  none;mso-border-left-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt;
  padding:0cm 5.4pt 0cm 5.4pt" width="80">
			<p align="center" class="MsoNormal" style="text-align:center;layout-grid-mode:
  char"><span style="font-family:&quot;微軟正黑體&quot;,sans-serif;mso-ascii-font-family:Arial;
  mso-hansi-font-family:Arial;mso-bidi-font-family:Arial">一</span><span lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:
  微軟正黑體"><o:p></o:p></span></p>
			</td>
			<td style="width:59.6pt;border:solid windowtext 1.0pt;border-left:
  none;mso-border-left-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt;
  padding:0cm 5.4pt 0cm 5.4pt" width="79">
			<p align="center" class="MsoNormal" style="text-align:center;layout-grid-mode:
  char"><span style="font-family:&quot;微軟正黑體&quot;,sans-serif;mso-ascii-font-family:Arial;
  mso-hansi-font-family:Arial;mso-bidi-font-family:Arial">二</span><span lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:
  微軟正黑體"><o:p></o:p></span></p>
			</td>
			<td style="width:59.6pt;border:solid windowtext 1.0pt;border-left:
  none;mso-border-left-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt;
  padding:0cm 5.4pt 0cm 5.4pt" width="79">
			<p align="center" class="MsoNormal" style="text-align:center;layout-grid-mode:
  char"><span style="font-family:&quot;微軟正黑體&quot;,sans-serif;mso-ascii-font-family:Arial;
  mso-hansi-font-family:Arial;mso-bidi-font-family:Arial">三</span><span lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:
  微軟正黑體"><o:p></o:p></span></p>
			</td>
			<td style="width:59.6pt;border:solid windowtext 1.0pt;border-left:
  none;mso-border-left-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt;
  padding:0cm 5.4pt 0cm 5.4pt" width="79">
			<p align="center" class="MsoNormal" style="text-align:center;layout-grid-mode:
  char"><span style="font-family:&quot;微軟正黑體&quot;,sans-serif;mso-ascii-font-family:Arial;
  mso-hansi-font-family:Arial;mso-bidi-font-family:Arial">四</span><span lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:
  微軟正黑體"><o:p></o:p></span></p>
			</td>
			<td style="width:59.6pt;border:solid windowtext 1.0pt;border-left:
  none;mso-border-left-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt;
  padding:0cm 5.4pt 0cm 5.4pt" width="79">
			<p align="center" class="MsoNormal" style="text-align:center;layout-grid-mode:
  char"><span style="font-family:&quot;微軟正黑體&quot;,sans-serif;mso-ascii-font-family:Arial;
  mso-hansi-font-family:Arial;mso-bidi-font-family:Arial">五</span><span lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:
  微軟正黑體"><o:p></o:p></span></p>
			</td>
			<td style="width:57.65pt;border:solid windowtext 1.0pt;border-left:
  none;mso-border-left-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt;
  padding:0cm 5.4pt 0cm 5.4pt" width="77">
			<p align="center" class="MsoNormal" style="text-align:center;layout-grid-mode:
  char"><span style="font-family:&quot;微軟正黑體&quot;,sans-serif;mso-ascii-font-family:Arial;
  mso-hansi-font-family:Arial;mso-bidi-font-family:Arial">六</span><span lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:
  微軟正黑體"><o:p></o:p></span></p>
			</td>
		</tr>
		<tr style="mso-yfti-irow:1">
			<td style="width:59.65pt;border:solid windowtext 1.0pt;border-top:
  none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt;
  padding:0cm 5.4pt 0cm 5.4pt" width="80">
			<p align="center" class="MsoNormal" style="text-align:center;layout-grid-mode:
  char"><span style="font-family:&quot;微軟正黑體&quot;,sans-serif;mso-ascii-font-family:Arial;
  mso-hansi-font-family:Arial;mso-bidi-font-family:Arial">上午</span><span lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:
  微軟正黑體"><o:p></o:p></span></p>
			</td>
			<td style="width:59.65pt;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt" width="80">
			<p align="center" class="MsoNormal" style="text-align:center;layout-grid-mode:
  char"><span lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:
  微軟正黑體"><o:p>&nbsp;</o:p></span></p>
			</td>
			<td style="width:59.6pt;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;mso-border-top-alt:
  solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;mso-border-alt:
  solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt" width="79">
			<p align="center" class="MsoNormal" style="text-align:center;layout-grid-mode:
  char"><span lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:
  微軟正黑體"><o:p>&nbsp;</o:p></span></p>
			</td>
			<td style="width:59.6pt;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;mso-border-top-alt:
  solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;mso-border-alt:
  solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt" width="79">
			<p align="center" class="MsoNormal" style="text-align:center;layout-grid-mode:
  char"><span style="font-family:&quot;微軟正黑體&quot;,sans-serif;mso-ascii-font-family:Arial;
  mso-hansi-font-family:Arial;mso-bidi-font-family:Arial">●</span><span lang="EN-US" style="font-size:10.0pt;mso-bidi-font-size:12.0pt;font-family:
  &quot;Arial&quot;,sans-serif;mso-fareast-font-family:微軟正黑體">(</span><span style="font-size:10.0pt;mso-bidi-font-size:12.0pt;font-family:&quot;微軟正黑體&quot;,sans-serif;
  mso-ascii-font-family:Arial;mso-hansi-font-family:Arial;mso-bidi-font-family:
  Arial">樹林</span><span lang="EN-US" style="font-size:10.0pt;mso-bidi-font-size:
  12.0pt;font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:微軟正黑體">)</span><span lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:
  微軟正黑體"><o:p></o:p></span></p>
			</td>
			<td style="width:59.6pt;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;mso-border-top-alt:
  solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;mso-border-alt:
  solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt" width="79">
			<p align="center" class="MsoNormal" style="text-align:center;layout-grid-mode:
  char"><span lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:
  微軟正黑體"><o:p>&nbsp;</o:p></span></p>
			</td>
			<td style="width:59.6pt;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;mso-border-top-alt:
  solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;mso-border-alt:
  solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt" width="79">
			<p align="center" class="MsoNormal" style="text-align:center;layout-grid-mode:
  char"><span lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:
  微軟正黑體"><o:p>&nbsp;</o:p></span></p>
			</td>
			<td style="width:57.65pt;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt" width="77">
			<p align="center" class="MsoNormal" style="text-align:center;layout-grid-mode:
  char"><span lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:
  微軟正黑體"><o:p>&nbsp;</o:p></span></p>
			</td>
		</tr>
		<tr style="mso-yfti-irow:2">
			<td style="width:59.65pt;border:solid windowtext 1.0pt;border-top:
  none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt;
  padding:0cm 5.4pt 0cm 5.4pt" width="80">
			<p align="center" class="MsoNormal" style="text-align:center;layout-grid-mode:
  char"><span style="font-family:&quot;微軟正黑體&quot;,sans-serif;mso-ascii-font-family:Arial;
  mso-hansi-font-family:Arial;mso-bidi-font-family:Arial">下午</span><span lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:
  微軟正黑體"><o:p></o:p></span></p>
			</td>
			<td style="width:59.65pt;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt" width="80">
			<p align="center" class="MsoNormal" style="text-align:center;layout-grid-mode:
  char"><span style="font-family:&quot;微軟正黑體&quot;,sans-serif;mso-ascii-font-family:Arial;
  mso-hansi-font-family:Arial;mso-bidi-font-family:Arial">●</span><span lang="EN-US" style="font-size:10.0pt;mso-bidi-font-size:12.0pt;font-family:
  &quot;Arial&quot;,sans-serif;mso-fareast-font-family:微軟正黑體">(</span><span style="font-size:10.0pt;mso-bidi-font-size:12.0pt;font-family:&quot;微軟正黑體&quot;,sans-serif;
  mso-ascii-font-family:Arial;mso-hansi-font-family:Arial;mso-bidi-font-family:
  Arial">佳里</span><span lang="EN-US" style="font-size:10.0pt;mso-bidi-font-size:
  12.0pt;font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:微軟正黑體">)</span><span lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:
  微軟正黑體"><o:p></o:p></span></p>
			</td>
			<td style="width:59.6pt;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;mso-border-top-alt:
  solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;mso-border-alt:
  solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt" width="79">
			<p align="center" class="MsoNormal" style="text-align:center;layout-grid-mode:
  char"><span lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:
  微軟正黑體"><o:p>&nbsp;</o:p></span></p>
			</td>
			<td style="width:59.6pt;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;mso-border-top-alt:
  solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;mso-border-alt:
  solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt" width="79">
			<p align="center" class="MsoNormal" style="text-align:center;layout-grid-mode:
  char"><span lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:
  微軟正黑體"><o:p>&nbsp;</o:p></span></p>
			</td>
			<td style="width:59.6pt;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;mso-border-top-alt:
  solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;mso-border-alt:
  solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt" width="79">
			<p align="center" class="MsoNormal" style="text-align:center;layout-grid-mode:
  char"><span lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:
  微軟正黑體"><o:p>&nbsp;</o:p></span></p>
			</td>
			<td style="width:59.6pt;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;mso-border-top-alt:
  solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;mso-border-alt:
  solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt" width="79">
			<p align="center" class="MsoNormal" style="text-align:center;layout-grid-mode:
  char"><span style="font-family:&quot;微軟正黑體&quot;,sans-serif;mso-ascii-font-family:Arial;
  mso-hansi-font-family:Arial;mso-bidi-font-family:Arial">●</span><span lang="EN-US" style="font-size:10.0pt;mso-bidi-font-size:12.0pt;font-family:
  &quot;Arial&quot;,sans-serif;mso-fareast-font-family:微軟正黑體">(</span><span style="font-size:10.0pt;mso-bidi-font-size:12.0pt;font-family:&quot;微軟正黑體&quot;,sans-serif;
  mso-ascii-font-family:Arial;mso-hansi-font-family:Arial;mso-bidi-font-family:
  Arial">柳營</span><span lang="EN-US" style="font-size:10.0pt;mso-bidi-font-size:
  12.0pt;font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:微軟正黑體">)</span><span lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:
  微軟正黑體"><o:p></o:p></span></p>
			</td>
			<td style="width:57.65pt;border:none;mso-border-top-alt:solid windowtext .5pt;
  mso-border-left-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt" width="77">
			<p align="center" class="MsoNormal" style="text-align:center;layout-grid-mode:
  char"><span lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:
  微軟正黑體"><o:p>&nbsp;</o:p></span></p>
			</td>
		</tr>
		<tr style="mso-yfti-irow:3;mso-yfti-lastrow:yes">
			<td style="width:59.65pt;border:solid windowtext 1.0pt;border-top:
  none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt;
  padding:0cm 5.4pt 0cm 5.4pt" width="80">
			<p align="center" class="MsoNormal" style="text-align:center;layout-grid-mode:
  char"><span style="font-family:&quot;微軟正黑體&quot;,sans-serif;mso-ascii-font-family:Arial;
  mso-hansi-font-family:Arial;mso-bidi-font-family:Arial">晚上</span><span lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:
  微軟正黑體"><o:p></o:p></span></p>
			</td>
			<td style="width:59.65pt;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt" width="80">
			<p align="center" class="MsoNormal" style="text-align:center;layout-grid-mode:
  char"><span lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:
  微軟正黑體"><o:p>&nbsp;</o:p></span></p>
			</td>
			<td style="width:59.6pt;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;mso-border-top-alt:
  solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;mso-border-alt:
  solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt" width="79">
			<p align="center" class="MsoNormal" style="text-align:center;layout-grid-mode:
  char"><span style="font-family:&quot;微軟正黑體&quot;,sans-serif;mso-ascii-font-family:Arial;
  mso-hansi-font-family:Arial;mso-bidi-font-family:Arial">●</span><span lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:
  微軟正黑體"><o:p></o:p></span></p>
			</td>
			<td style="width:59.6pt;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;mso-border-top-alt:
  solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;mso-border-alt:
  solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt" width="79">
			<p align="center" class="MsoNormal" style="text-align:center;layout-grid-mode:
  char"><span lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:
  微軟正黑體"><o:p>&nbsp;</o:p></span></p>
			</td>
			<td style="width:59.6pt;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;mso-border-top-alt:
  solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;mso-border-alt:
  solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt" width="79">
			<p align="center" class="MsoNormal" style="text-align:center;layout-grid-mode:
  char"><span lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:
  微軟正黑體"><o:p>&nbsp;</o:p></span></p>
			</td>
			<td style="width:59.6pt;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;mso-border-top-alt:
  solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;mso-border-alt:
  solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt" width="79">
			<p align="center" class="MsoNormal" style="text-align:center;layout-grid-mode:
  char"><span lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:
  微軟正黑體"><o:p>&nbsp;</o:p></span></p>
			</td>
			<td style="width:57.65pt;border:none;mso-border-left-alt:solid windowtext .5pt;
  padding:0cm 5.4pt 0cm 5.4pt" width="77">
			<p align="center" class="MsoNormal" style="text-align:center;layout-grid-mode:
  char"><span lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:
  微軟正黑體"><o:p>&nbsp;</o:p></span></p>
			</td>
		</tr>
	</tbody>
</table>
</div>

<div style="mso-element:para-border-div;border:none black 1.0pt;mso-border-alt:
none black 0cm;padding:0cm 0cm 0cm 0cm">
<p class="MsoNormal" style="line-height:18.0pt;mso-line-height-rule:exactly;
border:none;mso-border-alt:none black 0cm;padding:0cm;mso-padding-alt:0cm 0cm 0cm 0cm"><span lang="EN-US" style="font-family:&quot;微軟正黑體&quot;,sans-serif;mso-bidi-font-family:微軟正黑體"><o:p>&nbsp;</o:p></span></p>
</div>

<p class="MsoNormal" style="line-height:16.0pt;mso-line-height-rule:exactly"><span lang="EN-US" style="font-size:20.0pt;mso-bidi-font-size:14.0pt;font-family:&quot;Arial&quot;,sans-serif;
mso-fareast-font-family:標楷體;mso-bidi-font-family:&quot;Times New Roman&quot;"><o:p>&nbsp;</o:p></span></p>
<!--EndFragment-->]]></content:encoded>
<link>https://www.cnma.org.tw/page/news/show.aspx?num=53320</link>
<pubDate>Thu, 20 Aug 2026 00:00:00 GMT</pubDate>
<category>健康醫療</category>
<enclosure url="https://www.cnma.org.tw/upload/news/202608200332430.jpg" />
</item>
<item>
<title><![CDATA[延伸醫師的眼睛與雙手！達文西機器人微創手術，助成大醫院精準攻克胸腔腫瘤]]></title>
<description><![CDATA[<span style="font-size:22px;">記者黃冠源/台南報導&nbsp; &nbsp; &nbsp; &nbsp;<br />
破解胸腔「小密深」限制！成大醫院達文西機器人微創手術 精準切除複雜腫瘤<br />
現代胸腔外科的發展重點，已從過往的「能不能切除」，提升至「在安全前提下切得更精準、更微創」，並盡可能保留病人的健康組織與生理功能。成大醫院持續拓展胸腔外科機器人輔助...…]]></description>
<content:encoded><![CDATA[<span style="font-size:22px;">記者黃冠源/台南報導&nbsp; &nbsp; &nbsp; &nbsp;<br />
破解胸腔「小密深」限制！成大醫院達文西機器人微創手術 精準切除複雜腫瘤<br />
現代胸腔外科的發展重點，已從過往的「能不能切除」，提升至「在安全前提下切得更精準、更微創」，並盡可能保留病人的健康組織與生理功能。成大醫院持續拓展胸腔外科機器人輔助微創手術量能，導入達文西機器人手術系統，為複雜胸腔手術提供更精細的操作選擇。<br />
<span style="font-size:22px;"><img alt="" src="https://www.cnma.org.tw/upload/web/S__76013591.jpg" /></span><br />
成大醫院胸腔外科湯文睿醫師強調，微創手術的核心始終是以「病人安全」與「治療效果」為最高原則，為每位患者評估並選擇最適合的手術方式。<br />
<br />
臨床案例分享：高難度胸腔腫瘤的精準救援<br />
案例一：33 歲楊小姐（10 公分巨型胸腔腫瘤）<br />
楊小姐因呼吸不適至成大醫院就醫，經電腦斷層檢查發現胸腔內藏有約 10 公分的巨大腫瘤。由於腫瘤體積龐大且周邊結構複雜，湯文睿醫師評估後，以達文西機器人輔助微創方式順利完成腫瘤切除，患者術後恢復狀況相當良好。<br />
<br />
案例二：63 歲林女士（侵犯性肺腫瘤與淋巴轉移）<br />
無抽菸、喝酒習慣的林女士因慢性咳嗽受檢，發現局部侵犯性肺腫瘤並合併淋巴結轉移。醫療團隊先安排「前導性免疫治療」縮小病灶、爭取手術機會；後續再透過機器人微創手術，於中央大血管區進行精細剝離與完整切除，成功完成階段性治療。<br />
<br />
攻克「小密深」環境！延伸醫師雙手與視野的智慧醫療<br />
胸腔手術的難點在於「小、密、深」&mdash;&mdash;操作空間深受肋骨限制，且血管、支氣管與神經等關鍵結構緊密相鄰，肺門及深部淋巴結更位於胸腔深處。<br />
<img alt="" src="https://www.cnma.org.tw/upload/web/S__76013590.jpg" /><br />
湯文睿醫師表示：「機器人不是替代醫師開刀，而是把醫師的眼睛與雙手延伸進胸腔。」<br />
<br />
3D 立體 10 倍放大視野： 協助醫師清晰辨識血管、支氣管與組織層次。<br />
<br />
多關節靈活器械與穩定系統： 消除手部震顫，在狹小空間內靈活轉灣、剝離與精細縫合。<br />
<br />
整合智慧醫療流程： 串接 AI 影像判讀、3D 重建手術規劃與複合式手術室（Hybrid OR）即時定位，讓術前規劃與術中執行完美銜接。<br />
<br />
機器人手術適用族群與評估<br />
湯文睿醫師指出，機器人手術需在合適病況下才能發揮最大價值，並非每位患者都需要。以下情況可評估使用：<br />
<br />
早期肺癌： 需要進行精準肺節或亞肺節切除者。<br />
<br />
中央型 / 困難腫瘤： 病灶緊鄰大血管、支氣管、肺門或深部淋巴結者。<br />
<br />
前導治療後： 接受前導化療或免疫治療後，組織較黏稠緊密、需要細緻剝離與重建者。<br />
<br />
最終是否採用機器人手術，仍須依病灶位置、整體治療計畫與病人身體狀況進行個案評估。<br />
<br />
醫師呼籲：早期發現，爭取更多精準治療選擇<br />
湯文睿醫師提醒，即使沒有吸菸史，若出現持續咳嗽、呼吸不適等症狀仍應儘早就醫。符合國民健康署肺癌高風險族群條件者，應定期接受胸部低劑量電腦斷層（LDCT）檢查。早期發現不僅治療選擇更多，也更有機會實施微創與精準切除。<br />
<br />
成大醫院胸腔外科秉持「早期發現、精準治療、快速恢復」的理念，將先進醫療科技轉化為實質醫療價值，協助病人在安全的前提下獲得最佳預後。</span>]]></content:encoded>
<link>https://www.cnma.org.tw/page/news/show.aspx?num=53307</link>
<pubDate>Wed, 19 Aug 2026 00:00:00 GMT</pubDate>
<category>健康醫療</category>
<enclosure url="https://www.cnma.org.tw/upload/news/202608192234230.jpg" />
</item>
<item>
<title><![CDATA[奇美醫院推微創正前開人工髖關節手術 助病友擺脫疼痛重拾行動力]]></title>
<description><![CDATA[<span style="font-size:20px;">記者李宥漮/健康醫療報導<br />
<br />
<br />
隨著台灣邁入超高齡社會，退化性關節炎、股骨頭壞死及髖部骨折等疾病日益增加，人工髖關節置換手術需求也持續攀升。奇美醫院指出，近年導入「微創正前開（DAA）人工髖關節置換手術」，憑藉傷口小、肌肉破壞少、恢復快等優勢，幫助不同年齡層患者擺脫疼痛、改善長短腳問題，重拾行動自由...…]]></description>
<content:encoded><![CDATA[<span style="font-size:20px;">記者李宥漮/健康醫療報導<br />
<br />
<br />
隨著台灣邁入超高齡社會，退化性關節炎、股骨頭壞死及髖部骨折等疾病日益增加，人工髖關節置換手術需求也持續攀升。奇美醫院指出，近年導入「微創正前開（DAA）人工髖關節置換手術」，憑藉傷口小、肌肉破壞少、恢復快等優勢，幫助不同年齡層患者擺脫疼痛、改善長短腳問題，重拾行動自由。<br />
<img alt="" src="https://www.cnma.org.tw/upload/web/IMG_3864(1).jpeg" /><br />
53歲廖女士因車禍造成骨盆骨折，後續引發股骨頭缺血性壞死及創傷後關節炎，導致股骨頭塌陷，不僅出現明顯長短腳，也因劇烈疼痛長期依賴輪椅、助行器及高劑量止痛藥維持生活。經奇美醫院骨科部主治醫師張文碩評估後，接受微創正前開全人工髖關節置換手術，利用病人平躺姿勢精準校正雙腳長度，術後隔天即可下床活動，一週後順利出院，三個月內成功擺脫輪椅與止痛藥，恢復正常行走能力。<br />
<img alt="" src="https://www.cnma.org.tw/upload/web/img_3867(2).jpeg" /><br />
另一名74歲婦人因在家跌倒造成左側股骨頸骨折，送醫後接受微創正前開半人工髖關節置換手術。由於手術無須切斷重要肌群，大幅降低組織損傷，患者術後隔天便能在助行器輔助下行走，第三天順利出院，復原情況良好。<br />
<br />
張文碩醫生表示，微創正前開人工髖關節置換手術最大的特色，在於透過天然肌肉間隙進入髖關節，不需切斷重要肌肉，因此具有「肌肉破壞少、術後疼痛較低」、「降低人工關節脫臼風險」及「可精準校正雙腳長度，減少長短腳問題」等三大優勢，有助於病人加速復原、提早下床活動。<br />
<br />
張文碩醫生指出，對高齡患者而言，及早恢復行動能力可降低肺炎、褥瘡及深部靜脈血栓等長期臥床併發症；對年輕及中壯年患者而言，則有助於更快重返工作與日常生活。奇美醫院將依據病患年齡、病況及生活需求，量身規劃最適合的治療方式，協助病人重拾健康與生活品質。</span>]]></content:encoded>
<link>https://www.cnma.org.tw/page/news/show.aspx?num=53041</link>
<pubDate>Thu, 06 Aug 2026 00:00:00 GMT</pubDate>
<category>健康醫療</category>
<enclosure url="https://www.cnma.org.tw/upload/news/202608061138100.jpeg" />
</item>
<item>
<title><![CDATA[68歲翁攝護腺肥大尿滯留 國軍臺中總醫院微創水蒸氣消融術助重拾順暢人生]]></title>
<description><![CDATA[<span style="font-size:20px;">記者謝昀宸/健康醫療報導<br />
<br />
<br />
許多中高齡男性長期飽受頻尿、夜尿及排尿困難困擾，卻常誤以為只是老化現象而延誤就醫。適逢父親節前夕，國軍臺中總醫院提醒，若家中長輩出現頻尿、夜尿、尿流變細、排尿困難等症狀，應及早接受泌尿科檢查。68歲陳先生因攝護腺肥大導致嚴重尿滯留，在接受微創「水蒸氣消融術（Rezum...…]]></description>
<content:encoded><![CDATA[<span style="font-size:20px;">記者謝昀宸/健康醫療報導<br />
<br />
<br />
許多中高齡男性長期飽受頻尿、夜尿及排尿困難困擾，卻常誤以為只是老化現象而延誤就醫。適逢父親節前夕，國軍臺中總醫院提醒，若家中長輩出現頻尿、夜尿、尿流變細、排尿困難等症狀，應及早接受泌尿科檢查。68歲陳先生因攝護腺肥大導致嚴重尿滯留，在接受微創「水蒸氣消融術（Rezum）」治療後，排尿功能明顯改善，也重新找回自在的退休生活。<br />
<img alt="" src="https://www.cnma.org.tw/upload/web/IMG_4097(2).jpeg" /><br />
陳先生退休後原本熱愛旅遊，但近半年逐漸出現排尿困難，每次如廁都需等待許久才能排尿，尿流細弱且排尿後仍有膀胱未排空的感覺，離開廁所不久又頻頻想上廁所，導致不敢安排長途旅行。夜間更需起床如廁3至4次，嚴重影響睡眠品質與日常生活。<br />
<br />
日前，陳先生因急性尿滯留至國軍臺中總醫院急診就醫，經藥物治療及導尿處置後，雖順利拔除尿管，但頻尿、夜尿及排尿不乾淨等症狀仍未改善。後續門診安排尿流速檢查，發現尿流速度僅為正常值三分之一，膀胱鏡檢查也證實攝護腺明顯肥大，壓迫尿道造成嚴重阻塞。<br />
<br />
國軍臺中總醫院泌尿外科醫師楊証傑表示，臨床上不少男性因頻尿、急尿、夜尿等問題影響睡眠及生活品質，卻因害羞或認為是正常老化而選擇隱忍，直到發生尿滯留才緊急就醫。事實上，攝護腺肥大並非只能忍耐，只要透過完整檢查與專業評估，選擇適合的治療方式，大多數患者都能有效改善症狀。<br />
<br />
經醫療團隊評估後，陳先生接受微創水蒸氣消融術治療，術後順利拔除尿管，排尿逐漸恢復順暢，夜尿次數也明顯減少，生活品質大幅提升。<br />
<br />
楊証傑醫師指出，水蒸氣消融術（Rezum）是近年新型微創治療方式，利用高溫水蒸氣將熱能精準作用於攝護腺增生組織，使肥大的組織逐漸自然萎縮，進而減少尿道壓迫、改善排尿功能。相較於傳統手術，具有手術時間短、傷口小、恢復快等優點，也有助於保留男性性功能，對於高齡患者、患有心血管疾病，或不適合長時間麻醉的患者而言，是相當適合的治療選擇。<br />
<br />
此外，國軍臺中總醫院今年也導入另一項微創技術「攝護腺拉提手術（UroLift）」，透過特殊植入物將攝護腺增生組織向兩側固定，擴大尿道通道，過程無須切除或加熱攝護腺組織，同樣具有恢復快、創傷小的優勢。至於適合採用水蒸氣消融術、攝護腺拉提手術或其他治療方式，仍須依據患者攝護腺大小、阻塞位置、症狀嚴重程度及整體健康狀況，由專業醫師評估後決定最適合的治療方案。<br />
<br />
楊証傑醫師提醒，攝護腺肥大若長期未治療，尿路阻塞可能導致膀胱肌肉持續過度用力，久而久之造成膀胱彈性下降，甚至出現不可逆的膀胱功能退化，即使日後接受手術解除阻塞，也未必能完全恢復正常排尿功能，因此把握治療時機相當重要。<br />
<br />
適逢父親節，楊證傑呼籲，除了送上祝福與禮物，也別忘了關心爸爸的健康。若家中長輩出現尿流變細、排尿斷斷續續、解尿需等待或用力，以及頻尿、急尿、漏尿或夜尿增加等情形，甚至已影響睡眠品質與日常生活，切勿視為正常老化，應及早至泌尿科接受專業評估與治療，以降低尿滯留、泌尿道感染及膀胱功能受損等併發症風險，守護晚年生活品質。</span>]]></content:encoded>
<link>https://www.cnma.org.tw/page/news/show.aspx?num=53071</link>
<pubDate>Thu, 06 Aug 2026 00:00:00 GMT</pubDate>
<category>健康醫療</category>
<enclosure url="https://www.cnma.org.tw/upload/news/202608061308280.jpeg" />
</item>
<item>
<title><![CDATA[皮蛇劇痛如火燒！成醫：早期「神經阻斷術」精準止痛   防慢性神經痛纏身]]></title>
<description><![CDATA[<span style="font-size:22px;">記者黃冠源/台南報導 &nbsp; &nbsp; &nbsp;<br />
帶狀皰疹（俗稱「皮蛇」）發作時，往往伴隨令人難以忍受的劇烈灼熱與刺痛感，這種針扎或火燒般的疼痛，不僅嚴重影響患者的日常活動，更常常干擾夜間睡眠，導致生活品質大幅度降低。<br />
<span style="font-size:22px;"><img alt=...…]]></description>
<content:encoded><![CDATA[<span style="font-size:22px;">記者黃冠源/台南報導 &nbsp; &nbsp; &nbsp;<br />
帶狀皰疹（俗稱「皮蛇」）發作時，往往伴隨令人難以忍受的劇烈灼熱與刺痛感，這種針扎或火燒般的疼痛，不僅嚴重影響患者的日常活動，更常常干擾夜間睡眠，導致生活品質大幅度降低。<br />
<span style="font-size:22px;"><img alt="" src="https://www.cnma.org.tw/upload/web/IMG_3256(4).jpeg" /></span><br />
成大醫院麻醉部謝佑蓮醫師指出，根據臨床統計，超過九成的急性帶狀皰疹患者在發病期間會經歷嚴重的急性疼痛。更令人擔憂的是，即使在皮膚水泡癒合、經過標準治療後，仍有超過兩成的患者，其疼痛感會持續超過三個月以上，最終演變為極其難以治癒的「皰疹後神經痛」（Postherpetic Neuralgia, PHN），對患者的身心健康造成長期的折磨與負面影響。<br />
<br />
謝佑蓮醫師進一步說明，傳統上面對帶狀皰疹的臨床治療，主要是以抗病毒藥物搭配常規止痛藥物為主。然而，為了更有效率地在第一時間控制急性疼痛，並積極預防病程演變為難治的慢性疼痛，麻醉科醫師可以運用現代醫學的「神經阻斷術」進行早期介入。針對臨床上最常見發生於胸部及腹部的帶狀皰疹，醫師能透過高解析度超音波的精準導引，執行「豎脊肌平面神經阻斷」（Erector Spinae Plane Block, ESP block）或「胸椎旁神經阻斷」（Paravertebral Block, PVB）。此技術是將局部麻醉藥物及類固醇精確地注射至受影響的神經周圍，不僅能瞬間阻斷疼痛訊號向大腦傳遞，更有助於在源頭減輕神經的發炎反應。<br />
<img alt="" src="https://www.cnma.org.tw/upload/web/img_3259(1).jpeg" /><br />
根據近期多項國內外臨床研究證實，接受神經阻斷術治療的患者，在介入後的四週之內，其疼痛程度皆出現明顯且顯著的下降，同時也大幅減少了後續口服神經痛藥物及一般常見止痛藥物（如乙醯胺酚）的使用劑量。更重要的是，神經阻斷術除了能立即改善急性期的劇烈疼痛，更具備關鍵的「預防」慢性神經痛效果。醫學研究發現，急性期爆發的劇烈疼痛，正是引發人體中樞神經敏感化、進而導致慢性神經痛的核心危险因子；因此，若能在早期及時介入神經阻斷術，將能顯著降低患者在三至六個月後發展為皰疹後神經痛的風險。<br />
<br />
<span style="font-size:22px;"><img alt="" src="https://www.cnma.org.tw/upload/web/img_3257(3).jpeg" /></span>謝佑蓮醫師特別指出，在現行各項神經阻斷技術當中，超音波導引下的「豎脊肌平面神經阻斷」因其解剖位置的優勢，安全性極高，目前在臨床應用上尚未發現顯著的嚴重副作用，因此被各大醫學指引建議作為急性期止痛的首選策略。<br />
<br />
而另一項「胸椎旁神經阻斷」同樣具有相當優異的止痛及預防神經痛效果，不過少數患者在施作後可能會出現短暫的頭暈、嗜睡或注射部位局部疼痛等輕微不適，臨床上皆能妥善處理。疼痛雖然是身體發生異常時的保護警訊，但若是演變成持續性的劇烈疼痛，就會成為破壞生活品質的隱形殺手。<br />
<br />
謝佑蓮醫師再次呼籲並提醒民眾，面對急性帶狀皰疹發作，切勿聽信偏方，應儘速就醫接受正規的抗病毒治療；倘若發現身上疼痛感異常劇烈，或是口服止痛藥的效果非常有限，建議進一步至醫院的「疼痛科門診」進行專業評估。透過精準的超音波導引神經阻斷術，不僅能陪伴患者安全、舒適地度過急性期的「皮蛇」劇痛，更能大幅降低未來轉變為慢性神經痛的隱憂，重拾健康的生活品質。</span>]]></content:encoded>
<link>https://www.cnma.org.tw/page/news/show.aspx?num=53021</link>
<pubDate>Wed, 05 Aug 2026 00:00:00 GMT</pubDate>
<category>健康醫療</category>
<enclosure url="https://www.cnma.org.tw/upload/news/202608051621180.jpeg" />
</item>
<item>
<title><![CDATA[三分之一難治型憂鬱症藥石罔效走進死胡同？  奇美醫院採鼻噴劑＋加速型iTBS成功緩解輕生念頭]]></title>
<description><![CDATA[<span style="font-size:20px;"></span><!--StartFragment-->
<p align="right" class="MsoNormal" style="text-align:right;layout-grid-mode:char;
punctuation-wrap:simple;word-break:break-all"><span style=...…]]></description>
<content:encoded><![CDATA[<span style="font-size:20px;"></span><!--StartFragment-->
<p align="right" class="MsoNormal" style="text-align:right;layout-grid-mode:char;
punctuation-wrap:simple;word-break:break-all"><span style="font-size:13.0pt;
font-family:&quot;微軟正黑體&quot;,sans-serif;mso-ascii-font-family:Arial;mso-hansi-font-family:
Arial">記者:徐素秋 台南市報導<br />
<br />
奇美醫療財團法人奇美醫院精神醫學部主治醫師</span><span style="font-size:13.0pt;font-family:
&quot;Arial&quot;,sans-serif;mso-fareast-font-family:微軟正黑體;mso-bidi-font-family:&quot;Times New Roman&quot;"> </span><span style="font-size:13.0pt;font-family:&quot;微軟正黑體&quot;,sans-serif;mso-ascii-font-family:
Arial;mso-hansi-font-family:Arial">張俊鴻<img src="../../upload/web/images/精神醫學部主治醫師張俊鴻門診示意圖.jpg" /></span><span lang="EN-US" style="font-size:
13.0pt;font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:微軟正黑體;mso-bidi-font-family:
&quot;Times New Roman&quot;"><o:p></o:p></span></p>

<p class="MsoNormal" style="margin-top:12.0pt;mso-para-margin-top:1.0gd;
text-align:justify;text-justify:inter-ideograph"><b><span style="font-size:
14.0pt;font-family:&quot;微軟正黑體&quot;,sans-serif;mso-ascii-font-family:Arial;mso-hansi-font-family:
Arial;color:black;mso-color-alt:windowtext;background:#FDE9D9;mso-shading-themecolor:
accent6;mso-shading-themetint:51">難治療型憂鬱症一週整合治療見成效！奇美醫院研究登上國際期刊</span></b><b><span lang="EN-US" style="font-size:14.0pt;font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:
微軟正黑體;mso-bidi-font-family:&quot;Times New Roman&quot;;background:#FDE9D9;mso-shading-themecolor:
accent6;mso-shading-themetint:51"><o:p></o:p></span></b></p>

<p class="MsoNormal" style="text-align:justify;text-justify:inter-ideograph;
text-indent:24.0pt;mso-char-indent-count:2.0;punctuation-wrap:simple"><span style="font-family:&quot;新細明體&quot;,serif;mso-ascii-font-family:Arial;mso-hansi-font-family:
Arial">憂鬱症不是不知足，而是大腦生病了！根據衛生福利部統計，</span><span lang="EN-US" style="font-family:
&quot;Arial&quot;,sans-serif;mso-bidi-font-family:&quot;Times New Roman&quot;">2024</span><span style="font-family:&quot;新細明體&quot;,serif;mso-ascii-font-family:Arial;mso-hansi-font-family:
Arial">年國內自殺死亡人數達</span><span lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;
mso-bidi-font-family:&quot;Times New Roman&quot;">4,062</span><span style="font-family:
&quot;新細明體&quot;,serif;mso-ascii-font-family:Arial;mso-hansi-font-family:Arial">人，較前一年增加</span><span lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;mso-bidi-font-family:&quot;Times New Roman&quot;">164</span><span style="font-family:&quot;新細明體&quot;,serif;mso-ascii-font-family:Arial;mso-hansi-font-family:
Arial">人（成長</span><span lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;
mso-bidi-font-family:&quot;Times New Roman&quot;">4.2%</span><span style="font-family:
&quot;新細明體&quot;,serif;mso-ascii-font-family:Arial;mso-hansi-font-family:Arial">），再次進入國人十大死因第</span><span lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;mso-bidi-font-family:&quot;Times New Roman&quot;">10</span><span style="font-family:&quot;新細明體&quot;,serif;mso-ascii-font-family:Arial;mso-hansi-font-family:
Arial">位。其中</span><span lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;
mso-bidi-font-family:&quot;Times New Roman&quot;">25</span><span style="font-family:&quot;新細明體&quot;,serif;
mso-ascii-font-family:Arial;mso-hansi-font-family:Arial">至</span><span lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;mso-bidi-font-family:&quot;Times New Roman&quot;">44</span><span style="font-family:&quot;新細明體&quot;,serif;mso-ascii-font-family:Arial;mso-hansi-font-family:
Arial">歲族群自殺率增幅更超過一成，顯示憂鬱症及自殺防治已成為重要公共衛生議題。全球約有三分之一的憂鬱症病人即使接受多種抗憂鬱藥物、心理治療及經顱磁刺激</span><span lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;mso-bidi-font-family:&quot;Times New Roman&quot;">(TMS)</span><span style="font-family:&quot;新細明體&quot;,serif;mso-ascii-font-family:Arial;mso-hansi-font-family:
Arial">等治療，病情仍反覆發作，稱為「難治療型憂鬱症</span><span lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;
mso-bidi-font-family:&quot;Times New Roman&quot;">(TRD)</span><span style="font-family:
&quot;新細明體&quot;,serif;mso-ascii-font-family:Arial;mso-hansi-font-family:Arial">」，若同時出現高度自殺意念，更屬精神醫療急症，需要及時介入。</span><span lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;mso-bidi-font-family:&quot;Times New Roman&quot;;
color:red"><o:p></o:p></span></p>

<p class="MsoNormal" style="margin-top:12.0pt;mso-para-margin-top:1.0gd;
text-align:justify;text-justify:inter-ideograph;text-indent:24.0pt;mso-char-indent-count:
2.0;punctuation-wrap:simple"><span style="font-family:&quot;新細明體&quot;,serif;mso-ascii-font-family:
Arial;mso-hansi-font-family:Arial">奇美醫療財團法人奇美醫院精神醫學部主治醫師張俊鴻運用一<b style="mso-bidi-font-weight:normal">次性的「艾司氯胺酮</b></span><b style="mso-bidi-font-weight:
normal"><span lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;mso-bidi-font-family:
&quot;Times New Roman&quot;">(Esketamine)</span></b><b style="mso-bidi-font-weight:normal"><span style="font-family:&quot;新細明體&quot;,serif;mso-ascii-font-family:Arial;mso-hansi-font-family:
Arial">鼻噴劑</span></b><span style="font-family:&quot;新細明體&quot;,serif;mso-ascii-font-family:
Arial;mso-hansi-font-family:Arial">，以下簡稱<b style="mso-bidi-font-weight:normal">速效抗憂鬱鼻噴劑」結合一週內完成</b></span><b style="mso-bidi-font-weight:normal"><span lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;
mso-bidi-font-family:&quot;Times New Roman&quot;">10</span></b><b style="mso-bidi-font-weight:
normal"><span style="font-family:&quot;新細明體&quot;,serif;mso-ascii-font-family:Arial;
mso-hansi-font-family:Arial">次的「加速型間歇性希塔波叢集磁波刺激</span></b><b style="mso-bidi-font-weight:
normal"><span lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;mso-bidi-font-family:
&quot;Times New Roman&quot;">(aiTBS)</span></b><span style="font-family:&quot;新細明體&quot;,serif;
mso-ascii-font-family:Arial;mso-hansi-font-family:Arial">，以下簡稱<b style="mso-bidi-font-weight:normal">加速型</b></span><b style="mso-bidi-font-weight:
normal"><span lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;mso-bidi-font-family:
&quot;Times New Roman&quot;">iTBS</span></b><b style="mso-bidi-font-weight:normal"><span style="font-family:&quot;新細明體&quot;,serif;mso-ascii-font-family:Arial;mso-hansi-font-family:
Arial">」</span></b><span style="font-family:&quot;新細明體&quot;,serif;mso-ascii-font-family:
Arial;mso-hansi-font-family:Arial">整合治療，成功協助一名</span><span lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;mso-bidi-font-family:&quot;Times New Roman&quot;">29</span><span style="font-family:&quot;新細明體&quot;,serif;mso-ascii-font-family:Arial;mso-hansi-font-family:
Arial">歲重度難治型憂鬱症合併高風險自殺意念病人，在短短一週內改善憂鬱症狀及自殺意念。這項臨床經驗已正式發表於國際知名醫學期刊《</span><span lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;mso-bidi-font-family:&quot;Times New Roman&quot;">Frontiers in Psychiatry</span><span style="font-family:&quot;新細明體&quot;,serif;mso-ascii-font-family:
Arial;mso-hansi-font-family:Arial">》，雖然本研究屬單一個案報告，尚無法直接證明治療效果，但也為難治型憂鬱症家庭帶來新的治療方向，也值得未來透過更大型的臨床研究進一步驗證其安全性與療效。</span><span lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;mso-bidi-font-family:&quot;Times New Roman&quot;"><o:p></o:p></span></p>

<p class="MsoNormal" style="margin-top:12.0pt;mso-para-margin-top:1.0gd;
text-align:justify;text-justify:inter-ideograph"><b><span style="font-size:
14.0pt;font-family:&quot;微軟正黑體&quot;,sans-serif;mso-ascii-font-family:Arial;mso-hansi-font-family:
Arial;color:black;mso-color-alt:windowtext;background:#FDE9D9;mso-shading-themecolor:
accent6;mso-shading-themetint:51">多種治療仍藥石罔效，難治療型憂鬱症住院一週迎來改善契機</span></b><b><span lang="EN-US" style="font-size:14.0pt;font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:
微軟正黑體;mso-bidi-font-family:&quot;Times New Roman&quot;;background:#FDE9D9;mso-shading-themecolor:
accent6;mso-shading-themetint:51"><o:p></o:p></span></b></p>

<p class="MsoNormal" style="text-align:justify;text-justify:inter-ideograph;
text-indent:24.0pt;mso-char-indent-count:2.0;punctuation-wrap:simple"><span style="font-family:&quot;新細明體&quot;,serif;mso-ascii-font-family:Arial;mso-hansi-font-family:
Arial">傳統憂鬱症藥物通常需要幾週甚至幾個月才能見效，但對於處在自殺高風險邊緣的精神急症病人來說，「時間就是生命」。奇美醫療財團法人奇美醫院精神醫學部主治醫師張俊鴻表示，此次個案是一名</span><span lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;mso-bidi-font-family:&quot;Times New Roman&quot;">29</span><span style="font-family:&quot;新細明體&quot;,serif;mso-ascii-font-family:Arial;mso-hansi-font-family:
Arial">歲女性，長期罹患重度憂鬱症，過去曾接受多種抗憂鬱藥物、心理治療及超過</span><span lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;mso-bidi-font-family:&quot;Times New Roman&quot;">30</span><span style="font-family:&quot;新細明體&quot;,serif;mso-ascii-font-family:Arial;mso-hansi-font-family:
Arial">次傳統經顱磁刺激</span><span lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;
mso-bidi-font-family:&quot;Times New Roman&quot;">(TMS)</span><span style="font-family:
&quot;新細明體&quot;,serif;mso-ascii-font-family:Arial;mso-hansi-font-family:Arial">治療，病情卻依舊反覆發作，因憂鬱惡化並伴隨高度自殺意念緊急入住奇美醫院接受治療。對她與家屬而言，傳統治療途徑彷彿走進了死胡同，經張醫師評估後，安排病人接受一次</span><span lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;mso-bidi-font-family:&quot;Times New Roman&quot;">84</span><span style="font-family:&quot;新細明體&quot;,serif;mso-ascii-font-family:Arial;mso-hansi-font-family:
Arial">毫克速效抗憂鬱鼻噴劑治療，並於一週內完成</span><span lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;
mso-bidi-font-family:&quot;Times New Roman&quot;">10</span><span style="font-family:&quot;新細明體&quot;,serif;
mso-ascii-font-family:Arial;mso-hansi-font-family:Arial">次加速型</span><span lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;mso-bidi-font-family:&quot;Times New Roman&quot;">iTBS</span><span style="font-family:&quot;新細明體&quot;,serif;mso-ascii-font-family:Arial;mso-hansi-font-family:
Arial">療程，希望藉由新型抗憂鬱藥物與非侵入性腦刺激的整合治療，在短時間內協助病人度過最危險的急性期。</span><span lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;mso-bidi-font-family:&quot;Times New Roman&quot;"><o:p></o:p></span></p>

<p class="MsoNormal" style="margin-top:12.0pt;mso-para-margin-top:1.0gd;
text-align:justify;text-justify:inter-ideograph"><b><span style="font-size:
14.0pt;font-family:&quot;微軟正黑體&quot;,sans-serif;mso-ascii-font-family:Arial;mso-hansi-font-family:
Arial;color:black;mso-color-alt:windowtext;background:#FDE9D9;mso-shading-themecolor:
accent6;mso-shading-themetint:51">一週治療、兩週追蹤，雙管齊下讓憂鬱症狀與自殺意念持續改善</span></b><b><span lang="EN-US" style="font-size:14.0pt;font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:
微軟正黑體;mso-bidi-font-family:&quot;Times New Roman&quot;;background:#FDE9D9;mso-shading-themecolor:
accent6;mso-shading-themetint:51"><o:p></o:p></span></b></p>

<p class="MsoNormal" style="text-align:justify;text-justify:inter-ideograph;
text-indent:24.0pt;mso-char-indent-count:2.0;punctuation-wrap:simple"><span style="font-family:&quot;新細明體&quot;,serif;mso-ascii-font-family:Arial;mso-hansi-font-family:
Arial">奇美醫療財團法人奇美醫院精神醫學部主治醫師張俊鴻指出，治療完成後，病人的憂鬱症狀明顯改善，多項臨床評估量表皆呈現下降趨勢，包括病人健康狀況問卷</span><span lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;mso-bidi-font-family:&quot;Times New Roman&quot;">(PHQ-9)</span><span style="font-family:&quot;新細明體&quot;,serif;mso-ascii-font-family:Arial;mso-hansi-font-family:
Arial">由</span><span lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;
mso-bidi-font-family:&quot;Times New Roman&quot;">15</span><span style="font-family:&quot;新細明體&quot;,serif;
mso-ascii-font-family:Arial;mso-hansi-font-family:Arial">分降至</span><span lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;mso-bidi-font-family:&quot;Times New Roman&quot;">11</span><span style="font-family:&quot;新細明體&quot;,serif;mso-ascii-font-family:Arial;mso-hansi-font-family:
Arial">分、漢氏憂鬱量表</span><span lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;
mso-bidi-font-family:&quot;Times New Roman&quot;">(HAMD)</span><span style="font-family:
&quot;新細明體&quot;,serif;mso-ascii-font-family:Arial;mso-hansi-font-family:Arial">由</span><span lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;mso-bidi-font-family:&quot;Times New Roman&quot;">27</span><span style="font-family:&quot;新細明體&quot;,serif;mso-ascii-font-family:Arial;mso-hansi-font-family:
Arial">分降至</span><span lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;
mso-bidi-font-family:&quot;Times New Roman&quot;">20</span><span style="font-family:&quot;新細明體&quot;,serif;
mso-ascii-font-family:Arial;mso-hansi-font-family:Arial">分、貝克憂鬱量表</span><span lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;mso-bidi-font-family:&quot;Times New Roman&quot;">(BDI)</span><span style="font-family:&quot;新細明體&quot;,serif;mso-ascii-font-family:Arial;mso-hansi-font-family:
Arial">由</span><span lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;
mso-bidi-font-family:&quot;Times New Roman&quot;">41</span><span style="font-family:&quot;新細明體&quot;,serif;
mso-ascii-font-family:Arial;mso-hansi-font-family:Arial">分降至</span><span lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;mso-bidi-font-family:&quot;Times New Roman&quot;">28</span><span style="font-family:&quot;新細明體&quot;,serif;mso-ascii-font-family:Arial;mso-hansi-font-family:
Arial">分，病人也主觀表示自殺意念明顯減輕。兩週後持續追蹤時，改善情形仍持續，</span><span lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;mso-bidi-font-family:&quot;Times New Roman&quot;">PHQ-9</span><span style="font-family:&quot;新細明體&quot;,serif;mso-ascii-font-family:Arial;mso-hansi-font-family:
Arial">進一步降至</span><span lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;
mso-bidi-font-family:&quot;Times New Roman&quot;">8</span><span style="font-family:&quot;新細明體&quot;,serif;
mso-ascii-font-family:Arial;mso-hansi-font-family:Arial">分、</span><span lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;mso-bidi-font-family:&quot;Times New Roman&quot;">HAMD</span><span style="font-family:&quot;新細明體&quot;,serif;mso-ascii-font-family:Arial;mso-hansi-font-family:
Arial">降至</span><span lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;
mso-bidi-font-family:&quot;Times New Roman&quot;">17</span><span style="font-family:&quot;新細明體&quot;,serif;
mso-ascii-font-family:Arial;mso-hansi-font-family:Arial">分、</span><span lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;mso-bidi-font-family:&quot;Times New Roman&quot;">BDI</span><span style="font-family:&quot;新細明體&quot;,serif;mso-ascii-font-family:Arial;mso-hansi-font-family:
Arial">降至</span><span lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;
mso-bidi-font-family:&quot;Times New Roman&quot;">23</span><span style="font-family:&quot;新細明體&quot;,serif;
mso-ascii-font-family:Arial;mso-hansi-font-family:Arial">分，顯示整體臨床狀況維持穩定進步。張醫師認為，對於急性高風險難治型憂鬱症病人而言，若能在短時間內降低憂鬱症狀及自殺風險，將有助於爭取後續治療與復原的機會。</span><span lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;mso-bidi-font-family:&quot;Times New Roman&quot;"><o:p></o:p></span></p>

<p class="MsoNormal" style="margin-top:12.0pt;mso-para-margin-top:1.0gd;
text-align:justify;text-justify:inter-ideograph"><b><span lang="EN-US" style="font-size:14.0pt;font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:
微軟正黑體;mso-bidi-font-family:&quot;Times New Roman&quot;;color:black;mso-color-alt:windowtext;
background:#FDE9D9;mso-shading-themecolor:accent6;mso-shading-themetint:51">AI</span></b><b><span style="font-size:14.0pt;font-family:&quot;微軟正黑體&quot;,sans-serif;mso-ascii-font-family:
Arial;mso-hansi-font-family:Arial;color:black;mso-color-alt:windowtext;
background:#FDE9D9;mso-shading-themecolor:accent6;mso-shading-themetint:51">腦波同步評估，讓精神治療多一項客觀參考</span></b><b><span lang="EN-US" style="font-size:14.0pt;font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:
微軟正黑體;mso-bidi-font-family:&quot;Times New Roman&quot;;background:#FDE9D9;mso-shading-themecolor:
accent6;mso-shading-themetint:51"><o:p></o:p></span></b></p>

<p class="MsoNormal" style="text-align:justify;text-justify:inter-ideograph;
text-indent:24.0pt;mso-char-indent-count:2.0;punctuation-wrap:simple"><span style="font-family:&quot;新細明體&quot;,serif;mso-ascii-font-family:Arial;mso-hansi-font-family:
Arial">除了臨床症狀評估外，奇美醫療財團法人奇美醫院精神醫學部主治醫師張俊鴻也同步使用通過臺灣衛生福利部食品藥物管理署</span><span lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;mso-bidi-font-family:&quot;Times New Roman&quot;">(TFDA)</span><span style="font-family:&quot;新細明體&quot;,serif;mso-ascii-font-family:Arial;mso-hansi-font-family:
Arial">核准的</span><span lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;
mso-bidi-font-family:&quot;Times New Roman&quot;">Stress EEG Assessment(SEA)</span><span style="font-family:&quot;新細明體&quot;,serif;mso-ascii-font-family:Arial;mso-hansi-font-family:
Arial">人工智慧腦波分析系統，作為輔助評估工具。結果顯示，病人治療前的</span><span lang="EN-US" style="font-family:
&quot;Arial&quot;,sans-serif;mso-bidi-font-family:&quot;Times New Roman&quot;">SEA</span><span style="font-family:&quot;新細明體&quot;,serif;mso-ascii-font-family:Arial;mso-hansi-font-family:
Arial">壓力指數由</span><span lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;
mso-bidi-font-family:&quot;Times New Roman&quot;">7</span><span style="font-family:&quot;新細明體&quot;,serif;
mso-ascii-font-family:Arial;mso-hansi-font-family:Arial">分下降至治療後</span><span lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;mso-bidi-font-family:&quot;Times New Roman&quot;">3</span><span style="font-family:&quot;新細明體&quot;,serif;mso-ascii-font-family:Arial;mso-hansi-font-family:
Arial">分，其變化方向與臨床症狀改善一致。張醫師指出，</span><span lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;
mso-bidi-font-family:&quot;Times New Roman&quot;">AI</span><span style="font-family:&quot;新細明體&quot;,serif;
mso-ascii-font-family:Arial;mso-hansi-font-family:Arial">腦波分析有機會提供醫師更多客觀資訊，協助觀察治療反應，但目前仍屬探索性輔助工具，未來仍需要更多大型研究進一步驗證其臨床價值。</span><span lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;mso-bidi-font-family:&quot;Times New Roman&quot;"><o:p></o:p></span></p>

<p class="MsoNormal" style="margin-top:12.0pt;mso-para-margin-top:1.0gd;
text-align:justify;text-justify:inter-ideograph"><b><span style="font-size:
14.0pt;font-family:&quot;微軟正黑體&quot;,sans-serif;mso-ascii-font-family:Arial;mso-hansi-font-family:
Arial;color:black;mso-color-alt:windowtext;background:#FDE9D9;mso-shading-themecolor:
accent6;mso-shading-themetint:51">新藥搭配加速型腦刺激「雙管齊下」，縮短等待改善的時間</span></b><b><span lang="EN-US" style="font-size:14.0pt;font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:
微軟正黑體;mso-bidi-font-family:&quot;Times New Roman&quot;;background:#FDE9D9;mso-shading-themecolor:
accent6;mso-shading-themetint:51"><o:p></o:p></span></b></p>

<p class="MsoNormal" style="text-align:justify;text-justify:inter-ideograph;
text-indent:24.0pt;mso-char-indent-count:2.0;punctuation-wrap:simple"><span style="font-family:&quot;新細明體&quot;,serif;mso-ascii-font-family:Arial;mso-hansi-font-family:
Arial">奇美醫療財團法人奇美醫院精神醫學部主治醫師張俊鴻表示，<b style="mso-bidi-font-weight:normal"><u>速效抗憂鬱鼻噴劑</u></b>經黏膜快速吸收，部分病人在</span><span lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;mso-bidi-font-family:&quot;Times New Roman&quot;">24</span><span style="font-family:&quot;新細明體&quot;,serif;mso-ascii-font-family:Arial;mso-hansi-font-family:
Arial">小時內即可改善急性憂鬱症狀，緩解自殺意念。</span><span lang="EN-US"><a href="https://www.frontiersin.org/journals/psychiatry/articles/10.3389/fpsyt.2026.1774549/full"><span lang="EN-US" style="font-family:&quot;新細明體&quot;,serif;mso-ascii-font-family:Arial;
mso-hansi-font-family:Arial"><span lang="EN-US">國際大型臨床<span lang="EN-US">研究</span></span></span></a></span><a href="#_ftn1" name="_ftnref1" style="mso-footnote-id:ftn1" title=""><span class="MsoFootnoteReference"><span lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;
mso-bidi-font-family:&quot;Times New Roman&quot;"><span style="mso-special-character:
footnote"><!--[if !supportFootnotes]--><span class="MsoFootnoteReference"><span lang="EN-US" style="font-size:12.0pt;font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:
新細明體;mso-bidi-font-family:&quot;Times New Roman&quot;;mso-font-kerning:1.0pt;mso-ansi-language:
EN-US;mso-fareast-language:ZH-TW;mso-bidi-language:AR-SA">[1]</span></span><!--[endif]--></span></span></span></a><span style="font-family:&quot;新細明體&quot;,serif;mso-ascii-font-family:Arial;mso-hansi-font-family:
Arial">亦發現，約七成難治型憂鬱症病人接受完整四週的速效抗憂鬱鼻噴劑合併口服抗憂鬱劑治療後，憂鬱症狀改善約</span><span lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;mso-bidi-font-family:&quot;Times New Roman&quot;">52%</span><span style="font-family:&quot;新細明體&quot;,serif;mso-ascii-font-family:Arial;mso-hansi-font-family:
Arial">；而<b style="mso-bidi-font-weight:normal"><u>加速型</u></b></span><b style="mso-bidi-font-weight:normal"><u><span lang="EN-US" style="font-family:
&quot;Arial&quot;,sans-serif;mso-bidi-font-family:&quot;Times New Roman&quot;">iTBS</span></u></b><span style="font-family:&quot;新細明體&quot;,serif;mso-ascii-font-family:Arial;mso-hansi-font-family:
Arial">則是在短時間內完成多次非侵入性腦刺激治療，相較傳統經顱磁刺激療程，更有機會縮短整體治療時間，對於需要快速控制症狀的病人，提供新的治療方向。兩項技術皆已成為近年精神醫療的重要發展趨勢，也讓醫師能依病人病情規劃更適合的個人化治療策略。<img src="../../upload/web/images/精神醫學部主治醫師張俊鴻示範及協助病人使用一次性的「艾司氯胺酮(Esk...e。艾司氯胺酮(Esketamine)鼻噴劑具有快速抗憂鬱特性，近年已成為難治型憂鬱症的重要治療選擇之一.jpg" /></span><span lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;mso-bidi-font-family:&quot;Times New Roman&quot;"><o:p></o:p></span></p>

<p class="MsoNormal" style="margin-top:12.0pt;mso-para-margin-top:1.0gd;
text-align:justify;text-justify:inter-ideograph"><b><span style="font-size:
14.0pt;font-family:&quot;微軟正黑體&quot;,sans-serif;mso-ascii-font-family:Arial;mso-hansi-font-family:
Arial;color:black;mso-color-alt:windowtext;background:#FDE9D9;mso-shading-themecolor:
accent6;mso-shading-themetint:51">整合新藥、腦刺激與</span></b><b><span lang="EN-US" style="font-size:14.0pt;font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:
微軟正黑體;mso-bidi-font-family:&quot;Times New Roman&quot;;color:black;mso-color-alt:windowtext;
background:#FDE9D9;mso-shading-themecolor:accent6;mso-shading-themetint:51">AI</span></b><b><span style="font-size:14.0pt;font-family:&quot;微軟正黑體&quot;,sans-serif;mso-ascii-font-family:
Arial;mso-hansi-font-family:Arial;color:black;mso-color-alt:windowtext;
background:#FDE9D9;mso-shading-themecolor:accent6;mso-shading-themetint:51">，朝精準精神醫療邁進！</span></b><b><span lang="EN-US" style="font-size:14.0pt;font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:
微軟正黑體;mso-bidi-font-family:&quot;Times New Roman&quot;;background:#FDE9D9;mso-shading-themecolor:
accent6;mso-shading-themetint:51"><o:p></o:p></span></b></p>

<p class="MsoNormal" style="text-align:justify;text-justify:inter-ideograph;
text-indent:24.0pt;mso-char-indent-count:2.0;punctuation-wrap:simple"><span style="font-family:&quot;新細明體&quot;,serif;mso-ascii-font-family:Arial;mso-hansi-font-family:
Arial">奇美醫療財團法人奇美醫院精神醫學部主治醫師張俊鴻強調，精神醫療正逐步邁向「精準精神醫學</span><span lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;mso-bidi-font-family:&quot;Times New Roman&quot;">(Precision Psychiatry)</span><span style="font-family:&quot;新細明體&quot;,serif;mso-ascii-font-family:
Arial;mso-hansi-font-family:Arial">」發展，結合新型藥物、非侵入性腦刺激、人工智慧與大腦功能評估，希望能更早、更精準辨識出高風險病人，提供更快速、更個人化的治療策略，縮短病人等待療效的時間，提升治療成功率，亦呼應「健康臺灣深耕計畫」推動智慧醫療、精準照護及創新醫療服務的核心精神，為難治型憂鬱症病人帶來更多治療新希望。</span><span lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;mso-bidi-font-family:&quot;Times New Roman&quot;"><o:p></o:p></span></p>

<p class="MsoNormal" style="margin-top:12.0pt;mso-para-margin-top:1.0gd;
text-align:justify;text-justify:inter-ideograph;text-indent:24.0pt;mso-char-indent-count:
2.0;punctuation-wrap:simple"><span style="font-family:&quot;新細明體&quot;,serif;mso-ascii-font-family:
Arial;mso-hansi-font-family:Arial">奇美醫療財團法人奇美醫院精神醫學部主治醫師張俊鴻也提醒，憂鬱症是一種可以治療的疾病，並非「不知足」或「不夠堅強」。如果發現自己或身邊親友情緒低落持續超過兩週，合併失眠、食慾改變、對生活失去興趣，甚至出現自我傷害的念頭，請務必盡快尋求精神科專業協助。隨著醫學與人工智慧的與時俱進，難治型憂鬱症絕對不再走進死胡同！</span><span lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;mso-bidi-font-family:&quot;Times New Roman&quot;"><o:p></o:p></span></p>

<p align="center" class="MsoNormal" style="margin-top:12.0pt;mso-para-margin-top:
1.0gd;text-align:center;layout-grid-mode:char"><b style="mso-bidi-font-weight:
normal"><span style="font-size:16.0pt;mso-bidi-font-size:12.0pt;font-family:
&quot;微軟正黑體&quot;,sans-serif;mso-ascii-font-family:Arial;mso-hansi-font-family:Arial;
mso-bidi-font-family:Arial;color:black;mso-color-alt:windowtext;background:
#F2DBDB">奇美醫療財團法人奇美醫院精神醫學部主治醫師</span></b><b style="mso-bidi-font-weight:normal"><span style="font-size:16.0pt;mso-bidi-font-size:12.0pt;font-family:&quot;Arial&quot;,sans-serif;
mso-fareast-font-family:微軟正黑體;color:black;mso-color-alt:windowtext;background:
#F2DBDB"> </span></b><b style="mso-bidi-font-weight:normal"><span style="font-size:16.0pt;mso-bidi-font-size:12.0pt;font-family:&quot;微軟正黑體&quot;,sans-serif;
mso-ascii-font-family:Arial;mso-hansi-font-family:Arial;mso-bidi-font-family:
Arial;color:black;mso-color-alt:windowtext;background:#F2DBDB">張俊鴻</span></b><b style="mso-bidi-font-weight:normal"><span lang="EN-US" style="font-size:16.0pt;
mso-bidi-font-size:12.0pt;font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:
微軟正黑體;background:#F2DBDB"><o:p></o:p></span></b></p>

<p class="MsoNormal" style="layout-grid-mode:char"><b style="mso-bidi-font-weight:
normal"><span style="font-family:&quot;微軟正黑體&quot;,sans-serif;mso-ascii-font-family:Arial;
mso-hansi-font-family:Arial;mso-bidi-font-family:Arial">【專長】</span></b><b style="mso-bidi-font-weight:normal"><span lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;
mso-fareast-font-family:微軟正黑體"><o:p></o:p></span></b></p>

<p class="MsoListParagraph" style="text-align:justify;text-justify:inter-ideograph;
text-indent:-24.0pt;mso-list:l0 level1 lfo1;layout-grid-mode:char"><!--[if !supportLists]--><span lang="EN-US" style="font-family:Wingdings;mso-fareast-font-family:Wingdings;
mso-bidi-font-family:Wingdings"><span style="mso-list:Ignore">l<span style="font:7.0pt &quot;Times New Roman&quot;">&nbsp;&nbsp; </span></span></span><!--[endif]--><span style="font-family:&quot;微軟正黑體&quot;,sans-serif;mso-ascii-font-family:Arial;mso-hansi-font-family:
Arial">非侵入性腦刺激治療：經顱磁刺激</span><span lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;
mso-fareast-font-family:微軟正黑體;mso-bidi-font-family:新細明體">(rTMS</span><span style="font-family:&quot;微軟正黑體&quot;,sans-serif;mso-ascii-font-family:Arial;mso-hansi-font-family:
Arial">／</span><span lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;
mso-fareast-font-family:微軟正黑體;mso-bidi-font-family:新細明體">TBS)</span><span style="font-family:&quot;微軟正黑體&quot;,sans-serif;mso-ascii-font-family:Arial;mso-hansi-font-family:
Arial">、大腦微電流刺激</span><span lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;
mso-fareast-font-family:微軟正黑體;mso-bidi-font-family:新細明體">(CES)</span><span style="font-family:&quot;微軟正黑體&quot;,sans-serif;mso-ascii-font-family:Arial;mso-hansi-font-family:
Arial">、經顱光生物調節治療</span><span lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;
mso-fareast-font-family:微軟正黑體;mso-bidi-font-family:新細明體">(tPBM)<o:p></o:p></span></p>

<p class="MsoListParagraph" style="text-align:justify;text-justify:inter-ideograph;
text-indent:-24.0pt;mso-list:l0 level1 lfo1;layout-grid-mode:char"><!--[if !supportLists]--><span lang="EN-US" style="font-family:Wingdings;mso-fareast-font-family:Wingdings;
mso-bidi-font-family:Wingdings"><span style="mso-list:Ignore">l<span style="font:7.0pt &quot;Times New Roman&quot;">&nbsp;&nbsp; </span></span></span><!--[endif]--><span style="font-family:&quot;微軟正黑體&quot;,sans-serif;mso-ascii-font-family:Arial;mso-hansi-font-family:
Arial">精準精神醫學與腦科學：腦波評估、自律神經檢查</span><span lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;
mso-fareast-font-family:微軟正黑體;mso-bidi-font-family:新細明體">HRV</span><span style="font-family:&quot;微軟正黑體&quot;,sans-serif;mso-ascii-font-family:Arial;mso-hansi-font-family:
Arial">、人工智慧輔助精神醫學研究</span><span lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;
mso-fareast-font-family:微軟正黑體;mso-bidi-font-family:新細明體"><o:p></o:p></span></p>

<p class="MsoListParagraph" style="text-align:justify;text-justify:inter-ideograph;
text-indent:-24.0pt;mso-list:l0 level1 lfo1;layout-grid-mode:char"><!--[if !supportLists]--><span lang="EN-US" style="font-family:Wingdings;mso-fareast-font-family:Wingdings;
mso-bidi-font-family:Wingdings"><span style="mso-list:Ignore">l<span style="font:7.0pt &quot;Times New Roman&quot;">&nbsp;&nbsp; </span></span></span><!--[endif]--><span style="font-family:&quot;微軟正黑體&quot;,sans-serif;mso-ascii-font-family:Arial;mso-hansi-font-family:
Arial">情緒障礙治療：難治型憂鬱症、躁鬱症、焦慮症、強迫症、創傷後壓力症候群</span><span lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:微軟正黑體;mso-bidi-font-family:
新細明體">(PTSD)<o:p></o:p></span></p>

<p class="MsoListParagraph" style="text-align:justify;text-justify:inter-ideograph;
text-indent:-24.0pt;mso-list:l0 level1 lfo1;layout-grid-mode:char"><!--[if !supportLists]--><span lang="EN-US" style="font-family:Wingdings;mso-fareast-font-family:Wingdings;
mso-bidi-font-family:Wingdings"><span style="mso-list:Ignore">l<span style="font:7.0pt &quot;Times New Roman&quot;">&nbsp;&nbsp; </span></span></span><!--[endif]--><span style="font-family:&quot;微軟正黑體&quot;,sans-serif;mso-ascii-font-family:Arial;mso-hansi-font-family:
Arial">睡眠與身心醫學：失眠症、自律神經失調、壓力調適與身心症狀治療</span><span lang="EN-US" style="font-family:
&quot;Arial&quot;,sans-serif;mso-fareast-font-family:微軟正黑體;mso-bidi-font-family:新細明體"><o:p></o:p></span></p>

<p class="MsoListParagraph" style="text-align:justify;text-justify:inter-ideograph;
text-indent:-24.0pt;mso-list:l0 level1 lfo1;layout-grid-mode:char"><!--[if !supportLists]--><span lang="EN-US" style="font-family:Wingdings;mso-fareast-font-family:Wingdings;
mso-bidi-font-family:Wingdings"><span style="mso-list:Ignore">l<span style="font:7.0pt &quot;Times New Roman&quot;">&nbsp;&nbsp; </span></span></span><!--[endif]--><span style="font-family:&quot;微軟正黑體&quot;,sans-serif;mso-ascii-font-family:Arial;mso-hansi-font-family:
Arial">一般精神醫學與神經精神疾患：思覺失調症、失智症、腦傷後精神與認知功能障礙。</span><span lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:微軟正黑體;mso-bidi-font-family:
新細明體"><o:p></o:p></span></p>

<p class="MsoNormal" style="text-align:justify;text-justify:inter-ideograph;
layout-grid-mode:char"><b style="mso-bidi-font-weight:normal"><span style="font-family:&quot;微軟正黑體&quot;,sans-serif;mso-ascii-font-family:Arial;mso-hansi-font-family:
Arial;mso-bidi-font-family:Arial">【門診時間】</span></b><b style="mso-bidi-font-weight:
normal"><span lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:
微軟正黑體"><o:p></o:p></span></b></p>

<div align="center">
<table border="1" cellpadding="0" cellspacing="0" class="MsoTableGrid" style="border-collapse:collapse;mso-table-layout-alt:fixed;border:none;
 mso-border-alt:solid windowtext .5pt;mso-yfti-tbllook:1184;mso-padding-alt:
 0cm 5.4pt 0cm 5.4pt" width="554">
	<tbody>
		<tr style="mso-yfti-irow:0;mso-yfti-firstrow:yes">
			<td style="width:59.65pt;border:solid windowtext 1.0pt;mso-border-alt:
  solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt" width="80">
			<p align="center" class="MsoNormal" style="text-align:center;layout-grid-mode:
  char"><span style="font-family:&quot;微軟正黑體&quot;,sans-serif;mso-ascii-font-family:Arial;
  mso-hansi-font-family:Arial;mso-bidi-font-family:Arial">星期</span><span lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:
  微軟正黑體"><o:p></o:p></span></p>
			</td>
			<td style="width:59.65pt;border:solid windowtext 1.0pt;border-left:
  none;mso-border-left-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt;
  padding:0cm 5.4pt 0cm 5.4pt" width="80">
			<p align="center" class="MsoNormal" style="text-align:center;layout-grid-mode:
  char"><span style="font-family:&quot;微軟正黑體&quot;,sans-serif;mso-ascii-font-family:Arial;
  mso-hansi-font-family:Arial;mso-bidi-font-family:Arial">一</span><span lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:
  微軟正黑體"><o:p></o:p></span></p>
			</td>
			<td style="width:59.6pt;border:solid windowtext 1.0pt;border-left:
  none;mso-border-left-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt;
  padding:0cm 5.4pt 0cm 5.4pt" width="79">
			<p align="center" class="MsoNormal" style="text-align:center;layout-grid-mode:
  char"><span style="font-family:&quot;微軟正黑體&quot;,sans-serif;mso-ascii-font-family:Arial;
  mso-hansi-font-family:Arial;mso-bidi-font-family:Arial">二</span><span lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:
  微軟正黑體"><o:p></o:p></span></p>
			</td>
			<td style="width:59.6pt;border:solid windowtext 1.0pt;border-left:
  none;mso-border-left-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt;
  padding:0cm 5.4pt 0cm 5.4pt" width="79">
			<p align="center" class="MsoNormal" style="text-align:center;layout-grid-mode:
  char"><span style="font-family:&quot;微軟正黑體&quot;,sans-serif;mso-ascii-font-family:Arial;
  mso-hansi-font-family:Arial;mso-bidi-font-family:Arial">三</span><span lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:
  微軟正黑體"><o:p></o:p></span></p>
			</td>
			<td style="width:59.6pt;border:solid windowtext 1.0pt;border-left:
  none;mso-border-left-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt;
  padding:0cm 5.4pt 0cm 5.4pt" width="79">
			<p align="center" class="MsoNormal" style="text-align:center;layout-grid-mode:
  char"><span style="font-family:&quot;微軟正黑體&quot;,sans-serif;mso-ascii-font-family:Arial;
  mso-hansi-font-family:Arial;mso-bidi-font-family:Arial">四</span><span lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:
  微軟正黑體"><o:p></o:p></span></p>
			</td>
			<td style="width:59.6pt;border:solid windowtext 1.0pt;border-left:
  none;mso-border-left-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt;
  padding:0cm 5.4pt 0cm 5.4pt" width="79">
			<p align="center" class="MsoNormal" style="text-align:center;layout-grid-mode:
  char"><span style="font-family:&quot;微軟正黑體&quot;,sans-serif;mso-ascii-font-family:Arial;
  mso-hansi-font-family:Arial;mso-bidi-font-family:Arial">五</span><span lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:
  微軟正黑體"><o:p></o:p></span></p>
			</td>
			<td style="width:57.65pt;border:solid windowtext 1.0pt;border-left:
  none;mso-border-left-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt;
  padding:0cm 5.4pt 0cm 5.4pt" width="77">
			<p align="center" class="MsoNormal" style="text-align:center;layout-grid-mode:
  char"><span style="font-family:&quot;微軟正黑體&quot;,sans-serif;mso-ascii-font-family:Arial;
  mso-hansi-font-family:Arial;mso-bidi-font-family:Arial">六</span><span lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:
  微軟正黑體"><o:p></o:p></span></p>
			</td>
		</tr>
		<tr style="mso-yfti-irow:1">
			<td style="width:59.65pt;border:solid windowtext 1.0pt;border-top:
  none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt;
  padding:0cm 5.4pt 0cm 5.4pt" width="80">
			<p align="center" class="MsoNormal" style="text-align:center;layout-grid-mode:
  char"><span style="font-family:&quot;微軟正黑體&quot;,sans-serif;mso-ascii-font-family:Arial;
  mso-hansi-font-family:Arial;mso-bidi-font-family:Arial">上午</span><span lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:
  微軟正黑體"><o:p></o:p></span></p>
			</td>
			<td style="width:59.65pt;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt" width="80">
			<p align="center" class="MsoNormal" style="text-align:center;layout-grid-mode:
  char"><span lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:
  微軟正黑體"><o:p>&nbsp;</o:p></span></p>
			</td>
			<td style="width:59.6pt;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;mso-border-top-alt:
  solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;mso-border-alt:
  solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt" width="79">
			<p align="center" class="MsoNormal" style="text-align:center;layout-grid-mode:
  char"><span lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:
  微軟正黑體"><o:p>&nbsp;</o:p></span></p>
			</td>
			<td style="width:59.6pt;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;mso-border-top-alt:
  solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;mso-border-alt:
  solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt" width="79">
			<p align="center" class="MsoNormal" style="text-align:center;layout-grid-mode:
  char"><span style="font-family:&quot;微軟正黑體&quot;,sans-serif;mso-ascii-font-family:Arial;
  mso-hansi-font-family:Arial;mso-bidi-font-family:Arial">●</span><span lang="EN-US" style="font-size:10.0pt;mso-bidi-font-size:12.0pt;font-family:
  &quot;Arial&quot;,sans-serif;mso-fareast-font-family:微軟正黑體">(</span><span style="font-size:10.0pt;mso-bidi-font-size:12.0pt;font-family:&quot;微軟正黑體&quot;,sans-serif;
  mso-ascii-font-family:Arial;mso-hansi-font-family:Arial;mso-bidi-font-family:
  Arial">樹林</span><span lang="EN-US" style="font-size:10.0pt;mso-bidi-font-size:
  12.0pt;font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:微軟正黑體">)</span><span lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:
  微軟正黑體"><o:p></o:p></span></p>
			</td>
			<td style="width:59.6pt;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;mso-border-top-alt:
  solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;mso-border-alt:
  solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt" width="79">
			<p align="center" class="MsoNormal" style="text-align:center;layout-grid-mode:
  char"><span lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:
  微軟正黑體"><o:p>&nbsp;</o:p></span></p>
			</td>
			<td style="width:59.6pt;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;mso-border-top-alt:
  solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;mso-border-alt:
  solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt" width="79">
			<p align="center" class="MsoNormal" style="text-align:center;layout-grid-mode:
  char"><span lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:
  微軟正黑體"><o:p>&nbsp;</o:p></span></p>
			</td>
			<td style="width:57.65pt;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt" width="77">
			<p align="center" class="MsoNormal" style="text-align:center;layout-grid-mode:
  char"><span lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:
  微軟正黑體"><o:p>&nbsp;</o:p></span></p>
			</td>
		</tr>
		<tr style="mso-yfti-irow:2">
			<td style="width:59.65pt;border:solid windowtext 1.0pt;border-top:
  none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt;
  padding:0cm 5.4pt 0cm 5.4pt" width="80">
			<p align="center" class="MsoNormal" style="text-align:center;layout-grid-mode:
  char"><span style="font-family:&quot;微軟正黑體&quot;,sans-serif;mso-ascii-font-family:Arial;
  mso-hansi-font-family:Arial;mso-bidi-font-family:Arial">下午</span><span lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:
  微軟正黑體"><o:p></o:p></span></p>
			</td>
			<td style="width:59.65pt;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt" width="80">
			<p align="center" class="MsoNormal" style="text-align:center;layout-grid-mode:
  char"><span style="font-family:&quot;微軟正黑體&quot;,sans-serif;mso-ascii-font-family:Arial;
  mso-hansi-font-family:Arial;mso-bidi-font-family:Arial">●</span><span lang="EN-US" style="font-size:10.0pt;mso-bidi-font-size:12.0pt;font-family:
  &quot;Arial&quot;,sans-serif;mso-fareast-font-family:微軟正黑體">(</span><span style="font-size:10.0pt;mso-bidi-font-size:12.0pt;font-family:&quot;微軟正黑體&quot;,sans-serif;
  mso-ascii-font-family:Arial;mso-hansi-font-family:Arial;mso-bidi-font-family:
  Arial">佳里</span><span lang="EN-US" style="font-size:10.0pt;mso-bidi-font-size:
  12.0pt;font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:微軟正黑體">)</span><span lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:
  微軟正黑體"><o:p></o:p></span></p>
			</td>
			<td style="width:59.6pt;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;mso-border-top-alt:
  solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;mso-border-alt:
  solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt" width="79">
			<p align="center" class="MsoNormal" style="text-align:center;layout-grid-mode:
  char"><span lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:
  微軟正黑體"><o:p>&nbsp;</o:p></span></p>
			</td>
			<td style="width:59.6pt;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;mso-border-top-alt:
  solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;mso-border-alt:
  solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt" width="79">
			<p align="center" class="MsoNormal" style="text-align:center;layout-grid-mode:
  char"><span lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:
  微軟正黑體"><o:p>&nbsp;</o:p></span></p>
			</td>
			<td style="width:59.6pt;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;mso-border-top-alt:
  solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;mso-border-alt:
  solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt" width="79">
			<p align="center" class="MsoNormal" style="text-align:center;layout-grid-mode:
  char"><span lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:
  微軟正黑體"><o:p>&nbsp;</o:p></span></p>
			</td>
			<td style="width:59.6pt;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;mso-border-top-alt:
  solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;mso-border-alt:
  solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt" width="79">
			<p align="center" class="MsoNormal" style="text-align:center;layout-grid-mode:
  char"><span style="font-family:&quot;微軟正黑體&quot;,sans-serif;mso-ascii-font-family:Arial;
  mso-hansi-font-family:Arial;mso-bidi-font-family:Arial">●</span><span lang="EN-US" style="font-size:10.0pt;mso-bidi-font-size:12.0pt;font-family:
  &quot;Arial&quot;,sans-serif;mso-fareast-font-family:微軟正黑體">(</span><span style="font-size:10.0pt;mso-bidi-font-size:12.0pt;font-family:&quot;微軟正黑體&quot;,sans-serif;
  mso-ascii-font-family:Arial;mso-hansi-font-family:Arial;mso-bidi-font-family:
  Arial">柳營</span><span lang="EN-US" style="font-size:10.0pt;mso-bidi-font-size:
  12.0pt;font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:微軟正黑體">)</span><span lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:
  微軟正黑體"><o:p></o:p></span></p>
			</td>
			<td style="width:57.65pt;border:none;mso-border-top-alt:solid windowtext .5pt;
  mso-border-left-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt" width="77">
			<p align="center" class="MsoNormal" style="text-align:center;layout-grid-mode:
  char"><span lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:
  微軟正黑體"><o:p>&nbsp;</o:p></span></p>
			</td>
		</tr>
		<tr style="mso-yfti-irow:3;mso-yfti-lastrow:yes">
			<td style="width:59.65pt;border:solid windowtext 1.0pt;border-top:
  none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt;
  padding:0cm 5.4pt 0cm 5.4pt" width="80">
			<p align="center" class="MsoNormal" style="text-align:center;layout-grid-mode:
  char"><span style="font-family:&quot;微軟正黑體&quot;,sans-serif;mso-ascii-font-family:Arial;
  mso-hansi-font-family:Arial;mso-bidi-font-family:Arial">晚上</span><span lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:
  微軟正黑體"><o:p></o:p></span></p>
			</td>
			<td style="width:59.65pt;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt" width="80">
			<p align="center" class="MsoNormal" style="text-align:center;layout-grid-mode:
  char"><span lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:
  微軟正黑體"><o:p>&nbsp;</o:p></span></p>
			</td>
			<td style="width:59.6pt;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;mso-border-top-alt:
  solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;mso-border-alt:
  solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt" width="79">
			<p align="center" class="MsoNormal" style="text-align:center;layout-grid-mode:
  char"><span style="font-family:&quot;微軟正黑體&quot;,sans-serif;mso-ascii-font-family:Arial;
  mso-hansi-font-family:Arial;mso-bidi-font-family:Arial">●</span><span lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:
  微軟正黑體"><o:p></o:p></span></p>
			</td>
			<td style="width:59.6pt;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;mso-border-top-alt:
  solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;mso-border-alt:
  solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt" width="79">
			<p align="center" class="MsoNormal" style="text-align:center;layout-grid-mode:
  char"><span lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:
  微軟正黑體"><o:p>&nbsp;</o:p></span></p>
			</td>
			<td style="width:59.6pt;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;mso-border-top-alt:
  solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;mso-border-alt:
  solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt" width="79">
			<p align="center" class="MsoNormal" style="text-align:center;layout-grid-mode:
  char"><span lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:
  微軟正黑體"><o:p>&nbsp;</o:p></span></p>
			</td>
			<td style="width:59.6pt;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;mso-border-top-alt:
  solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;mso-border-alt:
  solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt" width="79">
			<p align="center" class="MsoNormal" style="text-align:center;layout-grid-mode:
  char"><span lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:
  微軟正黑體"><o:p>&nbsp;</o:p></span></p>
			</td>
			<td style="width:57.65pt;border:none;mso-border-left-alt:solid windowtext .5pt;
  padding:0cm 5.4pt 0cm 5.4pt" width="77">
			<p align="center" class="MsoNormal" style="text-align:center;layout-grid-mode:
  char"><span lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:
  微軟正黑體"><o:p>&nbsp;</o:p></span></p>
			</td>
		</tr>
	</tbody>
</table>
</div>

<div style="mso-element:para-border-div;border:none black 1.0pt;mso-border-alt:
none black 0cm;padding:0cm 0cm 0cm 0cm">
<p class="MsoNormal" style="line-height:18.0pt;mso-line-height-rule:exactly;
border:none;mso-border-alt:none black 0cm;padding:0cm;mso-padding-alt:0cm 0cm 0cm 0cm"><span lang="EN-US" style="font-family:&quot;微軟正黑體&quot;,sans-serif;mso-bidi-font-family:微軟正黑體"><o:p>&nbsp;</o:p></span></p>
</div>

<p class="MsoNormal" style="line-height:16.0pt;mso-line-height-rule:exactly"><span lang="EN-US" style="font-size:20.0pt;mso-bidi-font-size:14.0pt;font-family:&quot;Arial&quot;,sans-serif;
mso-fareast-font-family:標楷體;mso-bidi-font-family:&quot;Times New Roman&quot;"><o:p>&nbsp;</o:p></span></p>

<div style="mso-element:footnote-list"><!--[if !supportFootnotes]-->
<hr align="left" size="1" width="33%" /><!--[endif]-->
<div id="ftn1" style="mso-element:footnote">
<p class="MsoFootnoteText" style="text-align:justify;text-justify:inter-ideograph"><b style="mso-bidi-font-weight:normal"><span style="font-size:8.0pt;mso-bidi-font-size:
10.0pt;font-family:&quot;微軟正黑體&quot;,sans-serif;mso-ascii-font-family:Arial;mso-hansi-font-family:
Arial">參考文獻｜</span></b><b style="mso-bidi-font-weight:normal"><span lang="EN-US" style="font-size:8.0pt;mso-bidi-font-size:10.0pt;font-family:&quot;Arial&quot;,sans-serif;
mso-fareast-font-family:微軟正黑體;mso-bidi-font-family:&quot;Times New Roman&quot;"><o:p></o:p></span></b></p>

<p class="MsoFootnoteText" style="text-align:justify;text-justify:inter-ideograph"><span class="MsoFootnoteReference"><span lang="EN-US" style="font-size:8.0pt;mso-bidi-font-size:
10.0pt;font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:微軟正黑體;mso-bidi-font-family:
&quot;Times New Roman&quot;"><span style="mso-special-character:footnote"><!--[if !supportFootnotes]--><span class="MsoFootnoteReference"><span lang="EN-US" style="font-size:8.0pt;mso-bidi-font-size:
10.0pt;font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:微軟正黑體;mso-bidi-font-family:
&quot;Times New Roman&quot;;mso-font-kerning:1.0pt;mso-ansi-language:EN-US;mso-fareast-language:
ZH-TW;mso-bidi-language:AR-SA">[1]</span></span><!--[endif]--></span></span></span><span lang="EN-US" style="font-size:8.0pt;mso-bidi-font-size:10.0pt;font-family:&quot;Arial&quot;,sans-serif;
mso-fareast-font-family:微軟正黑體;mso-bidi-font-family:&quot;Times New Roman&quot;"> Chang C-H, Hsia Y-D, Liu W-C, Lin C-H, Ying J and Tsai H-C (2026) Case Report: Intranasal esketamine and accelerated intermittent theta-burst stimulation for severe treatment-resistant depression with suicidal ideation. Front. Psychiatry 17:1837402. doi: 10.3389/fpsyt.2026.1837402</span><span lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:微軟正黑體;mso-bidi-font-family:
&quot;Times New Roman&quot;"><o:p></o:p></span></p>
</div>
</div>
<!--EndFragment-->]]></content:encoded>
<link>https://www.cnma.org.tw/page/news/show.aspx?num=52985</link>
<pubDate>Mon, 03 Aug 2026 00:00:00 GMT</pubDate>
<category>健康醫療</category>
<enclosure url="https://www.cnma.org.tw/upload/news/202608030935260.jpg" />
</item>
<item>
<title><![CDATA[微創兼精準！成大醫口腔顎面外科手術再升級]]></title>
<description><![CDATA[<span style="font-size:22px;">記者黃冠源/台南報導 &nbsp; &nbsp; &nbsp; &nbsp; 口腔、顎骨及顏面疾病種類繁多，常影響患者的進食與容貌。成大醫院口腔醫學部王盛弘醫師指出，隨著醫療科技進展，成大醫院口腔顎面外科持續引進新技術與新設備，全面推動「微創」與「精準」醫療，積極提升手術成功率、降低術後併發症，並大幅減輕患者的術後不適。<br />
<...…]]></description>
<content:encoded><![CDATA[<span style="font-size:22px;">記者黃冠源/台南報導 &nbsp; &nbsp; &nbsp; &nbsp; 口腔、顎骨及顏面疾病種類繁多，常影響患者的進食與容貌。成大醫院口腔醫學部王盛弘醫師指出，隨著醫療科技進展，成大醫院口腔顎面外科持續引進新技術與新設備，全面推動「微創」與「精準」醫療，積極提升手術成功率、降低術後併發症，並大幅減輕患者的術後不適。<br />
<img alt="" src="https://www.cnma.org.tw/upload/web/img_2302(2).jpeg" /><br />
<br />
微創唾液腺內視鏡：2毫米微創傷口 隔日即可出院32歲的江先生，近兩個月來左側頸部在進食後常反覆腫痛，經檢查診斷為「唾液腺結石」。王盛弘醫師解釋，唾液腺導管開口僅約1至2毫米，結石會阻塞唾液排出導致發炎。傳統手術需在頸部或口內切開約3公分的傷口，嚴重者甚至得切除整個唾液腺，並住院觀察3至4天。而成大醫院目前發展的「唾液腺內視鏡取石手術」，僅需在口內切開約2至3毫米的微小傷口，即可利用取石網精準取出結石。此技術不僅能完整保留唾液腺的正常分泌功能，更能顯著降低術後疼痛，多數患者在手術隔日即可出院。目前院內已有多位醫師熟練運用此技術，臨床成效良好。<br />
<br />
<img alt="" src="https://www.cnma.org.tw/upload/web/IMG_2300(2).jpeg" /><br />
術中即時電腦斷層：精準對稱重建 避免二次手術風險另一位48歲的唐先生，因車禍導致顱內出血、肋骨骨折及嚴重的顏面骨併右眼眶底骨折，出現複視、眼球內陷及咬合改變等症狀。這類手術需將受壓迫的眼眶軟組織復位，並植入鈦金屬骨板進行重建。王盛弘醫師表示，傳統重建手術主要仰賴術前影像與醫師個人經驗。若術後發現植入位置不夠理想，患者往往必須再次開刀調整。為了打破此局限，成大醫院特別引進「術中即時電腦斷層（CT）」設備。以唐先生為例，醫療團隊在術中植入鈦板後，隨即在手術室內進行即時電腦斷層掃描。透過最新影像，團隊當場確認雙側眼眶底的對稱性，並依據畫面精細微調鈦板位置，確保重建結果與術前規劃完全契合。唐先生術後恢復極佳，困擾的複視與眼球轉動受限症狀，在術後兩週內已完全改善，順利重拾正常生活。持續精進醫療品質 守護民眾口腔顏面健康王盛弘醫師強調，科技的進步讓醫療能做到更小傷口、更高精準度。成大醫院口腔顎面外科團隊將持續掌握國際科技發展趨勢，導先進設備，讓每位患者都能享有高品質、低痛苦的精準治療服務。</span>]]></content:encoded>
<link>https://www.cnma.org.tw/page/news/show.aspx?num=52864</link>
<pubDate>Fri, 24 Jul 2026 00:00:00 GMT</pubDate>
<category>健康醫療</category>
<enclosure url="https://www.cnma.org.tw/upload/news/202607241537380.jpeg" />
</item>
<item>
<title><![CDATA[4成失智患者有糖尿病 醫籲控血糖護腦]]></title>
<description><![CDATA[<span style="font-size:20px;">記者陳秋蘭/健康醫療報導<br />
<br />
<br />
失智症不只是老化造成，恐怕與血糖控制息息相關。衛生福利部新營醫院失智症共同照護中心分析152名失智症個案發現，約有4成患者合併糖尿病，顯示代謝異常已成為影響腦部健康的重要危險因子。<br />
<img alt="" src="https://www.cnma.or...…]]></description>
<content:encoded><![CDATA[<span style="font-size:20px;">記者陳秋蘭/健康醫療報導<br />
<br />
<br />
失智症不只是老化造成，恐怕與血糖控制息息相關。衛生福利部新營醫院失智症共同照護中心分析152名失智症個案發現，約有4成患者合併糖尿病，顯示代謝異常已成為影響腦部健康的重要危險因子。<br />
<img alt="" src="https://www.cnma.org.tw/upload/web/IMG_3460(1).jpeg" /><br />
新營醫院院長莊毓民表示，近年醫界提出「第三型糖尿病」概念，指的是大腦細胞出現胰島素阻抗，使神經細胞無法有效利用能量，進而導致認知功能逐漸退化。他指出，控制血糖不僅能降低糖尿病併發症風險，也有助於保護腦部健康，減少失智症發生的可能。<br />
<br />
院方分析發現，多數失智患者在確診前，常伴隨腹部肥胖、體重增加及慢性發炎等代謝異常情形。莊毓民表示，這些並非偶然，而是長期代謝失衡對腦部造成慢性傷害的結果。<br />
<img alt="" src="https://www.cnma.org.tw/upload/web/img_3461(2).jpeg" /><br />
此外，血糖異常也可能影響大腦的「膠淋巴系統（Glymphatic System）」，這套系統會在深層睡眠時清除類澱粉蛋白等神經毒性物質。若長期血糖偏高或存在胰島素阻抗，將降低大腦排除廢物的能力，增加失智風險。<br />
<br />
新營醫院失智症共同照護中心目前提供代謝風險篩檢、認知功能評估及營養指導等整合照護服務，協助民眾及早發現風險。<br />
<br />
莊毓民呼籲，預防失智應從改善代謝健康著手，包括控制血糖、維持理想體重與腰圍、養成規律運動習慣，以及維持良好的睡眠品質，才能降低失智風險、守護腦部健康。</span>]]></content:encoded>
<link>https://www.cnma.org.tw/page/news/show.aspx?num=52801</link>
<pubDate>Wed, 22 Jul 2026 00:00:00 GMT</pubDate>
<category>健康醫療</category>
<enclosure url="https://www.cnma.org.tw/upload/news/202607221106180.jpeg" />
</item>
<item>
<title><![CDATA[中西醫攜手打造健康老化新模式　高榮跨團隊首度結合高齡周全性健康評估與中醫體質辨識]]></title>
<description><![CDATA[<p>&nbsp;</p>

<p><span style="font-size:20px;"><img alt="" src="https://www.cnma.org.tw/upload/web/IMG_8588(1).jpeg" /></span><br />
高齡醫學中心王郁鈞醫師、傳統醫學科主任邱鎮添、陳金順院長、傳統醫學科林琬羚醫師、林女士（左至右）</p>

<p><spa...…]]></description>
<content:encoded><![CDATA[<p>&nbsp;</p>

<p><span style="font-size:20px;"><img alt="" src="https://www.cnma.org.tw/upload/web/IMG_8588(1).jpeg" /></span><br />
高齡醫學中心王郁鈞醫師、傳統醫學科主任邱鎮添、陳金順院長、傳統醫學科林琬羚醫師、林女士（左至右）</p>

<p><span style="font-size:20px;">【記者唐景妍/高雄報導】<br />
高雄榮民總醫院今（21）日舉辦「中西醫結合促進健康老化」記者會，發表由傳統醫學科與高齡醫學中心跨團隊合作的最新研究成果，首度結合現代醫學的「高齡周全性健康評估（CGA）」與中醫體質辨識，期望透過跨領域整合評估，更全面掌握高齡者健康狀況，及早發現功能退化及老人症候群風險，作為健康老化整合照護的重要參考。</span><span style="font-size:20px;"><br />
本研究由高雄榮總傳統醫學科與高齡醫學中心共同完成，成果刊登於國際期刊《Archives of Gerontology and Geriatrics》。研究分析100位65歲以上長者，約六成具有「陽虛」、「陰虛」或「血瘀」等中醫體質失衡特徵，且與睡眠障礙、聽力退化、尿失禁、活動能力、生活功能及認知功能下降等老人症候群呈顯著正相關。<br />
<img alt="" src="https://www.cnma.org.tw/upload/web/IMG_8598(3).jpeg" /></span><span style="font-size:20px;"></span><span style="font-size:20px;">傳統醫學科林琬羚醫師表示，老人症候群越多，越容易出現體質失衡；具五項以上老人症候群者，體質失衡風險約增加六倍，七項以上更提高至約三十五倍。傳統醫學科主任邱鎮添醫師指出，中醫可依個人體質，透過中藥、針灸及生活型態調整，改善睡眠、疼痛等問題，並與高齡醫療團隊提供整合照護。</span><span style="font-size:20px;"><br />
高齡醫學中心王郁鈞醫師表示，現代高齡醫學重視功能維持，本研究首次結合CGA與中醫體質辨識，為健康老化提供新觀點。高齡醫學中心主任周明岳醫師指出，透過跨專業合作，可依長者需求規劃營養、復健、用藥安全、健康促進及中醫介入等個人化照護，延緩功能退化。</span></p>

<p><span style="font-size:20px;"><img alt="" src="https://www.cnma.org.tw/upload/web/IMG_8607(2).jpeg" />75歲林女士因雙膝退化接受高齡醫學與傳統醫學團隊整合照護後，膝痛改善、活動能力提升，如今外出旅行一天可步行兩萬步。院長陳金順醫師表示，高雄榮總將持續深化跨專業整合照護，結合高齡周全性健康評估與中醫體質辨識，協助長者維持生活功能與生活品質，落實健康老化。<br />
<img alt="" src="https://www.cnma.org.tw/upload/web/IMG_8596(1).jpeg" /></span></p>
<span style="font-size:20px;"></span><br />
&nbsp;]]></content:encoded>
<link>https://www.cnma.org.tw/page/news/show.aspx?num=52770</link>
<pubDate>Tue, 21 Jul 2026 00:00:00 GMT</pubDate>
<category>健康醫療</category>
<enclosure url="https://www.cnma.org.tw/upload/news/202607211237060.jpeg" />
</item>
<item>
<title><![CDATA[反覆長膿包別急著拔牙！顯微根尖手術成功率提升至94% 奇美醫院顯微設備精準清除感染病灶，爭取保留自然牙機會]]></title>
<description><![CDATA[記者:楊憲朋 台南市報導<br />
<br />
奇美醫療財團法人奇美醫院牙醫部牙髓病科主治醫師 廖怡清
<div><img src="../../upload/web/images/主講者牙醫部牙髓病科主治醫師廖怡清及其講題.jpg" /><br />
牙齦長膿近3個月消不掉！顯微鏡輔助根尖手術免拆填補物、免拔牙成功救回</div>

<div>案例一 39歲張女士因右側上顎頰側牙...…]]></description>
<content:encoded><![CDATA[記者:楊憲朋 台南市報導<br />
<br />
奇美醫療財團法人奇美醫院牙醫部牙髓病科主治醫師 廖怡清
<div><img src="../../upload/web/images/主講者牙醫部牙髓病科主治醫師廖怡清及其講題.jpg" /><br />
牙齦長膿近3個月消不掉！顯微鏡輔助根尖手術免拆填補物、免拔牙成功救回</div>

<div>案例一 39歲張女士因右側上顎頰側牙齦出現膿包已2至3個月，至奇美醫</div>

<div>療財團法人奇美醫院牙醫部牙髓病科主治醫師廖怡清門診求診。經完整評估檢查</div>

<div>後，右側上顎第二小臼齒雖然曾做過根管治療，但因為殘留細菌作怪，已經合併</div>

<div>慢性根尖膿腫。因張女士原本做的填補物邊緣密合 且先前的根管治療品質也相</div>

<div>對良好，若拆掉填補物重新治療反而可惜 經醫病溝通後，張女士決定進行顯微</div>

<div>鏡輔助根尖手術。術後定期追蹤皆無疼痛 腫脹及膿包，X光片也可以觀察到根尖</div>

<div>病變癒合良好 保住這顆珍貴的自然牙</div>

<div>假牙不密合變細菌溫床！歷經根管治療病灶仍擴大，根尖手術留住自然牙</div>

<div>案例二：『60歲蘇女士，左側上顎正中門齒因牙根尖病變，經診所轉診至奇</div>

<div>美醫醫療財團法人奇美醫院牙醫部牙髓病科主治醫師廖怡清門診就醫。經評估檢</div>

<div>查發現 該牙齒的假牙邊緣密合度不佳，根管治療不完整且牙根尖開口不規則，</div>

<div>伴隨有牙根吸收的情形。</div>

<div>為了救回這顆大門牙，廖醫師建議先拆除不密合的舊假牙 把原有的牙根進</div>

<div>行傳統非手術性根管治療 俗稱抽神經） 並套上新假牙保護；後續若效果不佳</div>

<div>，則進行手術性根管治療 即根尖手術</div>

<div>在完成傳統治療後滿一年的定期追蹤時，X光檢查發現牙根尖病變仍持續擴</div>

<div>大 為澈底根除病灶、避免走到拔牙和植牙的路，因此蘇女士接受顯微鏡輔助根</div>

<div>尖手術，並在術中取得病理檢體送驗，結果為良性的根尖囊腫。術後每半年的追</div>

<div>蹤皆無疼痛 腫脹及膿包，X光片也可以觀察到根尖病變癒合良好，讓蘇女士成功</div>

<div>留住自己最珍貴的大門牙牙根，免受拔牙之苦</div>

<div>根管治療失敗不一定只能拔牙！顯微鏡輔助讓成功率提升至94%</div>

<div>傳統根管治療（俗稱抽神經）後 牙齒仍反覆疼痛、腫脹或長膿包，難道只</div>

<div>能拔牙嗎？奇美醫療財團法人奇美醫院牙醫部牙髓病科主治醫師廖怡清指出，當</div>

<div>牙齒在接受傳統根管治療後症狀仍未改善，或因特殊狀況無法再進行傳統根管治</div>

<div>療時，可考慮接受「顯微鏡輔助根尖手術」。此項手術在門診局部麻醉下即可進</div>

<div>行，透過高達近25倍放大視野的顯微鏡，搭配超音波等器械，能直接清除牙根尖</div>

<div>周圍的感染病灶，以更微創、更精準的方式保留自然牙。根據研究顯示，傳統根</div>

<div>尖手術成功率約59%，導入顯微設備後，成功率可提升至94% 為許多面臨拔牙</div>

<div>危機的病人爭取保留自然牙的機會。</div>

<div>直接清除感染源！顯微根尖手術精準又微創</div>

<div>奇美醫療財團法人奇美醫院牙醫部牙髓病科主治醫師廖怡清解釋，牙齒的根</div>

<div>管系統十分複雜，根據研究顯示，在牙根尖0.3公分處的根管系統包含98%的根尖分叉及93%的側根管 傳統非手術性根管治療只能清潔主要根管，其他分枝則需</div>

<div>靠沖洗液或藥物來幫忙殺菌，才能將成功率達到80%至90% 若治療後仍持續疼</div>

<div>痛、感染未改善，或因特殊狀況無法接受傳統根管治療，則可能需要透過根尖手</div>

<div>術治療。</div>

<div>25倍放大視野＋逆向治療！精密顯微設備精準清除根尖感染</div>

<div>根尖手術是在門診局部麻醉下，將牙齦翻開，清除牙根尖周圍的發炎病變組</div>

<div>織，修整受感染的牙根，再從牙根末端進行逆向根管填補，直接去除感染來源。</div>

<div>手術後會開立止痛藥以及漱口水，並由醫師指導術後注意事項和口腔清潔維護方</div>

<div>式。另外在檢查治療過程中，若有取得根尖組織標本，會將其送病理切片檢查。</div>

<div>圖一：顯微根尖手術流程<img src="../../upload/web/images/牙齦長膿近3個月消不掉！顯微鏡輔助根尖手術免拆填補物、免拔牙成功救回.jpg" /></div>

<div>圖片來源：https://www.nature.com/articles/s41368-024-00334-8/figures/1</div>

<div>奇美醫療財團法人奇美醫院牙醫部牙髓病科主治醫師廖怡清指出，根尖手術</div>

<div>的操作範圍極為狹小，過去受限於肉眼視野，容易忽略牙根裂縫、隱藏根管或其</div>

<div>他感染原因。顯微鏡提供高倍率放大及充足的光線，可清楚辨識牙根斷裂、根管</div>

<div>狹縫及複雜根管結構，不僅能更精準修整牙根，也能減少不必要的骨頭移除，降</div>

<div>低手術創傷，提高治療成功率。搭配專用超音波等各項精密顯微設備及器械可產</div>

<div>生較微創的手術傷口，增加手術成功的機率。目前健保已給付大部份牙髓病手術</div>

<div>，但治療過程中所使用的特殊儀器與材料，以及在手術中為了修補骨頭凹洞而視</div>

<div>情況使用的骨粉和再生膜，仍屬部分自費項目，民眾在術前可與醫師詳細討論</div>

<div>和傳統根尖手術相比，顯微鏡輔助根尖手術多了以下的優點</div>

<div>1.良好的視野：能清楚檢視根管治療失敗的原因，例如：牙根斷裂、根管狹縫或是複雜的根管系</div>

<div>統。</div>

<div>2.減少手術中移除過多的骨頭：不再像以往為了操作視野以及手術設備受限，移除較多骨頭。</div>

<div>3.確認手術位置，減少不確定性</div>

<div>4.能更精準地針對牙根尖端進行修整與清潔。</div>

<div>5.無使用顯微設備輔助手術的成功率約為59% 有使用顯微設備輔助手術的成功率可高達94%專業術前評估不可少，全身性因素與局部性因素都要考量</div>

<div>奇美醫療財團法人奇美醫院牙醫部牙髓病科主治醫師廖怡清強調，醫療決策</div>

<div>需「量身打造」，需要牙醫師詳細完整的檢查後，針對牙齒的狀況擬定出合適的</div>

<div>治療計畫，並非所有情況都適合根尖手術。主要會從全身性與局部性兩大因素來</div>

<div>考量：</div>

<div>評估面向 具體不適合手術的狀況（禁忌症） 為何需要評估</div>

<div>全身性因素</div>

<div>（評估身體整體健康</div>

<div>）</div>

<div>未控制的全身性疾病</div>

<div>如嚴重高血壓、不穩定心臟病、控</div>

<div>制不良的糖尿病等。</div>

<div>可能在手術時引發嚴重的身體併發症。</div>

<div>凝血功能異常</div>

<div>患有血友病或長期服用抗凝血劑且</div>

<div>未經內科醫師評估停藥者。</div>

<div>手術中可能造成出血不止。</div>

<div>免疫系統嚴重低下</div>

<div>如正在接受化療、放療，或患有免</div>

<div>疫不全疾病者。</div>

<div>術後感染及傷口癒合風險較高。</div>

<div>無法配合手術者</div>

<div>如患有嚴重精神疾病、無法久躺或</div>

<div>配合局部麻醉手術者。</div>

<div>可能影響手術安全與治療進行。</div>

<div>局部性因素</div>

<div>（聚焦牙齒本身條件)</div>

<div>&nbsp;</div>

<div>牙根過短或齒槽骨吸收嚴重</div>

<div>切除根尖後，殘留的牙根太短，會導致牙齒失去</div>

<div>支持力而搖晃。</div>

<div>嚴重牙周病</div>

<div>牙齒周邊組織已廣泛破壞，即使做完根尖手術，</div>

<div>牙齒也無法長期保留。</div>

<div>牙根垂直斷裂</div>

<div>牙根若已發生裂縫，細菌會持續自裂縫滲出，此</div>

<div>時手術無法解決問題，通常必須拔牙。</div>

<div>接近重要解剖構造</div>

<div>若牙根過於靠近下顎神經管或上顎竇，手術易造</div>

<div>成神經受損或口鼻竇相通。</div>

<div>未嘗試傳統根管重新治療</div>

<div>若根管仍有機會透過常規再治療清乾淨，應優先</div>

<div>選擇非手術性的顯微根管治療。</div>

<div>術後短暫腫脹屬正常，配合定期回診 留住自然牙壽命更長久</div>

<div>與其他牙科手術相同，根尖手術後 手術區或顏面可能有疼痛及腫脹現象，</div>

<div>可透過止痛藥物 冰敷緩解 其他可能產生手術區滲血、顏面瘀青、術後感染或</div>

<div>傷口癒合不良、部分皮膚感覺麻木 牙齦退縮或形成疤痕組織等併發症 因此術</div>

<div>後應配合傷口照護指導與定期回診追蹤，就能將併發症發生機率降到最低</div>

<div>奇美醫療財團法人奇美醫院牙醫部牙髓病科主治醫師廖怡清也提醒 大多數</div>

<div>情況下，手術治療可去除或減輕病因，而保留或延長牙齒的使用壽命。精密的顯</div>

<div>微設備與生醫材料的應用，更使得上述治療步驟不再憑著牙醫師本身的經驗執行</div>

<div>，能夠直觀了解病因並解決問題，有效保留自然牙的使用壽命 奇美醫院持續響</div>

<div>應健康臺灣深耕計畫，透過智慧醫療與精準治療，提升口腔照護品質，守護民眾</div>

<div>健康與生活品質。</div>

<div>奇美醫療財團法人奇美醫院</div>

<div>牙醫部牙髓病科主治醫師 廖怡清</div>

<div>【專長】</div>

<div>顯微根管治療、牙髓病難症處理、牙髓再生術、根尖手術、牙齒漂白等。</div>

<div>【門診時間】</div>

<div>星期 一 二 三 四 五 六上午 ●(佳里) ● ●(佳里) ●(佳里) ●</div>

<div>下午 ● ●(佳里) ● ●(佳里)</div>

<div>晚上 ●</div>

<div>&nbsp;</div>]]></content:encoded>
<link>https://www.cnma.org.tw/page/news/show.aspx?num=52718</link>
<pubDate>Fri, 17 Jul 2026 00:00:00 GMT</pubDate>
<category>健康醫療</category>
<enclosure url="https://www.cnma.org.tw/upload/news/202607170852490.jpg" />
</item>
<item>
<title><![CDATA[深化醫療合作 成大斗六分院與高榮臺南分院交流整合照護成果]]></title>
<description><![CDATA[<span style="font-size:20px;">記者李宥漮/健康醫療報導<br />
<br />
<br />
面對超高齡社會來臨及腦中風患者急性治療後復健、照護銜接與返家準備需求增加，急性後期整合照護（PAC）已成為醫療體系共同關注的重要議題，高雄榮民總醫院臺南分院深耕腦中風PAC服務逾10年，累積服務近3,000名患者，並以持續精進之照護成果榮獲「2025成果卓越獎」肯定。...…]]></description>
<content:encoded><![CDATA[<span style="font-size:20px;">記者李宥漮/健康醫療報導<br />
<br />
<br />
面對超高齡社會來臨及腦中風患者急性治療後復健、照護銜接與返家準備需求增加，急性後期整合照護（PAC）已成為醫療體系共同關注的重要議題，高雄榮民總醫院臺南分院深耕腦中風PAC服務逾10年，累積服務近3,000名患者，並以持續精進之照護成果榮獲「2025成果卓越獎」肯定。成大醫院斗六分院院長何宗憲於8日率領副院長、護理部及內科、外科、復健科、家庭醫學科等跨專業團隊，自斗六南下蒞臨高榮臺南分院參訪，實地了解PAC團隊運作、照護流程及仿家屋訓練環境，雙方就急性後期照護模式進行經驗交流。<br />
<img alt="" src="https://www.cnma.org.tw/upload/web/IMG_3061(1).jpeg" /><br />
此次參訪成員涵蓋院級主管、護理及多個臨床科別，顯示PAC照護已不僅是單一科別服務，而是橫跨急性治療、復健介入、護理照護、出院準備及社區銜接的整合性照護工作。參訪過程中，雙方針對中風患者轉銜流程、跨專業團隊合作、家屬照護支持、返家準備及後續社區資源銜接等議題深入討論，期望透過院際交流，持續精進急性後期照護服務品質。<br />
<img alt="" src="https://www.cnma.org.tw/upload/web/IMG_3059(1).jpeg" /><br />
<img alt="" src="https://www.cnma.org.tw/upload/web/img_3060(2).jpeg" /><br />
高榮臺南分院院長鄭名芳表示，PAC服務的核心是以病人重返家庭與社區為目標的整體照護規劃，本院整合復健科、內科、外科、傳統醫學科、高齡醫學科、護理部及個案管理等跨專業團隊，串連急性期轉銜、住院復健、出院準備與社區照護資源，協助病人把握黃金復原期，提升生活自理能力，並減輕家屬照顧負擔。<br />
<br />
復健科主治醫師兼主任王一舟指出，中風患者離院後能否安全回家並重新適應日常生活，是急性後期照護的重要關鍵。高榮臺南分院打造接近真實居家情境的「仿家屋訓練」空間，讓患者在治療師陪同下練習起身、移位、步行、如廁、用餐及家中動線移動等日常活動，並邀請照顧者共同參與，學習正確扶持技巧、輔具使用及居家環境安全注意事項，使院內復健成果能延伸至實際生活，提升患者返家後的安全感與照護信心。<br />
<br />
高榮臺南分院表示，此次成大醫院斗六分院跨專業團隊來訪，促進兩院在PAC照護模式、跨專業合作及返家銜接服務上的交流。未來本院將持續深化急性後期整合照護，推動智能神經復健設備導入與照護流程優化，讓更多病患在專業且溫暖的陪伴下，順利走過復原歷程，重返家庭與社區。</span>]]></content:encoded>
<link>https://www.cnma.org.tw/page/news/show.aspx?num=52577</link>
<pubDate>Thu, 09 Jul 2026 00:00:00 GMT</pubDate>
<category>健康醫療</category>
<enclosure url="https://www.cnma.org.tw/upload/news/202607091806540.jpeg" />
</item>
<item>
<title><![CDATA[耳朵突然聽不見！學測考生耳中風 72小時搶回聽力]]></title>
<description><![CDATA[<span style="font-size:20px;">記者黃士軒/健康醫療報導<br />
<br />
<br />
面對考季壓力，不少考生將身體不適視為疲勞或壓力反應而選擇忍耐。然而，耳鳴、耳悶或聽力突然下降，可能並非單純疲勞所致，而是俗稱「耳中風」的突發性警訊。國軍臺中總醫院近日分享一名高三鄧姓考生的治療案例，患者在發病後及時就醫，把握黃金治療期接受藥物合併高壓氧治療，72小時內...…]]></description>
<content:encoded><![CDATA[<span style="font-size:20px;">記者黃士軒/健康醫療報導<br />
<br />
<br />
面對考季壓力，不少考生將身體不適視為疲勞或壓力反應而選擇忍耐。然而，耳鳴、耳悶或聽力突然下降，可能並非單純疲勞所致，而是俗稱「耳中風」的突發性警訊。國軍臺中總醫院近日分享一名高三鄧姓考生的治療案例，患者在發病後及時就醫，把握黃金治療期接受藥物合併高壓氧治療，72小時內聽力明顯恢復，順利重返備考生活。<br />
<img alt="" src="https://www.cnma.org.tw/upload/web/IMG_3092(1).jpeg" /><br />
鄧同學於年初備戰學測期間，某週末返家途中突然出現右側耳鳴，起初以為是行經山區道路造成耳壓變化所致，因此未特別在意。然而到了當天下午，耳鳴症狀不僅沒有緩解，反而症狀持續加劇，並伴隨明顯聽力下降及身體不適等情形。經區域聽力中心檢查確認右耳聽力異常下降，家屬隨即陪同前往國軍臺中總醫院急診就醫。<br />
<br />
急診團隊評估後，研判為俗稱「耳中風」的突發性耳聾，立即啟動綠色通道轉介耳鼻喉科進行專科診治。耳鼻喉科主任賴文森醫師表示，鄧同學的臨床表現符合典型突發性耳聾，是一種耳科急症，常與病毒感染、內耳血液循環不良、組織缺氧或發炎反應有關。<br />
<br />
賴文森醫師指出，突發性耳聾的治療關鍵在於「與時間賽跑」。若錯過黃金治療期，可能造成聽神經不可逆損傷，甚至留下永久性聽力障礙。尤其考生在備考期間常因作息不規律、精神壓力大，容易忽略身體發出的警訊；一旦出現單側耳鳴、耳悶或聽力異常，應儘速就醫，不宜自行觀察過久。<br />
<br />
賴文森醫師說，聽力圖顯示患者右耳臨床症狀符合三天內連續三個頻率聽力落差逾30分貝的診斷標準，稱之為突發性聽力障礙。為提高聽力恢復機會，第一時間啟動複合式治療方案，除了第一時間給予高劑量類固醇藥物，減輕內耳發炎與腫脹外，也同步安排耳內類固醇注射及密集高壓氧療程，多管齊下搶救聽力。高壓氧療程以每日兩次方式進行，藉由提高血液含氧量，改善內耳缺氧與循環不良情形，協助受損聽覺細胞修復。<br />
<br />
在藥物與高壓氧治療同步介入下，鄧同學的恢復情況相當理想。接受兩天密集治療後，惱人的耳鳴與不適感已大幅緩解；持續治療至第三天，臨床聽力評估顯示恢復狀況良好，成功在72小時內扭轉聽力惡化危機，讓原本擔心影響學測準備的鄧同學終於放下心中大石，並於第六天順利出院。<br />
<br />
賴文森醫師提醒，若突然出現單側耳鳴、耳悶、聽力下降，或伴隨暈眩、噁心等症狀，應立即就醫，把握黃金治療期，才能有效降低永久性聽力受損風險。尤其考生在備考期間常因課業壓力與作息改變而忽略身體警訊，更應提高警覺，切勿輕忽任何突如其來的聽力異常，以免錯失治療時機，影響未來生活品質。</span>]]></content:encoded>
<link>https://www.cnma.org.tw/page/news/show.aspx?num=52588</link>
<pubDate>Thu, 09 Jul 2026 00:00:00 GMT</pubDate>
<category>健康醫療</category>
<enclosure url="https://www.cnma.org.tw/upload/news/202607091836150.jpeg" />
</item>


</channel>
</rss>
